US20190336198A1 - Systems, devices, and methods for ablation using surgical clamps - Google Patents
Systems, devices, and methods for ablation using surgical clamps Download PDFInfo
- Publication number
- US20190336198A1 US20190336198A1 US15/970,404 US201815970404A US2019336198A1 US 20190336198 A1 US20190336198 A1 US 20190336198A1 US 201815970404 A US201815970404 A US 201815970404A US 2019336198 A1 US2019336198 A1 US 2019336198A1
- Authority
- US
- United States
- Prior art keywords
- electrodes
- electrode
- jaw
- tissue
- spaced apart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B18/1233—Generators therefor with circuits for assuring patient safety
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/25—Bioelectric electrodes therefor
- A61B5/279—Bioelectric electrodes therefor specially adapted for particular uses
- A61B5/28—Bioelectric electrodes therefor specially adapted for particular uses for electrocardiography [ECG]
- A61B5/283—Invasive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1442—Probes having pivoting end effectors, e.g. forceps
- A61B18/1445—Probes having pivoting end effectors, e.g. forceps at the distal end of a shaft, e.g. forceps or scissors at the end of a rigid rod
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00577—Ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00613—Irreversible electroporation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00702—Power or energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/124—Generators therefor switching the output to different electrodes, e.g. sequentially
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/128—Generators therefor generating two or more frequencies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1405—Electrodes having a specific shape
- A61B2018/144—Wire
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1442—Probes having pivoting end effectors, e.g. forceps
- A61B2018/145—Probes having pivoting end effectors, e.g. forceps wherein the effectors remain parallel during closing and opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1442—Probes having pivoting end effectors, e.g. forceps
- A61B2018/1462—Tweezers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1467—Probes or electrodes therefor using more than two electrodes on a single probe
Definitions
- the embodiments described herein relate generally to medical devices for therapeutic electrical energy delivery, and more particularly to a surgical clamp device for delivering electrical energy to ablate tissue.
- the electroporation is irreversible and the pores remain open, permitting exchange of material across the membrane and leading to necrosis and/or apoptosis (cell death). Subsequently the tissue heals in a natural process.
- pulsed DC voltages are known to drive electroporation under the right circumstances, known approaches do not provide for ease of navigation, placement and therapy delivery from one or more devices and for safe energy delivery, especially in the context of ablation therapy for cardiac arrhythmias with epicardial catheter devices.
- An apparatus may include a first jaw including a plurality of first electrodes.
- a second jaw may include a plurality of second electrodes.
- the first jaw and the second jaw may be substantially rigid, elongate, and may collectively define a longitudinal axis.
- the first jaw and the second jaw may be further configured to engage tissue therebetween during use.
- Each electrode of the plurality of first electrodes may have a width orthogonal to the longitudinal axis that is less than a length of that electrode measured parallel to the longitudinal axis.
- the plurality of first electrodes may be spaced apart laterally with respect to the longitudinal axis.
- Each electrode of the plurality of second electrodes may have a width orthogonal to the longitudinal axis that is less than a length of that electrode measured parallel to the longitudinal axis.
- the plurality of second electrodes may be spaced apart laterally with respect to the longitudinal axis.
- Each electrode of the plurality of first electrodes and the plurality of second electrodes may be configured to deliver a pulse waveform of at least about 200 Volts.
- each electrode of the plurality of first electrodes and the plurality of second electrodes may be independently addressable.
- the longitudinal axis has one or more of a straight portion and curved portion.
- an electrode of the plurality of first electrodes may be configured as an anode and an electrode from the plurality of second electrodes may be configured as a cathode, the anode being disposed directly across from the cathode.
- an electrode from the plurality of first electrodes may be configured as an anode and another electrode from the plurality of first electrodes is configured as a cathode. The anode may be spaced apart laterally from the cathode.
- At least two of the plurality of first electrodes may be spaced apart by a first measure.
- the first jaw and the second jaw may be spaced apart by a second measure.
- a ratio of the second measure to the first measure may be between about 0.1:1 and about 12:1.
- a distance between a midpoint of at least two of the plurality of first electrodes in a cross-section orthogonal to the longitudinal axis may be between about 1 mm and about 10 mm.
- any two adjacent electrodes of the plurality of first electrodes may be spaced apart by a first measure of between about 0.5 mm and about 10 mm and any two adjacent electrodes of the plurality of second electrodes may be spaced apart by a second measure of between about 0.5 mm and about 10 mm.
- any two adjacent electrodes of the plurality of first electrodes may be spaced apart by a first measure and any two adjacent electrodes of the plurality of second electrodes are spaced apart by a second measure.
- a ratio of the first measure to the second measure may be between about 0.05:1 and about 20:1.
- any two adjacent electrodes of the plurality of first electrodes may be spaced apart by a first measure and any two adjacent electrodes of the plurality of second electrodes may be spaced apart by a second measure.
- a ratio of the width of any electrode of the plurality of first electrodes to the width of any electrode of the plurality of second electrodes to the first measure may be between about 0.01:1 and about 10:1.
- each electrode of the plurality of first electrodes and the plurality of second electrodes may have a length of between about 10 mm and about 120 mm.
- the first and second jaws may be configured to transition between a first configuration for positioning the first and second jaws through or around a body cavity, organ system, or anatomical structure and a second configuration for engaging the tissue.
- the first and second jaws may be spaced apart by a spacing distance in the second configuration.
- the cross-section of each electrode of the plurality of first electrodes and the plurality of second electrodes may be substantially rectangular.
- each electrode of the plurality of first electrodes and the plurality of second electrodes may include a curved portion. In some of these embodiments, the curved portion may have a radius of curvature of about 1 cm or larger. In some embodiments, the curved portion may have a J shape.
- each electrode of the plurality of first electrodes and the plurality of second electrodes may include an exposed portion in electrical contact with the tissue during use.
- the exposed portion of each electrode of the plurality of first electrodes and the plurality of second electrodes may be flat or convex.
- the first and second jaws may be parallel.
- a pulse generator may include a generator.
- the generator may be coupled to each electrode of the plurality of first electrodes and the plurality of second electrodes.
- the controller may include a processor and memory.
- the generator may be configured to generate a pulse waveform of at least about 200 Volts.
- a first set of electrodes of the plurality of first electrodes and the plurality of second electrodes may be configured for pulse waveform delivery.
- the pulse waveform may be delivered to the first set of electrodes.
- the generator may be further configured to configure a second set of electrodes of the plurality of first electrodes and the plurality of second electrodes for receiving electrical activity of tissue, and receive signal data corresponding to electrical activity of the tissue using the second set of electrodes.
- Electrocardiography data may be generated using the signal data.
- a handle may be coupled to the first jaw and the second jaw.
- the handle may include one or more of a jaw control, electrode selection control, and pulse waveform control.
- a pivot may couple the first jaw to the second jaw.
- a spring may be configured to bias the first and second jaws closed.
- one or more lead wires may be coupled to the plurality of first electrodes and the plurality of second electrodes.
- an apparatus may include a first jaw including a first electrode and a second electrode.
- a second jaw may include a third electrode and a fourth electrode.
- the first jaw and the second jaw may be substantially rigid, elongate, and collectively define a longitudinal axis.
- the first jaw and the second jaw may be further configured to engage tissue therebetween during use.
- the first electrode may be disposed directly across the third electrode.
- the second electrode may be disposed directly across the fourth electrode.
- a processor may be operably coupled to the first jaw and the second jaw. The processor may be configured to, during use, configure the first electrode as an anode and the third electrode as a cathode. Pulsed electric field ablative energy may be delivered via the first electrode and the third electrode.
- each of the first electrode, second electrode, third electrode, and fourth electrode are independently addressable.
- the longitudinal axis may have one or more of a straight portion and a curved portion.
- the first electrode and the second electrode may be spaced apart by a first measure of between about 0.5 mm and about 10 mm
- the third electrode and the fourth electrode may be spaced apart by a second measure of between about 0.5 mm and about 10 mm.
- the first electrode and the second electrode may be spaced apart by a first measure and the third electrode and the fourth electrode may be spaced apart by a second measure.
- a ratio of the first measure to the second measure may be between about 0.05:1 and about 20:1.
- the first electrode and the second electrode may be spaced apart by a first measure.
- a ratio of a width of the first electrode to the first measure may be between about 0.01:1 and about 10:1.
- the first, second, third, and fourth electrode may each have a length of between about 10 mm and about 120 mm.
- the first and second jaws may be configured to transition between a first configuration for positioning the first and second jaws through or around a body cavity, organ system, or anatomical structure and a second configuration for engaging the tissue. In some of these embodiments, the first and second jaws may be spaced apart by a spacing distance in the second configuration. In some embodiments, the cross-section of the first, second, third, and fourth electrodes may be substantially rectangular. In some embodiments, the first, second, third, and fourth electrodes may include a curved portion.
- the curved portion may have a radius of curvature of about 1 cm or larger. In some of these embodiments, the curved portion may have a J shape.
- the first, second, third, and fourth electrodes may include an exposed portion in electrical contact with the tissue during use. In some of these embodiments, the exposed portion of each of the electrodes may be flat or convex. In some embodiments, the first and second jaws may be parallel.
- a pulse generator may include a controller.
- the pulse generator may be coupled to the first, second, third, and fourth electrodes.
- the controller may include a processor and memory.
- the generator may be configured to generate a pulse waveform of at least about 200 Volts.
- a first set of electrodes of the first, second, third, and fourth electrodes may be configured for pulse waveform delivery.
- the pulse waveform may be delivered to the first set of electrodes.
- the generator may be further configured to configure a second set of electrodes of the first, second, third, and fourth electrodes for receiving electrical activity of tissue.
- Signal data may be received corresponding to electrical activity of the tissue using the second set of electrodes.
- Electrocardiography data may be generated using the signal data.
- a handle may be coupled to the first jaw and the second jaw.
- the handle may include one or more of a jaw control, electrode selection control, and pulse waveform control.
- a pivot may couple the first jaw to the second jaw.
- a spring may be configured to bias the first and second jaws closed.
- one or more lead wires may be coupled to the first, second, third, and fourth electrodes.
- a method of ablating tissue via irreversible electroporation may include the steps of clamping tissue between a first jaw and a second jaw of an apparatus.
- the first jaw may include a plurality of first electrodes and the second jaw may include a plurality of second electrodes.
- the first jaw and the second jaw may be substantially rigid, elongate, and may collectively define a longitudinal axis.
- Each electrode of the plurality of first electrodes may have a width orthogonal to the longitudinal axis that is less than a length parallel to the longitudinal axis of that electrode.
- the plurality of first electrodes may be spaced apart laterally with respect to the longitudinal axis.
- Each electrode of the plurality of second electrodes may have a width orthogonal to the longitudinal axis that is less than a length parallel to the longitudinal axis of that electrode.
- the plurality of second electrodes may be spaced apart laterally with respect to the longitudinal axis.
- An electrode of the plurality of first electrodes may be configured as an anode.
- An electrode of the plurality of second electrodes may be configured as a cathode.
- the anode and the cathode may be disposed diagonally across the longitudinal axis and may be spaced apart laterally with respect to the longitudinal axis.
- Ablative energy may be delivered to the tissue via the anode and the cathode.
- the longitudinal axis may have one or more of a straight portion and curved portion.
- clamping the tissue may include transitioning the first and second jaws between a first configuration for advancing the apparatus and a second configuration for clamping the tissue.
- the tissue may be a region of the atrial base of a pulmonary vein.
- the pulse waveform may include a first level of a hierarchy of the pulsed waveform includes a first set of pulses, each pulse having a pulse time duration, and a first time interval separating successive pulses.
- a second level of the hierarchy of the pulsed waveform may include a plurality of first sets of pulses as a second set of pulses, a second time interval separating successive first sets of pulses, the second time interval being at least three times the duration of the first time interval.
- a third level of the hierarchy of the pulsed waveform may include a plurality of second sets of pulses as a third set of pulses, a third time interval separating successive second sets of pulses, the third time interval being at least thirty times the duration of the second level time interval.
- signal data may be received corresponding to electrical activity of the tissue using one or more of the plurality of first electrodes and the plurality of second electrodes. Electrocardiography data may be generated using the signal data.
- the first and second jaws may be positioned through or around a body cavity, organ system, or anatomical structure. In some embodiments, each electrode of the plurality of first electrodes and the plurality of second electrodes may be independently addressable.
- FIG. 1A is a schematic perspective view of an ablation device, according to embodiments.
- FIG. 1B is a schematic cross-sectional side view of an ablation device, according to other embodiments.
- FIG. 2A is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device, according to other embodiments.
- FIG. 2B is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device with the electrodes spaced further apart than those in FIG. 2A , according to other embodiments.
- FIG. 2C is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device with the electrodes spaced further apart than those in FIG. 2B , according to other embodiments.
- FIG. 3A is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device, according to other embodiments.
- FIG. 3B is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device with the electrodes spaced further apart than those in FIG. 3A , according to other embodiments.
- FIG. 3C is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device with the electrodes spaced further apart than those in FIG. 3B , according to other embodiments.
- FIG. 4A is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device, according to other embodiments.
- FIG. 4B is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device with the jaws spaced further apart than those in FIG. 4A , according to other embodiments.
- FIG. 4C is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device with the jaws spaced further apart than those in FIG. 4B , according to other embodiments.
- FIG. 4D is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device with the jaws spaced further apart than those in FIG. 4C , according to other embodiments.
- FIG. 4E is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device with the jaws spaced further apart than those in FIG. 4D , according to other embodiments.
- FIG. 5A is a schematic cross-sectional side view of an ablation device generating an electric field, according to other embodiments.
- FIG. 5B is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device with the jaws spaced further apart than those in FIG. 5A , according to other embodiments.
- FIG. 5C is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device with the jaws spaced further apart than those in FIG. 5B , according to other embodiments.
- FIG. 5D is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device using a higher voltage than applied in FIG. 5C , according to other embodiments.
- FIG. 5E is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device with the jaws spaced further apart than those in FIG. 5D , according to other embodiments.
- FIG. 5F is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device using a higher voltage than applied in FIG. 5E , according to other embodiments.
- FIG. 6 is a block diagram of an electroporation system, according to embodiments.
- FIG. 7 is a side view of an ablation device, according to other embodiments.
- FIG. 8 is a perspective view of a distal end of an ablation device, according to embodiments.
- FIG. 9A is a perspective view of a distal end of an ablation device, according to embodiments.
- FIG. 9B is a perspective view of a distal end of an ablation device shown in FIG. 9A having tissue disposed in between the arms of the device, according to embodiments.
- FIG. 10 is a perspective view of a distal end of an ablation device having a pulmonary vein disposed between the arms of the device, according to embodiments.
- FIG. 11 illustrates a method for tissue ablation, according to embodiments.
- FIG. 12 is an example waveform showing a sequence of voltage pulses with a pulse width defined for each pulse, according to embodiments.
- FIG. 13 schematically illustrates a hierarchy of pulses showing pulse widths, intervals between pulses, and groupings of pulses, according to embodiments.
- FIG. 14 provides a schematic illustration of a nested hierarchy of monophasic pulses displaying different levels of nested hierarchy, according to embodiments.
- FIG. 15 is a schematic illustration of a nested hierarchy of biphasic pulses displaying different levels of nested hierarchy, according to embodiments.
- FIG. 16 illustrates schematically a time sequence of electrocardiograms and cardiac pacing signals together with atrial and ventricular refractory time periods and indicating a time window for irreversible electroporation ablation, according to embodiments.
- An ablation device may include a set of jaws or arms each having a set of electrodes that may be configured to hold (e.g., clamp, grasp, compress) a portion of tissue therebetween and provide tissue ablation with reduced energy delivery.
- the set of electrodes may be configured to contact tissue during use.
- the jaws may transition from a closed configuration to an open configuration for grasping tissue such as a pulmonary vein.
- the set of jaws may be transformed into any intermediate configuration between the open and closed configurations, continuously or in discrete steps.
- the jaws may transition from a closed configuration to an open configuration to allow tissue to be placed between the jaws. Then, the jaws may be brought closer together to apply compression force to tissue disposed therebetween to target energy delivery to a desired portion of tissue.
- An irreversible electroporation system as described herein may include a signal generator and a processor configured to apply one or more voltage pulse waveforms to a selected set of electrodes of an ablation device (e.g., clamp, clip, forcep, hemostat) to deliver energy to a region of interest (e.g., portion of a pulmonary vein) and provide a highly configurable a set of electrode channels (e.g., allow independent and arbitrary electrode selection).
- the ablation device may generally include a pair of opposable members configured to hold tissue therebetween. In some embodiments, the opposable members may be movable relative to each other.
- the pulse waveforms disclosed herein may aid in therapeutic treatment of a variety of cardiac arrhythmias (e.g., atrial fibrillation).
- the ablation device may comprise one or more elongate parallel electrodes.
- the electrodes may be independently addressable such that each electrode may be controlled (e.g., deliver energy) independently of any other electrode of the device.
- an anode-cathode energy delivery sequence may be selected to ablate desired regions of tissue and/or to reduce the possibility of shorting. In this manner, the electrodes may deliver different energy waveforms with different timing synergistically for electroporation of tissue.
- electroporation refers to the application of an electric field to a cell membrane to change the permeability of the cell membrane to the extracellular environment.
- reversible electroporation refers to the application of an electric field to a cell membrane to temporarily change the permeability of the cell membrane to the extracellular environment.
- a cell undergoing reversible electroporation may observe the temporary and/or intermittent formation of one or more pores in its cell membrane that close up upon removal of the electric field.
- irreversible electroporation refers to the application of an electric field to a cell membrane to permanently change the permeability of the cell membrane to the extracellular environment.
- a cell undergoing irreversible electroporation may observe the formation of one or more pores in its cell membrane that persist upon removal of the electric field.
- Pulse waveforms for electroporation energy delivery as disclosed herein may enhance the safety, efficiency, and effectiveness of energy delivery to tissue by reducing the electric field threshold associated with irreversible electroporation, thus yielding more effective ablative lesions with a reduction in total energy delivered.
- the voltage pulse waveforms disclosed herein may be hierarchical and have a nested structure.
- the pulse waveform may include hierarchical groupings of pulses having associated timescales.
- the methods, systems, and devices disclosed herein may comprise one or more of the methods, systems, and devices described in International Application Serial No. PCT/US2016/057664, filed on Oct. 19, 2016, and titled “SYSTEMS, APPARATUSES AND METHODS FOR DELIVERY OF ABLATIVE ENERGY TO TISSUE,” the contents of which are hereby incorporated by reference in its entirety.
- the systems may further include a cardiac stimulator used to synchronize the generation of the pulse waveform to a paced heartbeat.
- the cardiac stimulator may electrically pace the heart with a cardiac stimulator and ensure pacing capture to establish periodicity and predictability of the cardiac cycle.
- a time window within a refractory period of the periodic cardiac cycle may be selected for voltage pulse waveform delivery.
- voltage pulse waveforms may be delivered in the refractory period of the cardiac cycle to avoid disruption of the sinus rhythm of the heart.
- the ablation device may transform into different configurations (e.g., compact and expanded) to navigate and position the device within a body cavity.
- the system may optionally include one or more return electrodes.
- the device may be surgically placed at a target location.
- the electrodes through which the voltage pulse waveform is delivered may be disposed on opposing sides of a pair of jaws of an ablation device.
- the methods described here may include placing tissue (e.g., pulmonary vein) between the jaws in contact with the electrodes.
- a pulse waveform may be generated and delivered to one or more electrodes of the device to ablate tissue.
- the pulse waveform may be generated in synchronization with a pacing signal of the heart to avoid disruption of the sinus rhythm of the heart.
- the electrodes may be configured in anode-cathode (e.g., bipole) subsets.
- the pulse waveform may include hierarchical waveforms to aid in tissue ablation and reduce damage to healthy tissue.
- a system for ablating tissue described here may include a signal generator and an ablation device having one or more electrodes for the selective and rapid application of DC voltage to drive electroporation. Voltages may be applied to a selected subset of the electrodes, with independent subset selections for anode and cathode electrode selections.
- the ablation device may be coupled to one or more electrode channels of the signal generator. Each electrode channel may be independently configured as an anode or cathode and a voltage pulse waveform may be delivered through one or more of the electrode channels in a predetermined sequence.
- a pacing signal for cardiac stimulation may be generated and used to generate the pulse waveform by the signal generator in synchronization with the pacing signal.
- FIG. 7 is a side view of an ablation device ( 700 ) configured to hold tissue and deliver energy for tissue ablation.
- the ablation device ( 700 ) may include a first jaw ( 710 ) and a second jaw ( 712 ) coupled to a distal end of a body (e.g., shaft, elongate member) ( 720 ).
- a proximal end of the body ( 720 ) may be coupled to a handle ( 730 ).
- the handle ( 730 ) may include an actuator ( 740 ) that may be configured to control one or more of the jaws ( 710 , 720 ) and energy delivery, as described in more detail herein.
- the actuator ( 740 ) may include an input device such as one or more of a lever, trigger, button, slide, switch, and the like. For example, a user may engage the actuator to transition and hold the jaws in an open configuration to permit the release of tissue held therebetween. When a desired portion of tissue is positioned between the open jaws, the user may disengage the actuator to transition the jaws to a closed configuration suitable for tissue ablation.
- a user may engage the actuator to transition the jaws from an open configuration to a closed configuration to allow, for example, the device to be advanced into a body cavity.
- the user may disengage the actuator to transition the jaws to an open configuration to allow the desired portion of tissue to be positioned between the open jaws.
- the user may then engage the actuator to transition the jaws to a closed configuration suitable for tissue ablation.
- the actuator may be configured for direct movement of the jaws such that when engaged, the actuator causes the jaws to move in a 1:1 ratio or some other ratio. That is, the actuator may be configured to limit, attenuate, and/or amplify a force applied by the jaws based on an amount of force applied to the actuator.
- the ablation device ( 740 ) may include a spring configured to bias the jaws ( 710 , 720 ) between different configurations.
- a spring may be coupled to the jaws ( 710 , 720 ) and be configured to bias the jaws ( 710 , 720 ) towards the tissue ablation configuration in order to apply a compressive force to tissue held between the jaws ( 710 , 720 ) when the ablation device is advanced into or retracted from a body cavity, the jaws may transition to a closed configuration where the jaws contact each other.
- FIG. 6 illustrates an ablation system ( 600 ) configured to deliver voltage pulse waveforms for tissue ablation.
- the system ( 600 ) may include a signal generator ( 610 ), ablation device ( 640 ), and optionally a cardiac stimulator ( 650 ).
- the signal generator ( 610 ) may be coupled to at least one ablation device ( 640 ), and optionally to the cardiac stimulator ( 650 ).
- the ablation device ( 640 ) may include a first jaw ( 650 a ) and a second jaw ( 650 b ).
- the first jaw ( 650 a ) may include a set of one or more electrodes ( 642 a , 642 b , . . . , 642 n ).
- the second jaw ( 650 a ) may include a set of one or more electrodes ( 644 a , 644 b , . . . , 644 n ).
- the signal generator ( 610 ) may be configured to generate pulse waveforms for irreversible electroporation of tissue, such as, for example, heart tissue.
- the signal generator ( 610 ) may be a voltage pulse waveform generator and deliver a pulse waveform to a set of electrodes ( 642 a , 642 b , . . . , 642 n , and 644 a , 644 b , . . . , 644 n ) of the ablation device ( 640 ).
- the signal generator ( 610 ) may generate and deliver several types of signals including, but not limited to, radiofrequency (RF), direct current (DC) impulses (such as high-voltage, ultra-short pulses used in electroporation), stimulus range impulses, and/or hybrid electrical impulses.
- RF radiofrequency
- DC direct current
- the signal generator ( 610 ) may generate monophasic (DC) pulses or biphasic pulses (pulses of both polarities).
- the signal generator ( 610 ) may include a processor ( 620 ), memory ( 622 ), a set of electrode channels ( 624 a , 624 b , . . . , 624 n , and 625 a , 625 b , . . .
- the processor ( 620 ) may incorporate data received from one or more of memory ( 622 ), electrode channels ( 624 a , 624 b , . . . , 624 n , and 625 a , 625 b , . . .
- the memory ( 622 ) may further store instructions to cause the processor ( 620 ) to execute modules, processes and/or functions associated with the system ( 600 ), such as pulse waveform generation and delivery, electrode channel configuration, and/or cardiac pacing synchronization.
- the memory ( 622 ) may be configured to store anode/cathode configuration data, electrode channel configuration data, pulse waveform data, fault data, energy discharge data, heart pacing data, patient data, clinical data, procedure data, electromyography data, sensor data, temperature data, and/or the like.
- the ablation device ( 640 ) may include a catheter configured to receive and/or deliver the pulse waveforms described herein.
- the ablation device ( 640 ) may be introduced into an epicardial space of the left atrium and positioned to align one or more electrodes ( 642 a , 642 b , . . . , 642 n , and 644 a , 644 b , . . . , 644 n ) to heart tissue (e.g., pulmonary vein), and then deliver the pulse waveforms to ablate tissue.
- the ablation device ( 140 ) may include one or more electrodes ( 642 a , 642 b , . . .
- anode-cathode subsets such as, for example, a subset including one anode and one cathode, a subset including two anodes and two cathodes, a subset including two anodes and one cathode, a subset including one anode and two cathodes, a subset including three anodes and one cathode, a subset including three anodes and two cathodes, and/or the like.
- the methods, systems, and devices disclosed herein may comprise one or more of the methods, systems, and devices described in U.S. patent application Ser. No. 15/499,804, filed on Apr. 27, 2017, and titled “SYSTEMS, DEVICES, AND METHODS FOR SIGNAL GENERATION,” and International Application Serial No. PCT/US17/12099, filed on Jan. 4, 2017, and titled “SYSTEMS, DEVICES, AND METHODS FOR DELIVERY OF PULSED ELECTRIC FIELD ABLATIVE ENERGY TO ENDOCARDIAL TISSUE,” and International Application Serial No.
- the processor ( 620 ) may be any suitable processing device configured to run and/or execute a set of instructions or code and may include one or more data processors, image processors, graphics processing units, physics processing units, digital signal processors, and/or central processing units.
- the processor ( 620 ) may be, for example, a general purpose processor, Field Programmable Gate Array (FPGA), an Application Specific Integrated Circuit (ASIC), and/or the like.
- the processor ( 620 ) may be configured to run and/or execute application processes and/or other modules, processes and/or functions associated with the system and/or a network associated therewith (not shown).
- the processor may comprise both a microcontroller unit and an FPGA unit, with the microcontroller sending electrode sequence instructions to the FPGA.
- the underlying device technologies may be provided in a variety of component types, e.g., metal-oxide semiconductor field-effect transistor (MOSFET) technologies like complementary metal-oxide semiconductor (CMOS), bipolar technologies like emitter-coupled logic (ECL), polymer technologies (e.g., silicon-conjugated polymer and metal-conjugated polymer-metal structures), mixed analog and digital, and/or the like.
- MOSFET metal-oxide semiconductor field-effect transistor
- CMOS complementary metal-oxide semiconductor
- ECL emitter-coupled logic
- polymer technologies e.g., silicon-conjugated polymer and metal-conjugated polymer-metal structures
- mixed analog and digital and/or the like.
- the memory ( 622 ) may include a database (not shown) and may be, for example, a random access memory (RAM), a memory buffer, a hard drive, an erasable programmable read-only memory (EPROM), an electrically erasable read-only memory (EEPROM), a read-only memory (ROM), Flash memory, etc.
- the memory ( 622 ) may store instructions to cause the processor ( 620 ) to execute modules, processes and/or functions associated with the system ( 600 ), such as pulse waveform generation, electrode channel configuration, and/or cardiac pacing.
- a set of electrode channels ( 624 a , 624 b , . . . , 624 n , and 625 a , 625 b , . . . , 625 n ) may include a set of active solid-state switches.
- the set of electrode channels ( 624 a , 624 b , . . . , 624 n , and 625 a , 625 b , . . . , 625 n ) may be configured in a number of ways, including independent anode/cathode configuration for each electrode channel.
- anode-cathode subsets such as, for example, a subset including one anode and one cathode, a subset including two anodes and two cathodes, a subset including two anodes and one cathode, a subset including one anode and two cathodes, a subset including three anodes and one cathode, a subset including three anodes and two cathodes, and/or the like.
- Electrode channels may include any number of channels, for example, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, or more electrode channels.
- Energy delivery may use any combination of electrode channels ( 624 a , 624 b , . . . , 624 n , and 625 a , 625 b , . . . , 625 n ) and any order for an energy delivery sequence.
- the set of electrode channels ( 624 a , 624 b , . . . , 624 n , and 625 a , 625 b , . . . , 625 n ) may be coupled to a routing console ( 630 ) to deliver energy to a set of electrodes ( 642 ) coupled to the routing console ( 630 ).
- the set of electrode channels ( 624 a , 624 b , . . . , 624 n , and 625 a , 625 b , . . . , 625 n ) may be coupled to an energy source ( 626 ) to receive energy (e.g., a pulse waveform).
- Processor ( 620 ) may be coupled to each electrode channel ( 624 a , 624 b , . . . , 624 n , and 625 a , 625 b , . . . , 625 n ) to configure an anode/cathode configuration for each electrode channel ( 624 ), which may be configured on a per pulse basis, per operator input, and/or the like.
- the processor ( 620 ) and energy source ( 626 ) may be collectively configured to deliver a pulse waveform to the set of electrodes ( 642 , 644 ) through the set of electrode channels ( 624 a , 624 b , . . .
- each electrode channel ( 624 a , 624 b , . . . , 624 n , and 625 a , 625 b , . . . , 625 n ) may include an electronic switch (e.g., bipolar transistor) and a drive circuit, as described in detail herein.
- the pulse duration of voltage pulses delivered through an electrode channel may be in the range of between about 1 microsecond and about 1000 microseconds. In biphasic mode, this corresponds to an approximate frequency range of between about 500 Hz and about 500 KHz for the frequency associated with the voltage pulses.
- a controller including the processor ( 620 ) and memory ( 622 ) may be coupled to each electrode of the set of first electrodes ( 642 ) and the set of second electrodes ( 644 ).
- the controller may be configured to generate a pulse waveform, configure a first set of electrodes of the set of first electrodes ( 642 ) and the set of second electrodes ( 644 ) for pulse waveform delivery.
- the pulse waveform may be delivered to the first set of electrodes ( 642 ).
- a second set of electrodes of the set of first electrodes ( 642 ) and the set of second electrodes ( 644 ) may be configured for receiving electrical activity of tissue. Signal data corresponding to the electrical activity of the tissue may be received using the second set of electrodes. Electrocardiography data may be generated using the signal data.
- an energy source ( 626 ) may be configured to convert and supply energy to a set of electrodes ( 642 , 644 ) coupled to the signal generator ( 610 ).
- the energy source ( 626 ) of the signal generator ( 610 ) may include a DC power supply and be configured as an AC/DC switcher.
- an energy source ( 626 ) of the signal generator ( 610 ) may deliver rectangular-wave pulses with a voltage in the range between about 300 V and about 5000 V.
- the energy source ( 626 ) may be configured to store energy.
- the energy source ( 626 ) may include one or more capacitors to store energy from a power supply. While these examples are included for purely non-limiting illustrative purposes, it is noted that a variety of pulse waveforms with a range of pulse durations, intervals between pulses, pulse groupings, etc. may be generated depending on the clinical application.
- a sensing circuit ( 628 ) may be configured to determine an amount of current being delivered to a device coupled to the signal generator ( 610 ) (e.g., electrode ( 642 ) coupled to the electrode channel ( 624 )). As described in more detail herein, the sensing circuit ( 628 ) may also be used to classify an electrode channel fault, monitor capacitor discharge, and/or sense arcing. In some embodiments, the sensing circuit ( 628 ) may be a direct current sensing circuit and/or a low-side sensing circuit. The sensing circuit may include one or more operational amplifiers, difference amplifiers (DA), instrumentation amplifiers (IA), and/or current shunt monitors (CSM).
- DA difference amplifiers
- IA instrumentation amplifiers
- CSM current shunt monitors
- the routing console ( 630 ) may be configured to electrically couple a set of electrodes ( 642 ) of an ablation device ( 640 ) to a set of electrode channels ( 624 a , 624 b , . . . , 624 n , and 625 a , 625 b , . . . , 625 n ).
- the routing console ( 630 ) may be configured to selectively deliver energy to the set of electrodes ( 642 ) using the set of electrode channels ( 624 a , 624 b , . . . , 624 n , and 625 a , 625 b , . . . , 625 n ).
- One or more ablation devices ( 640 ) each having a set of electrodes ( 642 , 644 ) may be coupled to the routing console ( 630 ).
- the set of electrodes ( 642 , 644 ) may include any number of electrodes, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, or more electrodes.
- an ablation device ( 640 ) may include three electrodes with a first jaw ( 650 a ) having a first electrode ( 642 a ) and a second jaw ( 650 b ) having a second electrode ( 644 a ) and a third electrode ( 644 b ).
- the electrode channels ( 624 a , 624 b , . . . , 624 n , and 625 a , 625 b , . . . , 625 n ) configured for energy delivery may not be adjacent to each other.
- the set of electrode channels ( 624 a , 624 b , . . . , 624 n , and 625 a , 625 b , . . . , 625 n ) may include a set of N electrode channels ( 624 a , 624 b , . . .
- a first electrode channel may correspond to a first electrode channel ( 624 a ) in the parallel array of N electrode channels ( 624 a , 624 b , . . . , 624 n , and 625 a , 625 b , . . . , 625 n ).
- One or more of a second and third electrode channel ( 624 b , 624 c ) may not be adjacent to the first electrode channel ( 624 a ) in the parallel array of N electrode channels ( 624 a , 624 b , . . . , 624 n , and 625 a , 625 b , . . . , 625 n ).
- a multi-electrode ablation device may allow targeted and precise energy delivery to tissue.
- the electrodes ( 642 , 644 ) of an ablation device ( 640 ) may be configured for energy delivery (e.g., as an anode/cathode pair of electrodes ( 642 , 644 )) and may be disposed on opposing jaws on respective parallel arrays of the ablation device ( 640 ).
- an ablation device ( 640 ) may include a first jaw ( 650 a ) having a set of first electrodes ( 642 ) as a parallel array of N electrodes ( 142 n ) and a second jaw ( 650 b ) having a set of second electrodes ( 644 ) as a parallel array of M electrodes ( 644 n ).
- the signal generator ( 610 ) coupled to the ablation device ( 640 ) may include a set of electrode channels ( 624 a , 624 b , . . . , 624 n , and 625 a , 625 b , . . .
- the first electrode channel ( 624 a ) of the N electrode channels ( 624 a , 624 b , . . . , 624 n , and 625 a , 625 b , . . . , 625 n ) may correspond to a first electrode ( 642 a ) in the parallel array of M electrodes ( 642 n ) of the first jaw ( 650 a ).
- second and third electrode channel ( 624 b , 624 c ) of the N electrode channels ( 624 n ) may not correspond to any of the electrodes adjacent to the first electrode ( 642 a ) in the parallel array of M electrodes ( 642 n ).
- the second electrode channel ( 642 b ) may correspond to a second electrode ( 644 a ) in the parallel array of M electrodes ( 644 n ) of the second jaw ( 650 b ).
- Configurable electrode channel and electrode selection may provide flexibility in positioning the electrodes for ablating a desired region of interest, as described in more detail herein.
- the routing console ( 630 ) may couple to a set of four or six electrodes ( 642 , 644 ) of an ablation device ( 640 ).
- the routing console ( 630 ) may receive input from the processor ( 620 ) and/or user interface ( 632 ) for electrode channel selection and energy delivery to one or more electrodes ( 642 , 644 ).
- the routing console ( 630 ) may couple to a cardiac stimulator ( 650 ) and be configured to receive data from devices (e.g., heart pacing data from a pacing device) used for synchronization of a pulse waveform with a patient cardiac cycle.
- devices e.g., heart pacing data from a pacing device
- a user interface ( 632 ) may be configured as a communication interface between an operator and the system ( 600 ).
- the user interface ( 632 ) may include an input device and output device (e.g., touch surface and display).
- patient data from memory ( 622 ) may be received by user interface ( 632 ) and output visually and/or audibly.
- Electric current data from sensing circuit ( 628 ) may be received and output on a display of user interface ( 632 ).
- operator control of an input device having one or more buttons, knobs, dials, switches, trackball, touch surface, and/or the like, may generate a control signal to the signal generator ( 610 ) and/or ablation device ( 640 ).
- an input device of the user interface ( 632 ) may include a touch surface for operator input and may be configured to detect contact and movement on the touch surface using any of a plurality of touch sensitivity technologies including capacitive, resistive, infrared, optical imaging, dispersive signal, acoustic pulse recognition, and surface acoustic wave technologies. Additionally or alternatively, the user interface ( 632 ) may include a step switch or foot pedal.
- an output device of the user interface ( 632 ) may include one or more of a display device and audio device.
- the display device may include at least one of a light emitting diode (LED), liquid crystal display (LCD), electroluminescent display (ELD), plasma display panel (PDP), thin film transistor (TFT), and organic light emitting diodes (OLED).
- An audio device may audibly output patient data, sensor data, system data, other data, alarms, warnings, and/or the like.
- the audio device may include at least one of a speaker, piezoelectric audio device, magnetostrictive speaker, and/or digital speaker. In one embodiment, the audio device may output an audible warning upon detection of a fault in the signal generator ( 610 ) and/or ablation device ( 640 ).
- the signal generator ( 610 ) may be mounted on a trolley or cart.
- the user interface ( 632 ) may be formed in the same or different housing as the signal generator ( 610 ).
- the user interface ( 632 ) may be mounted to any suitable object, such as furniture (e.g., a bed rail), a wall, a ceiling, or may be self-standing.
- the input device may include a wired and/or wireless transmitter configured to transmit a control signal to a wired and/or wireless receiver of the signal generator ( 610 ).
- a cardiac stimulator ( 650 ) including a pacing device may be configured to generate a heart pacing signal to be delivered to a patient via the pacing device.
- An indication of the pacing signal may be transmitted by the cardiac stimulator ( 650 ) to the signal generator ( 610 ).
- an indication of a voltage pulse waveform may be selected, computed, and/or otherwise identified by the processor ( 620 ) and generated by the signal generator ( 610 ).
- the signal generator ( 610 ) may be configured to generate the voltage pulse waveform in synchronization with the indication of the pacing signal (e.g., within a common refractory window).
- the common refractory window may start substantially immediately following a ventricular pacing signal (or after a very small delay) and last for a duration of between about 150 ms and about 250 ms thereafter. In such embodiments, an entire pulse waveform may be delivered within this duration.
- the systems described herein may include one or more sterile coverings configured to create a sterile barrier around portions of the system ( 600 ).
- the system ( 600 ) may include one or more sterile coverings to form a sterile field.
- a sterile covering may be placed over the user interface of the signal generator.
- the sterile covering may include, for example, a sterile drape configured to cover at least a portion of a system component.
- a sterile covering (e.g., sterile drape) may be configured to create a sterile barrier with respect to a user interface ( 632 ) of the system ( 600 ).
- the sterile drape may be clear and allow an operator to visualize and manually manipulate the user interface ( 632 ).
- the sterile covering may conform tightly around one or more system components or may drape loosely to allow components to be adjusted within the sterile field.
- the systems described here may include one or more multi-electrode ablation devices configured to ablate tissue for treating atrial fibrillation.
- the ablation devices may include a first jaw and a second jaw sized and shaped to physically engage, hold, and (optionally) compress tissue therebetween for delivery of ablation energy.
- a distal end of the first jaw and the second jaw may be generally atraumatic to decrease the risk of damage to tissue through laceration, puncture, and other damage when releasably coupled thereto.
- the first jaw and second jaw may form atraumatic surfaces and edges (e.g., rounded, blunt) to contact and/or hold tissue without causing damage.
- a set of metallic electrodes disposed on each of the jaws may also be generally atraumatic to decrease the risk of damage to tissue through laceration and puncture.
- the edges of the electrodes may be rounded to reduce tissue damage and to increase the uniformity of the electric field generated at a central portion and a peripheral portion of the electrodes.
- the electrodes may generally form an elongate member (e.g., bar, strip) that extends generally parallel to a length of the jaws.
- the electrodes may have a length greater than a width or height/depth dimension of the electrode.
- the jaws as described in more detail herein may be composed of an electrically insulating material such as a polymeric or ceramic material.
- one or more electrodes of the ablation device may have an insulated electrical lead configured for sustaining a voltage potential of at least about 300 V without dielectric breakdown of its corresponding insulation.
- the insulation on each of the electrical leads may sustain an electrical potential difference of between about 200 V to about 3,000 V across its thickness without dielectric breakdown, including all values and sub-ranges in between.
- the electrodes may be independently addressable such that each electrode may be controlled (e.g., deliver energy) independently of any other electrode of the device. In this manner, the electrodes may deliver different energy waveforms with different timing synergistically for electroporation of tissue.
- the electrodes may, for example, be connected to an insulated electrical lead leading to a handle to receive pulse waveforms generated by a signal generator as discussed above with respect to FIG. 6 .
- FIG. 1A is a schematic perspective view of an exemplary ablation device ( 100 ) including a first jaw ( 102 ) and a second jaw ( 104 ) that may be structurally and/or functionally similar to the ablation device in FIG. 6 .
- the first jaw ( 102 ) may include a set of first electrodes ( 110 a , 110 b , . . . , 110 n ) and the second jaw ( 104 ) may include a set of second electrodes ( 120 a , 120 b , . . . , 120 n ), as shown in FIG. 1B .
- the first jaw ( 102 ) and the second jaw ( 104 ) may be spaced apart and substantially parallel and configured to engage tissue ( 130 ) therebetween during use.
- the first jaw ( 102 ) and the second jaw ( 104 ) may transition between a set of configurations having different jaw measures ( 132 ) (e.g., spacing, distance).
- the first jaw ( 102 ) and second jaw ( 104 ) may be configured to transition between a first configuration for passing the first and second jaws through a body cavity, organ system, or anatomical structure and a second configuration for engaging the tissue ( 130 ).
- the first jaw ( 102 ) and the second jaw ( 104 ) may be spaced apart by a spacing distance in the second configuration (e.g., third measure ( 132 ) as described in more detail herein).
- the first jaw ( 102 ) and the second jaw ( 104 ) may be collectively configured to define a longitudinal axis ( 140 ).
- the first jaw ( 102 ) and the second jaw ( 104 ) may be substantially rigid.
- the set of first electrodes ( 110 ) and the set of second electrodes ( 120 ) may be arranged parallel to the longitudinal axis ( 140 ) of the jaws ( 102 , 104 ).
- Each of the first electrodes ( 110 ) may be spaced apart from an adjacent first electrode ( 110 ) by a first measure ( 106 ) (e.g., spacing, distance) and each of the second electrodes ( 120 ) may be spaced apart from an adjacent second electrode ( 120 ) by a second measure ( 108 ).
- the set of first electrodes ( 110 ) may be disposed on a side of the first jaw ( 102 ) facing the second jaw ( 104 ) with each of the set of first electrodes ( 110 ) spaced apart laterally with respect to the longitudinal axis ( 140 ).
- the set of second electrodes ( 120 ) may be disposed on a side of the second jaw ( 104 ) facing the first jaw ( 102 ) with each of the set of second electrodes ( 120 ) spaced apart laterally with respect to the longitudinal axis ( 140 ).
- each electrode of the set of first electrodes ( 110 ) and the set of second electrodes ( 120 ) may include an exposed portion in electrical contact with tissue ( 130 ) during use.
- the exposed portion of each electrode of the set of first electrodes ( 110 ) and the set of second electrodes ( 120 ) may be flat or convex.
- At least two of the set of first electrodes ( 110 ) may be spaced apart by a first measure ( 106 ), and at least two of the set of second electrodes ( 120 ) may be spaced apart by a second measure ( 108 ), as shown in FIG. 1B .
- the first jaw ( 102 ) and the second jaw ( 104 ) may be spaced apart by a third measure ( 132 ).
- the set of first electrodes may be spaced apart by a distance between about 1 mm and about 6 mm
- the set of second electrodes may be spaced apart by a distance between about 1 mm and about 4 mm.
- the first jaw and the second jaw may be spaced apart by a distance between about 1 mm and about 15 mm.
- each electrode of the set of first electrodes ( 110 ) and the set of second electrodes ( 120 ) may have a width orthogonal to the longitudinal axis that is less than a length of that electrode that is parallel to the longitudinal axis ( 140 ) where the set of first electrodes ( 110 ) are spaced apart laterally with respect to the longitudinal axis ( 140 ).
- any two adjacent electrodes of the set of first electrodes ( 110 ) may have a first measure of between about 0.5 mm and about 10 mm and any two adjacent electrodes of the set of second electrodes ( 120 ) may have a second measure of between about 0.5 mm and about 10 mm.
- each electrode of the set of first electrodes ( 110 ) and the set of second electrodes ( 120 ) may have a length of between about 1 cm and about 8 cm, a width of between about 1 mm and about 5 mm, and a height of between about 0.5 mm and about 3 mm. In some embodiments, the set of first electrodes ( 110 ) and the set of second electrodes ( 120 ) may have a length to width ratio of at least about 3:1.
- the set of first electrodes ( 110 ) and the set of second electrodes ( 120 ) may have a shape of an elongate electrode.
- each electrode of the set of first electrodes ( 110 ) and the set of second electrodes ( 120 ) may be substantially rectangular.
- each electrode of the set of first electrodes ( 110 ) and the set of second electrodes ( 120 ) may include a curved portion.
- each electrode of the set of first electrodes ( 110 ) and the set of second electrodes ( 120 ) may be independently addressable.
- One or more lead wires may be coupled to the set of first electrodes ( 110 ) and the set of second electrodes ( 120 ).
- the electrodes may comprise a generally elliptical or circular cross-section.
- a length of a semi-major axis of the electrode may be between about 0.5 mm and about 5 mm. In some of these embodiments, a length to width ratio of the electrode may be at least about 3:1.
- an electrode of the set of first electrodes ( 110 ) may be configured as an anode and an electrode of the set of second electrodes ( 120 ) may be configured as a cathode.
- the anode may be disposed directly across from the cathode.
- a first electrode pairing may include electrodes ( 110 a , 120 a ) directly across from each other on opposing jaws ( 102 , 104 )
- a second electrode pairing may include electrodes ( 110 b , 120 b ) directly across from each other on opposing jaws ( 102 , 104 ), and so forth for n electrodes.
- the anode may be diagonal from the cathode. In some embodiments, the anode may generally be spaced apart laterally from the cathode.
- a first electrode pairing may include electrodes ( 110 a , 120 b ) spaced apart laterally from each other on opposing jaws ( 102 , 104 ) and a second electrode pairing may include electrodes ( 110 b , 120 a ) spaced apart laterally from each other on opposing jaws ( 102 , 104 ), and so forth for n electrodes.
- one electrode of the set of first electrodes ( 110 ) may be configured as an anode while another electrode of the set of first electrodes ( 110 ) may be configured as a cathode.
- one electrode of one of the jaws may be configured as an anode while another electrode of the same jaw may be configured as a cathode.
- a first electrode pairing may include electrodes ( 110 a , 110 b ) adjacent to each other on the same first jaw ( 102 )
- a second electrode pairing may include electrodes ( 120 a , 120 b ) adjacent to each other on the same second jaw ( 104 ), and so forth for n electrodes.
- a pre-determined ablation sequence may include delivering ablation pulse waveforms over a sequence of pre-defined electrode pairings.
- the sequenced delivery may be triggered from a cardiac stimulator and/or pacing device.
- the ablation pulse waveforms may be applied in a refractory period of the cardiac cycle to avoid disruption of the sinus rhythm of the heart, as described in more detail herein.
- One or more of the electrodes may be configured to receive signal data corresponding to electrical activity of the tissue (e.g., electrocardiography data).
- a handle such as the handle shown in FIG. 7 may be coupled to the first jaw ( 102 ) and the second jaw ( 104 ).
- the handle may include one or more of a jaw control configured to control a spacing and/or angle between the first jaw ( 102 ) and the second jaw ( 104 ), electrode selection control, and pulse waveform control.
- the first jaw ( 102 ) and the second jaw ( 104 ) may be coupled by a pivot (not shown) in which case, the jaws may form an angle with respect to each other.
- the device ( 100 ) may include a spring (not shown) configured to bias the first jaw ( 102 ) and the second jaw ( 104 ) toward each other.
- the first jaw ( 102 ) may be fixed relative to the handle while the second jaw ( 104 ) is configured to move relative to the first jaw ( 102 ).
- FIG. 8 is a perspective view of a distal end of an ablation device ( 800 ) that may be structurally and/or functionally similar to the ablation device in FIG. 6 .
- the ablation device ( 800 ) may include a body ( 830 ) having a lumen extending therethrough, a first jaw ( 810 ), and a second jaw ( 820 ).
- the first jaw ( 810 ) may include a first shaft ( 814 ) that extends through the lumen of the body ( 830 ).
- the second jaw ( 820 ) may include a second shaft ( 824 ) that extends through the lumen of the body ( 830 ).
- one or both of the jaws ( 810 , 820 ) may move in a direction ( 840 ) relative to each other in order to modify a spacing between the first and second jaws ( 810 , 820 ).
- the jaws ( 810 , 820 ) may be movable relative to the body ( 830 ) such that the jaws ( 810 , 820 ) may advance and retract into and out of the body ( 830 ). Retraction of the jaws ( 810 , 820 ) permits grasping a portion of tissue between the jaws. When the moveable jaw is released, the tissue may then be firmly held in place between the jaws.
- FIG. 8 shows a first jaw ( 810 ) and a second jaw ( 820 ) having a generally elliptical (e.g., arcuate) shape.
- the jaws ( 810 , 820 ) may be substantially rigid and parallel to each other.
- a distal end of the first jaw ( 810 ) may include a set of first electrodes such as the two electrodes ( 812 a , 812 b ) shown in FIG. 8 .
- a distal end of the second jaw ( 812 ) may include a set of second electrodes such as the two electrodes ( 822 a , 822 b ) shown in FIG. 8 .
- the pair of first electrodes ( 812 a , 812 b ) and the pair of second electrodes ( 822 a , 822 b ) may be arranged to be parallel, although they may be arcuate along their lengths.
- a set of tangent vectors to the elongate shape of each jaw may be defined, and a local longitudinal axis may, for example, pass through the center of the cross-section of either jaw such that the local longitudinal axis is parallel to the local tangent vector.
- Each of the first electrodes ( 812 a , 812 b ) may be spaced apart from each other and each of the second electrodes ( 822 a , 822 b ) may be spaced apart from each other.
- the local electrode cross-section may be generally perpendicular to the local longitudinal axis.
- the set of first electrodes ( 812 ) and the set of second electrodes ( 822 ) may be elongate electrodes.
- each electrode of the set of first electrodes ( 812 ) and the set of second electrodes ( 822 ) may be substantially rectangular.
- each electrode of the set of first electrodes ( 812 ) and the set of second electrodes ( 822 ) may include a curved portion such as a generally arcuate shape or rounded edges.
- the electrodes may include a curvature that generally follows a curvature of its respective jaw.
- the first electrodes ( 812 a , 812 b ) may be disposed on a side of the first jaw ( 810 ) facing the second jaw ( 820 ).
- the second electrodes ( 822 a , 822 b ) may be disposed on a side of the second jaw ( 820 ) facing the first jaw ( 810 ).
- Each electrode of the first electrodes ( 812 a , 812 b ) and the second electrodes ( 822 a , 822 b ) may include an exposed portion in electrical contact with tissue during use.
- the exposed portion of each electrode of the first electrodes ( 812 a , 812 b ) and the second electrodes ( 822 a , 822 b ) may be flat or convex.
- Each electrode ( 812 a , 812 b , 822 a , 822 b ) may have an insulated electrical lead associated therewith.
- the insulated electrical leads may be disposed in a corresponding shaft.
- each electrode of the set of first electrodes ( 812 ) and the set of second electrodes ( 822 ) may be independently addressable.
- the electrodes ( 812 a , 812 b , 822 a , 822 b ) may have a length of between about 1 cm and about 8 cm, a width of between about 1 mm and about 5 mm, and a height of between about 0.5 mm and about 3 mm.
- the electrodes ( 812 a , 812 b , 822 a , 822 b ) may have a length to width ratio of at least about 3:1.
- an electrode of the set of first electrodes ( 812 ) may be configured as an anode and an electrode of the set of second electrodes ( 822 ) may be configured as a cathode.
- the anode may be disposed directly across from the cathode.
- a first electrode pairing may include electrodes ( 812 a , 822 a ) directly across from each other on opposing jaws ( 810 , 820 ) and a second electrode pairing may include electrodes ( 812 b , 822 b ) directly across from each other on opposing jaws ( 810 , 820 ).
- the anode may be diagonal from the cathode such that the anode is laterally spaced apart from the cathode and/or does not intersect a line perpendicular to the cathode.
- a first electrode pairing may include electrodes ( 812 a , 822 b ) spaced apart laterally from each other on opposing jaws ( 810 , 820 ) and a second electrode pairing may include electrodes ( 812 b , 822 a ) spaced apart laterally from each other on opposing jaws ( 810 , 820 ). This combination of electrode pairing may reduce, if not eliminate, the risk of the electrodes electrically shorting in cases where tissue is incompletely grasped between the jaws and/or portions of the jaws touch each other.
- one electrode of one of the jaws may be configured as an anode while another electrode of the same jaw may be configured as a cathode.
- a first electrode pairing may include electrodes ( 812 a , 812 b ) adjacent to each other on the same jaw ( 810 ) and a second electrode pairing may include electrodes ( 822 a , 822 b ) adjacent to each other on the same jaw ( 820 ).
- a pre-determined ablation sequence may include delivering ablation pulse waveforms sequentially over a pre-defined set of electrode pairings, for example first and second electrode pairings when a set of two electrode pairings are configured.
- the sequenced delivery may be triggered from a cardiac stimulator and/or pacing device.
- the ablation pulse waveforms may be applied in a refractory period of the cardiac cycle to avoid disruption of the sinus rhythm of the heart, as described in more detail herein.
- One or more of the electrodes may be configured to receive signal data corresponding to electrical activity of the tissue (e.g., electrocardiography data).
- a handle such as the handle shown in FIG. 7 may be coupled to the first jaw ( 810 ) and the second jaw ( 820 ).
- the handle may include one or more of a jaw control configured to control a spacing and/or angle between the first jaw ( 810 ) and the second jaw ( 820 ), electrode selection control, and pulse waveform control.
- the first jaw ( 810 ) and the second jaw ( 820 ) may be coupled by a pivot (not shown) in which case, the jaws may form an angle with respect to each other.
- the device ( 800 ) may include a spring (not shown) configured to bias the first jaw ( 810 ) and the second jaw ( 820 ) toward each other.
- the first jaw ( 810 ) may be fixed relative to the handle while the second jaw ( 820 ) is configured to move relative to the first jaw ( 810 ).
- FIGS. 9A-9B are perspective views of a distal end of an ablation device ( 900 ) that may be structurally and/or functionally similar to the ablation device in FIG. 6 .
- the ablation device ( 900 ) may include a first jaw ( 910 ) and a second jaw ( 920 ).
- one or both of the jaws ( 910 , 920 ) may move in a direction relative to each other in order to modify a spacing between the first and second jaws ( 910 , 920 ).
- FIGS. 9A-9B show a first jaw ( 910 ) and a second jaw ( 920 ) having a generally elliptical (e.g., arcuate) shape.
- the jaws ( 910 , 920 ) may be substantially rigid and parallel to each other.
- the jaws ( 910 , 920 ) may collectively define a curved longitudinal axis ( 950 ).
- a distal end of the first jaw ( 910 ) may include a set of first electrodes such as the three electrodes ( 912 a , 912 b , 912 c ) shown in FIGS. 9A-9B .
- a distal end of the second jaw ( 912 ) may include a set of second electrodes such as the three electrodes ( 922 a , 922 b , 922 c ) shown in FIGS. 9A-9B .
- the trio of first electrodes ( 912 a , 912 b , 912 c ) and the trio of second electrodes ( 922 a , 922 b , 922 c ) may be arranged parallel to the curve of a long edge of the jaws.
- Each of the first electrodes ( 912 a , 912 b , 912 c ) may be spaced apart from each other and each of the second electrodes ( 922 a , 922 b , 922 c ) may be spaced apart from each other.
- the set of first electrodes ( 912 ) and the set of second electrodes ( 922 ) may be elongate electrodes.
- each electrode of the set of first electrodes ( 912 ) and the set of second electrodes ( 922 ) may be substantially rectangular.
- each electrode of the set of first electrodes ( 912 ) and the set of second electrodes ( 922 ) may include a curved portion such as a generally arcuate shape or rounded edges.
- the electrodes may include a curvature such that generally each electrode follows the curvature of its respective jaw.
- the first electrodes ( 912 a , 912 b , 912 c ) may be disposed on a side of the first jaw ( 910 ) facing the second jaw ( 920 ).
- the second electrodes ( 922 a , 922 b , 922 c ) may be disposed on a side of the second jaw ( 920 ) facing the first jaw ( 910 ).
- Each electrode of the first electrodes ( 912 a , 912 b , 912 c ) and the second electrodes ( 922 a , 922 b , 922 c ) may include an exposed portion in electrical contact with tissue during use ( FIG. 9B ).
- each electrode of the first electrodes ( 912 a , 912 b , 912 c ) and the second electrodes ( 922 a , 922 b , 922 c ) may be flat or convex.
- Each electrode ( 912 a , 912 b , 912 c , 922 a , 922 b , 922 c ) may have an insulated electrical lead associated therewith.
- the insulated electrical leads may be disposed in a corresponding shaft.
- each electrode of the set of first electrodes ( 912 ) and the set of second electrodes ( 922 ) may be independently addressable.
- the electrodes ( 912 a , 912 b , 912 c , 922 a , 922 b , 922 c ) may have a length of between about 1 cm and about 8 cm, a width of between about 1 mm and about 5 mm, and a height of between about 0.5 mm and about 3 mm. In some embodiments the electrodes ( 912 a , 912 b , 912 c , 922 a , 922 b , 922 c ) may have a length to width ratio of at least about 3:1.
- an electrode of the set of first electrodes ( 912 ) may be configured as an anode and an electrode of the set of second electrodes ( 922 ) may be configured as a cathode.
- the anode may be disposed directly across from the cathode.
- a first electrode pairing may include electrodes ( 912 a , 922 a ) directly across from each other on opposing jaws ( 910 , 920 ), a second electrode pairing may include electrodes ( 912 b , 922 b ) directly across from each other on opposing jaws ( 810 , 820 ), and a third electrode pairing may include electrodes ( 912 c , 922 c ) directly across from each other on opposing jaws ( 910 , 920 ).
- a first electrode pairing may include electrodes ( 912 a , 922 b ) spaced apart laterally from each other on opposing jaws ( 910 , 920 ), a second electrode pairing may include electrodes ( 912 b , 922 a ) spaced apart laterally from each other on opposing jaws ( 910 , 920 ), a third electrode pairing may include electrodes ( 912 b , 922 c ) spaced apart laterally from each other on opposing jaws ( 910 , 920 ), and a fourth electrode pairing may include electrodes ( 912 c , 922 b ) spaced apart laterally from each other on opposing jaws ( 910 , 920 ).
- one electrode of one of the jaws may be configured as an anode while another electrode of the same jaw may be configured as a cathode.
- a first electrode pairing may include electrodes ( 912 a , 912 b ) adjacent to each other on the same first jaw ( 910 )
- a second electrode pairing may include electrodes ( 912 b , 912 c ) adjacent to each other on the same first jaw ( 910 )
- a third electrode pairing may include electrodes ( 922 a , 922 b ) adjacent to each other on the same second jaw ( 920 )
- a fourth electrode pairing may include electrodes ( 922 b , 922 c ) adjacent to each other on the same second jaw ( 920 ).
- a pre-determined ablation sequence may include delivering ablation pulse waveforms sequentially over a pre-defined set of electrode pairings.
- the sequenced delivery may be triggered from a cardiac stimulator and/or pacing device.
- the ablation pulse waveforms may be applied in a refractory period of the cardiac cycle to avoid disruption of the sinus rhythm of the heart, as described in more detail herein.
- One or more of the electrodes may be configured to receive signal data corresponding to electrical activity of the tissue (e.g., electrocardiography data).
- FIG. 9B is a perspective view of the ablation device ( 900 ) coupled to tissue ( 930 ) after undergoing one or more ablation sequences as described herein.
- tissue ( 930 ) is held between the jaws ( 910 , 920 ) of the device ( 900 ).
- a tissue ablation zone ( 932 ) may have a width ( 940 ) that substantially corresponds to at least an end-to-end width between the electrodes ( 912 a and 912 c , 922 a and 922 c ) of a jaw ( 910 , 920 ).
- the tissue ( 930 ) may comprise a portion of a pulmonary vein as shown, for example, in FIG. 10 .
- Tissue between the jaws ( 910 , 920 ) may be compressed relative to other portions of tissue ( 940 ).
- a handle such as the handle shown in FIG. 7 may be coupled to the first jaw ( 910 ) and the second jaw ( 920 ).
- the handle may include one or more of a jaw control configured to control a spacing and/or angle between the first jaw ( 910 ) and the second jaw ( 920 ), electrode selection control, and pulse waveform control.
- the first jaw ( 910 ) and the second jaw ( 920 ) may be coupled by a pivot (not shown) in which case, the jaws may form an angle with respect to each other.
- the device ( 900 ) may include a spring (not shown) configured to bias the first jaw ( 910 ) and the second jaw ( 920 ) toward each other.
- the first jaw ( 910 ) may be fixed relative to the handle while the second jaw ( 920 ) is configured to move relative to the first jaw ( 910 ).
- the electrodes as described may be composed of any suitable biocompatible conductive material including, but not limited to, one or more of silver, palladium, stainless steel, platinum, titanium, platinum-iridium alloys, gold, copper, nickel, combinations thereof, and the like.
- the electrode materials may be plated, coated, and/or otherwise applied in an appropriately thick layer on top of a different substrate material.
- electrode portions may be coupled using annealing, soldering, welding, crimping, lamination, combinations thereof, and the like.
- the jaws and body of the ablation devices disclosed may be composed of any suitable electrically insulating biocompatible material including polymers, ceramics, glasses, combinations thereof, and the like.
- the ablation devices described herein may be used for ablation of cardiac features/structures identified to cause arrhythmia.
- the pulmonary vein may be connected to the left atrium of the heart.
- the methods described here include introducing and disposing a device in contact with one or more pulmonary vein regions.
- a pulse waveform may be delivered by one or more electrodes of the device to ablate tissue.
- a cardiac pacing signal may synchronize the delivered pulse waveforms with the cardiac cycle.
- the pulse waveforms may include a set of levels of a hierarchy.
- the tissue ablation thus performed may be delivered in synchrony with paced heartbeats. It should be appreciated that any of the ablation devices described herein may be used to ablate tissue using the methods discussed below as appropriate.
- FIG. 11 is a method ( 1100 ) for one embodiment of a tissue ablation process.
- the voltage pulse waveforms described herein may be applied during a refractory period of the cardiac cycle to avoid disruption of the sinus rhythm of the heart.
- the method ( 1100 ) includes introduction of a device (e.g., ablation device, such as the ablation device ( 100 ), and/or any of the ablation devices ( 200 , 300 , 400 , 500 , 640 , 700 , 800 , 900 , 1000 ) into a chest cavity of a patient by any suitable means at step ( 1102 ).
- a device e.g., ablation device, such as the ablation device ( 100 )
- the ablation devices 200 , 300 , 400 , 500 , 640 , 700 , 800 , 900 , 1000
- the chest of the patient may be surgically exposed to provide access to a desired ablation site, for example pulmonary vein in the region of the posterior left atrium.
- a desired ablation site for example pulmonary vein in the region of the posterior left atrium.
- the jaws/arms and body of the ablation device may enter the chest cavity at an oblique angle. It may be helpful to angle the jaws/arms in a manner that permits access to a posterior side of a patient's body (where the pulmonary veins may be located) through access from an anterior side of the patient's body.
- a surgical excision may open and expose the chest cavity.
- the ablation device may be advanced in a first configuration where the jaws/arms are closely spaced and/or in contact with each other to aid advancement of the ablation device towards a target tissue (e.g., pulmonary vein).
- a target tissue e.g., pulmonary vein
- FIG. 10 is a perspective view of a distal end of an ablation device ( 1000 ) having a first jaw ( 1010 ) and a second jaw ( 1012 ) coupled to a pulmonary vein ( 1030 ) at a basal location (at the portion of tissue connecting the pulmonary vein to the left atrium) on a posterior side of the left atrium ( 1040 ).
- the ablation device ( 1000 ) may be transformed to contact tissue between the jaws/arms at step ( 1104 ).
- the jaws of the ablation device ( 1000 ) may transition from a closed configuration to an open configuration to allow a portion of the pulmonary vein ( 1030 ) to be held between the jaws ( 1010 , 1020 ).
- Saline may be introduced into the chest cavity to at least partially surround the electrodes and create an electrically conductive environment for optimal delivery of current to tissue.
- the electrodes of the device may be configured in one or more anode/cathode subsets using, for example, the signal generator as described with respect to FIG. 6 .
- electrodes on opposing jaws and which are laterally spaced apart from each other may be configured in anode-cathode sets, as described with respect to FIGS. 8 and 9 . This configuration may reduce the risk of shorting and may help generate uniform ablation across the compressed portion of tissue.
- one or more electrodes may be configured to receive signal data corresponding to electrocardiography data. Electrocardiography data may be generated for display from the recorded signal data.
- a pacing signal may be generated for cardiac stimulation of the heart.
- the pacing signal may then be applied to the heart.
- the heart may be electrically paced with a cardiac stimulator to ensure pacing capture to establish periodicity and predictability of the cardiac cycle.
- One or more of atrial and ventricular pacing may be applied.
- An indication of the pacing signal may be transmitted to a signal generator.
- a time window within the refractory period of the cardiac cycle may then be defined within which one or more voltage pulse waveforms may be delivered.
- a refractory time window may follow a pacing signal.
- a common refractory time window may lie between both atrial and ventricular refractory time windows.
- a pulse waveform may be generated in synchronization with the pacing signal ( 1108 ).
- a voltage pulse waveform may be applied in the common refractory time window.
- the pulse waveform may be generated with a time offset with respect to the indication of the pacing signal.
- the start of a refractory time window may be offset from the pacing signal by a time offset.
- the voltage pulse waveform(s) may be applied over a series of heartbeats over corresponding common refractory time windows.
- hierarchical voltage pulse waveforms having a nested structure and a hierarchy of time intervals as described herein may be useful for irreversible electroporation, providing control and selectivity in different tissue types.
- a pulse waveform may be generated by a signal generator (e.g., the signal generator 610 ) and may include a set of levels in a hierarchy.
- a variety of hierarchical waveforms may be generated with a signal generator as disclosed herein.
- the pulse waveform may include a first level of a hierarchy of the pulse waveform including a first set of pulses. Each pulse has a pulse time duration and a first time interval separating successive pulses.
- a second level of the hierarchy of the pulse waveform may include a plurality of first sets of pulses as a second set of pulses.
- a second time interval may separate successive first sets of pulses.
- the second time interval may be at least three times the duration of the first time interval.
- a third level of the hierarchy of the pulse waveform may include a plurality of second sets of pulses as a third set of pulses.
- a third time interval may separate successive second sets of pulses.
- the third time interval may be at least thirty times the duration of the second level time interval.
- the pulse waveform may be delivered to pulmonary vein of a heart of a patient via one or more electrodes of a set of jaws of an ablation device.
- voltage pulse waveforms as described herein may be selectively delivered to electrode subsets such as paired anode-cathode subsets for ablation and isolation of the pulmonary vein.
- a first electrode of a first jaw may be configured as an anode and a second electrode of a second jaw may be configured as a cathode.
- FIGS. 2A-2C depict a set of simulation results in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device ( 200 ) that may be structurally and/or functionally similar to the ablation device in FIG. 6 .
- the ablation device ( 200 ) includes a first jaw ( 202 ) and a second jaw ( 204 ).
- the first jaw ( 202 ) may include a first electrode ( 210 ) and a second electrode ( 220 ).
- the second jaw ( 204 ) may include a third electrode ( 230 ) and a fourth electrode ( 240 ).
- the first jaw ( 202 ) and the second jaw ( 204 ) may be spaced apart and substantially parallel, and configured to engage tissue ( 260 ) therebetween during use.
- the first jaw ( 202 ) and the second jaw ( 204 ) may be spaced apart by a third measure ( 262 , 264 , 266 ).
- the first electrode ( 210 ) and the second electrode ( 220 ) may be may be disposed on a side of the first jaw ( 202 ) facing the second jaw ( 204 ).
- the third electrode ( 230 ) and the fourth electrode ( 240 ) may be disposed on a side of the second jaw ( 204 ) facing the first jaw ( 202 ).
- Each electrode ( 210 , 220 , 230 , 240 ) may include an exposed portion in electrical contact with tissue ( 260 ) during use.
- the first electrode ( 210 ) and the second electrode ( 220 ) may be spaced apart by a first measure ( 203 , 206 ).
- the third electrode ( 230 ) and the fourth electrode ( 240 ) may be spaced apart by a second measure ( 205 , 207 ).
- the electrodes ( 210 , 220 , 230 , 240 ) may be elongate electrodes as described herein.
- each electrode ( 210 , 220 , 230 , 240 ) may be independently addressable.
- the electrodes configured to deliver energy to tissue ( 260 ) may be adjacent electrodes on the same jaw.
- a first electrode ( 210 ) may be configured as an anode and a second electrode ( 220 ) may be configured as a cathode.
- the first jaw ( 202 ) may deliver 200 V to tissue ( 260 ) between first electrode ( 210 ) and second electrode ( 220 ) to generate respective ablation zones ( 270 , 272 , 274 ) having an electric field strength of about 460 V/cm.
- the first measure ( 203 , 206 ) may be 1 mm in FIG. 2A , 2 mm in FIG. 2B , and 3 mm in FIG. 2C .
- decreasing separation between electrodes ( 210 , 220 ) may generate an ablation zone of lesser width and greater depth.
- FIGS. 3A-3C depict a set of simulation results in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device ( 300 ).
- the plots in FIGS. 3A-3C simulate higher voltages and greater separation between electrodes than the plots in FIGS. 2A-2C .
- the ablation device ( 300 ) includes a first jaw ( 302 ) and a second jaw ( 304 ).
- the first jaw ( 302 ) may include a first electrode ( 310 ) and a second electrode ( 320 ).
- the second jaw ( 304 ) may include a third electrode ( 330 ) and a fourth electrode ( 340 ).
- the first jaw ( 302 ) and the second jaw ( 304 ) may be spaced apart and substantially parallel and configured to engage tissue ( 360 ) therebetween during use.
- the first jaw ( 302 ) and the second jaw ( 304 ) may be spaced apart by a third measure ( 360 , 362 , 364 ).
- the first electrode ( 310 ) and the second electrode ( 320 ) may be may be disposed on a side of the first jaw ( 302 ) facing the second jaw ( 304 ).
- the third electrode ( 330 ) and the fourth electrode ( 340 ) may be disposed on a side of the second jaw ( 304 ) facing the first jaw ( 302 ).
- Each electrode ( 310 , 320 , 330 , 340 ) may include an exposed portion in electrical contact with tissue ( 360 ) during use.
- the first electrode ( 310 ) and the second electrode ( 320 ) may be spaced apart by a first measure ( 303 , 306 , 308 ).
- the third electrode ( 330 ) and the fourth electrode ( 340 ) may be spaced apart by a second measure ( 305 , 307 , 309 ).
- the electrodes ( 310 , 320 , 330 , 340 ) may be elongate electrodes as described herein. In some embodiments, each electrode ( 310 , 320 , 330 , 340 ) may be independently addressable.
- the electrodes configured to deliver energy to tissue ( 360 ) may be adjacent electrodes on the same jaw.
- a first electrode ( 310 ) may be configured as an anode and a second electrode ( 320 ) may be configured as a cathode.
- the first jaw ( 302 ) may deliver 300 V to tissue ( 360 ) between first electrode ( 310 ) and second electrode ( 320 ) to generate respective ablation zones ( 370 , 372 , 374 ) having an electric field strength of about 460 V/cm.
- the first measure ( 303 , 306 , 308 ) may be 3 mm in FIG. 3A , 4 mm in FIG. 3B , and 5 mm in FIG.
- decreasing separation between electrodes ( 310 , 320 ) may generate an ablation zone of lesser width and greater depth.
- a separation of 5 mm in FIG. 3C may generate non-contiguous ablation zones ( 374 ).
- FIGS. 4A-4E depict a set of simulation results in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device ( 400 ).
- the plots in FIGS. 4A-4E generate electric fields using electrodes on opposing jaws rather than adjacent electrodes on the same jaw as shown in FIGS. 2A-3C .
- the ablation device ( 400 ) includes a first jaw ( 402 ) and a second jaw ( 404 ).
- the first jaw ( 402 ) may include a first electrode ( 410 ) and a second electrode ( 420 ).
- the second jaw ( 404 ) may include a third electrode ( 430 ) and a fourth electrode ( 440 ).
- the first jaw ( 402 ) and the second jaw ( 404 ) may be spaced apart and substantially parallel and configured to engage tissue ( 460 ) therebetween during use.
- the first jaw ( 402 ) and the second jaw ( 404 ) may be spaced apart by a third measure ( 460 , 462 , 464 , 466 , 468 ).
- the first electrode ( 410 ) and the second electrode ( 420 ) may be may be disposed on a side of the first jaw ( 402 ) facing the second jaw ( 404 ).
- the third electrode ( 430 ) and the fourth electrode ( 440 ) may be disposed on a side of the second jaw ( 404 ) facing the first jaw ( 402 ).
- Each electrode ( 410 , 420 , 430 , 440 ) may include an exposed portion in electrical contact with tissue ( 460 ) during use.
- the first electrode ( 410 ) and the second electrode ( 420 ) may be spaced apart by a first measure ( 403 ).
- the third electrode ( 430 ) and the fourth electrode ( 440 ) may be spaced apart by a second measure ( 405 ).
- the electrodes ( 410 , 420 , 430 , 440 ) may be elongate electrodes as described herein. In some embodiments, each electrode ( 410 , 420 , 430 , 440 ) may be independently addressable.
- the electrodes configured to deliver energy to tissue ( 460 ) may be electrodes that directly oppose each other on different jaws.
- a second electrode ( 420 ) may be configured as an anode and a fourth electrode ( 440 ) may be configured as a cathode.
- the first jaw ( 402 ) may deliver 200 V to tissue ( 460 ) between second electrode ( 420 ) and fourth electrode ( 440 ) to generate ablation zones ( 470 ) having an electric field strength of about 460 V/cm across a depth of the tissue ( 460 ) held by between the jaws ( 402 , 404 ).
- the first jaw ( 402 ) may deliver 300 V to tissue ( 360 ) between second electrode ( 420 ) and fourth electrode ( 440 ) to generate respective ablation zones ( 470 , 472 , 474 , 476 , 478 ) having an electric field strength of about 460 V/cm.
- the third measure ( 460 ) may be 2 mm in FIG. 4A
- third measure ( 462 ) may be 3 mm in FIG. 4B
- third measure ( 464 ) may be and 4 mm in FIG. 4C
- third measure ( 466 ) may be 5 mm in FIG. 4D
- third measure ( 468 ) may be 6 mm in FIG. 4E .
- decreasing separation between electrodes ( 420 , 440 ) may generate an ablation zone of greater intensity.
- a separation of 6 mm in FIG. 4E may generate non-contiguous ablation zones ( 478 ).
- FIGS. 5A-5F depict a set of simulation results in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device ( 500 ).
- the plots in FIGS. 5A-5F generate electric fields using electrodes disposed diagonally on opposing jaws rather than adjacent electrodes on the same jaw as shown in FIGS. 2A-3C .
- the ablation device ( 500 ) includes a first jaw ( 502 ) and a second jaw ( 504 ).
- the first jaw ( 502 ) may include a first electrode ( 510 ) and a second electrode ( 520 ).
- the second jaw ( 504 ) may include a third electrode ( 530 ) and a fourth electrode ( 540 ).
- the first jaw ( 502 ) and the second jaw ( 504 ) may be spaced apart and substantially parallel and configured to engage tissue ( 560 ) therebetween during use.
- the first jaw ( 502 ) and the second jaw ( 504 ) may be spaced apart by a third measure ( 560 , 562 , 564 , 566 , 568 , 569 ).
- the first electrode ( 510 ) and the second electrode ( 520 ) may be disposed on a side of the first jaw ( 502 ) facing the second jaw ( 504 ).
- the third electrode ( 530 ) and the fourth electrode ( 540 ) may be disposed on a side of the second jaw ( 504 ) facing the first jaw ( 502 ).
- Each electrode ( 510 , 520 , 530 , 540 ) may include an exposed portion in electrical contact with tissue ( 560 ) during use.
- the first electrode ( 510 ) and the second electrode ( 520 ) may be spaced apart by a first measure ( 503 ).
- the third electrode ( 530 ) and the fourth electrode ( 540 ) may be spaced apart by a second measure ( 505 ).
- the electrodes ( 510 , 520 , 530 , 540 ) may be elongate electrodes as described herein. In some embodiments, each electrode ( 510 , 520 , 530 , 540 ) may be independently addressable.
- the electrodes configured to deliver energy to tissue may be electrodes that are laterally spaced apart and adjacent on opposing different jaws.
- a second electrode ( 520 ) may be configured as an anode and a third electrode ( 530 ) may be configured as a cathode.
- This anode-cathode configuration of the electrodes reduces the risk of electrical shorting since the anode and cathode will not contact each other even if the jaws are brought into contact with each other.
- the first jaw ( 502 ) may deliver 200 V to tissue ( 560 ) between second electrode ( 520 ) and third electrode ( 540 ) to generate ablation zone ( 560 ) having an electric field strength of about 460 V/cm across a depth of the tissue ( 460 ) held between the jaws ( 502 , 504 ).
- the first jaw ( 502 ) may deliver 300 V to tissue ( 560 ) between second electrode ( 520 ) and third electrode ( 530 ) to generate respective ablation zones ( 572 , 574 ) having an electric field strength of about 460 V/cm.
- the first jaw ( 502 ) may deliver 400 V to tissue ( 560 ) between second electrode ( 520 ) and third electrode ( 530 ) to generate respective ablation zones ( 576 , 578 ) having an electric field strength of about 460 V/cm).
- the first jaw ( 502 ) may deliver 500 V to tissue ( 560 ) between second electrode ( 520 ) and third electrode ( 530 ) to generate ablation zone ( 579 ) having an electric field strength of about 460 V/cm.
- the third measure ( 560 ) may be 2 mm in FIG. 5A
- third measure ( 562 ) may be 4 mm in FIG. 5B
- third measure ( 564 ) may be and 5 mm in FIG. 5C
- third measure ( 566 ) may be 5 mm in FIG. 5D
- third measure ( 568 ) may be 6 mm in FIG. 5E
- third measure ( 569 ) may be 6 mm in FIG. 5F .
- the pulse waveform(s) as disclosed herein are usable with any of the systems ( 600 ), devices (e.g., 200 , 300 , 400 , 500 , 640 , 700 , 800 , 900 , 1000 ), and methods (e.g., 1100 ) described herein.
- Some embodiments are directed to pulsed high voltage waveforms together with a sequenced delivery scheme for delivering energy to tissue via sets of electrodes.
- peak electric field values may be reduced and/or minimized while at the same time sufficiently large electric field magnitudes may be maintained in regions where tissue ablation is desired.
- a system useful for irreversible electroporation includes a signal generator and a processor capable of being configured to apply pulsed voltage waveforms to a selected plurality or a subset of electrodes of an ablation device.
- the processor is configured to control inputs whereby selected pairs of anode-cathode subsets of electrodes may be sequentially triggered based on a pre-determined sequence, and in one embodiment the sequenced delivery may be triggered from a cardiac stimulator and/or pacing device.
- the ablation pulse waveforms are applied in a refractory period of the cardiac cycle to avoid disruption of the sinus rhythm of the heart.
- One example method of enforcing this is to electrically pace the heart with a cardiac stimulator and ensure pacing capture to establish periodicity and predictability of the cardiac cycle, and then to define a time window well within the refractory period of this periodic cycle within which the ablation waveform is delivered.
- the pulsed voltage waveforms disclosed herein are hierarchical in organization and have a nested structure.
- the pulsed waveform includes hierarchical groupings of pulses with a variety of associated timescales.
- the associated timescales and pulse widths, and the numbers of pulses and hierarchical groupings may be selected to satisfy one or more of a set of Diophantine inequalities involving the frequency of cardiac pacing.
- Pulsed waveforms for electroporation energy delivery as disclosed herein may enhance the safety, efficiency and effectiveness of the energy delivery by reducing the electric field threshold associated with irreversible electroporation, yielding more effective ablative lesions with reduced total energy delivered. This in turn may broaden the areas of clinical application of electroporation including therapeutic treatment of a variety of cardiac arrhythmias.
- FIG. 12 illustrates a pulsed voltage waveform in the form of a sequence of rectangular double pulses, with each pulse, such as the pulse ( 1200 ) being associated with a pulse width or duration.
- the pulse width/duration may be about 0.5 microseconds, about 1 microsecond, about 5 microseconds, about 10 microseconds, about 25 microseconds, about 50 microseconds, about 100 microseconds, about 125 microseconds, about 140 microseconds, about 150 microseconds, including all values and sub-ranges in between.
- the pulsed waveform of FIG. 12 illustrates a set of monophasic pulses where the polarities of all the pulses are the same (all positive in FIG. 12 , as measured from a zero baseline).
- the height of each pulse ( 1200 ) or the voltage amplitude of the pulse ( 1200 ) may be in the range of about 300 volts, about 1,000 volts, or about 5,000 volts, including all values and sub ranges in between.
- the pulse ( 1200 ) is separated from a neighboring pulse by a time interval ( 1202 ), also sometimes referred to as a first time interval.
- the first time interval may be about 10 microseconds, about 50 microseconds, about 100 microseconds, about 200 microseconds, about 500 microseconds, about 800 microseconds, about 1 millisecond including all values and sub ranges in between, in order to generate irreversible electroporation.
- FIG. 13 introduces a pulse waveform with the structure of a hierarchy of nested pulses.
- FIG. 13 shows a series of monophasic pulses such as pulse ( 1300 ) with pulse width/pulse time duration w, separated by a time interval (also sometimes referred to as a first time interval) such as ( 1302 ) of duration t 1 between successive pulses, a number m 1 of which are arranged to form a group of pulses ( 1310 ) (also sometimes referred to as a first set of pulses).
- a time interval also sometimes referred to as a first time interval
- the waveform has a number m 2 of such groups of pulses (also sometimes referred to as a second set of pulses) separated by a time interval ( 1312 ) (also sometimes referred to as a second time interval) of duration t 2 between successive groups.
- the collection of m 2 such pulse groups, marked by ( 1320 ) in FIG. 13 constitutes the next level of the hierarchy, which may be referred to as a packet and/or as a third set of pulses.
- the pulse width and the time interval t 1 between pulses may both be in the range of microseconds to hundreds of microseconds, including all values and sub ranges in between.
- the time interval t 2 may be at least three times larger than the time interval t 1 .
- the ratio t 2 /t 1 may be in the range between about 3 and about 300, including all values and sub-ranges in between.
- FIG. 14 further elaborates the structure of a nested pulse hierarchy waveform.
- a series of m 1 pulses (individual pulses not shown) form a group of pulses ( 1400 ) (e.g., a first set of pulses).
- a series of m 2 such groups separated by an inter-group time interval ( 1410 ) of duration t 2 (e.g., a second time interval) between one group and the next form a packet 132 (e.g., a second set of pulses).
- the time interval t 3 may be at least about thirty times larger than the time interval t 2 .
- the time interval t 3 may be at least fifty times larger than the time interval t 2 .
- the ratio t 3 /t 2 may be in the range between about 30 and about 800, including all values and sub-ranges in between.
- the amplitude of the individual voltage pulses in the pulse hierarchy may be anywhere in the range from 300 volts to 7,000 volts or higher, including all values and sub ranges in between.
- FIG. 15 provides an example of a biphasic waveform sequence with a hierarchical structure.
- biphasic pulses such as ( 1500 ) have a positive voltage portion as well as a negative voltage portion to complete one cycle of the pulse.
- There is a time delay ( 1502 ) (e.g., a first time interval) between adjacent cycles of duration t 1 , and n 1 such cycles form a group of pulses ( 1510 ) (e.g., a first set of pulses).
- the figure also shows a second packet ( 1530 ), with a time delay ( 1532 ) (e.g., a third time interval) of duration t 3 between the packets.
- a time delay 1532
- amplitude of each pulse or the voltage amplitude of the biphasic pulse may be anywhere in the range from 300 volts to 7,000 volts or higher, including all values and sub ranges in between.
- the pulse width/pulse time duration may be in the range from nanoseconds or even sub-nanoseconds to tens of microseconds, while the delays t 1 may be in the range from zero to several microseconds.
- the inter-group time interval t 2 may be at least ten times larger than the pulse width.
- the time interval t 3 may be at least about twenty times larger than the time interval t 2 .
- the time interval t 3 may be at least fifty times larger than the time interval t 2 .
- Embodiments disclosed herein include waveforms structured as hierarchical waveforms that include waveform elements/pulses at various levels of the hierarchy.
- the individual pulses such as ( 1300 ) in FIG. 13 includes the first level of the hierarchy, and have an associated pulse time duration and a first time interval between successive pulses.
- a set of pulses, or elements of the first level structure form a second level of the hierarchy such as the group of pulses/second set of pulses ( 1310 ) in FIG. 13 .
- associated with the waveform are parameters such as a total time duration of the second set of pulses (not shown), a total number of first level elements/first set of pulses, and second time intervals between successive first level elements that describe the second level structure/second set of pulses.
- the total time duration of the second set of pulses may be between about 20 microseconds and about 10 milliseconds, including all values and subranges in between.
- a set of groups, second set of pulses, or elements of the second level structure form a third level of the hierarchy such as the packet of groups/third set of pulses ( 1320 ) in FIG. 13 .
- there is a total time duration of the third set of pulses (not shown), a total number of second level elements/second set of pulses, and third time intervals between successive second level elements that describe the third level structure/third set of pulses.
- the total time duration of the third set of pulses may be between about 60 microseconds and about 200 milliseconds, including all values and sub ranges in between.
- the generally iterative or nested structure of the waveforms may continue to a higher plurality of levels, such as ten levels of structure, or more.
- hierarchical waveforms with a nested structure and hierarchy of time intervals as described herein are useful for irreversible electroporation ablation energy delivery, providing a good degree of control and selectivity for applications in different tissue types.
- a variety of hierarchical waveforms may be generated with a suitable pulse generator. It is understood that while the examples herein identify separate monophasic and biphasic waveforms for clarity, it should be noted that combination waveforms, where some portions of the waveform hierarchy are monophasic while other portions are biphasic, may also be generated/implemented.
- the ablation pulse waveforms described herein are applied during the refractory period of the cardiac cycle to avoid disruption of the sinus rhythm of the heart.
- a method of treatment includes electrically pacing the heart with a cardiac stimulator to ensure pacing capture to establish periodicity and predictability of the cardiac cycle, and then defining a time window within the refractory period of the cardiac cycle within which one or more pulsed ablation waveforms may be delivered.
- FIG. 16 illustrates an example where both atrial and ventricular pacing is applied (for instance, with pacing leads or catheters situated in the right atrium and right ventricle respectively). With time represented on the horizontal axis, FIG.
- FIG. 16 illustrates a series of ventricular pacing signals such as ( 1600 ) and ( 1610 ), and a series of atrial pacing signals ( 1620 , 1630 ), along with a series of ECG waveforms ( 1640 , 1642 ) that are driven by the pacing signals.
- a series of ventricular pacing signals such as ( 1600 ) and ( 1610 )
- a series of atrial pacing signals 1620 , 1630
- ECG waveforms 1640 , 1642
- a common refractory time window ( 1650 ) of duration T r may be defined that lies within both atrial and ventricular refractory time windows ( 1622 , 1602 ).
- the electroporation ablation waveform(s) may be applied in this common refractory time window ( 1650 ).
- the start of this refractory time window ( 1622 ) is offset from the pacing signal ( 1600 ) by a time offset ( 1604 ) as indicated in FIG. 16 .
- the time offset ( 1604 ) may be smaller than about 25 milliseconds, in some embodiments.
- a similarly defined common refractory time window ( 1652 ) is the next time window available for application of the ablation waveform(s).
- the ablation waveform(s) may be applied over a series of heartbeats, at each heartbeat remaining within the common refractory time window.
- each packet of pulses as defined above in the pulse waveform hierarchy may be applied over a heartbeat, so that a series of packets is applied over a series of heartbeats, for a given electrode set.
- the terms “about” and/or “approximately” when used in conjunction with numerical values and/or ranges generally refer to those numerical values and/or ranges near to a recited numerical value and/or range. In some instances, the terms “about” and “approximately” may mean within ⁇ 10% of the recited value. For example, in some instances, “about 100 [units]” may mean within ⁇ 10% of 100 (e.g., from 90 to 110). The terms “about” and “approximately” may be used interchangeably.
- Some embodiments described herein relate to a computer storage product with a non-transitory computer-readable medium (also may be referred to as a non-transitory processor-readable medium) having instructions or computer code thereon for performing various computer-implemented operations.
- the computer-readable medium (or processor-readable medium) is non-transitory in the sense that it does not include transitory propagating signals per se (e.g., a propagating electromagnetic wave carrying information on a transmission medium such as space or a cable).
- the media and computer code also may be referred to as code or algorithm
- non-transitory computer-readable media include, but are not limited to, magnetic storage media such as hard disks, floppy disks, and magnetic tape; optical storage media such as Compact Disc/Digital Video Discs (CD/DVDs), Compact Disc-Read Only Memories (CD-ROMs), and holographic devices; magneto-optical storage media such as optical disks; carrier wave signal processing modules; and hardware devices that are specially configured to store and execute program code, such as Application-Specific Integrated Circuits (ASICs), Programmable Logic Devices (PLDs), Read-Only Memory (ROM) and Random-Access Memory (RAM) devices.
- ASICs Application-Specific Integrated Circuits
- PLDs Programmable Logic Devices
- ROM Read-Only Memory
- RAM Random-Access Memory
- Other embodiments described herein relate to a computer program product, which may include, for example, the instructions and/or computer code disclosed herein.
- Hardware modules may include, for example, a general-purpose processor (or microprocessor or microcontroller), a field programmable gate array (FPGA), and/or an application specific integrated circuit (ASIC).
- Software modules (executed on hardware) may be expressed in a variety of software languages (e.g., computer code), including C, C++, Java®, Ruby, Visual Basic®, and/or other object-oriented, procedural, or other programming language and development tools.
- Examples of computer code include, but are not limited to, micro-code or micro-instructions, machine instructions, such as produced by a compiler, code used to produce a web service, and files containing higher-level instructions that are executed by a computer using an interpreter. Additional examples of computer code include, but are not limited to, control signals, encrypted code, and compressed code.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Otolaryngology (AREA)
- Plasma & Fusion (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Surgical Instruments (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Abstract
Description
- The embodiments described herein relate generally to medical devices for therapeutic electrical energy delivery, and more particularly to a surgical clamp device for delivering electrical energy to ablate tissue.
- In the past two decades, the technique of electroporation has advanced from the laboratory to clinical applications, while the effects of brief pulses of high voltages and large electric fields on tissue has been investigated for the past forty years or more. Application of brief, high DC voltages to tissue, thereby generating locally high electric fields typically in the range of hundreds of Volts/centimeter, can disrupt cell membranes by generating pores in the cell membrane. While the precise mechanism of this electrically-driven pore generation (or electroporation) is not well understood, it is thought that the application of relatively large electric fields generates instabilities in the lipid bilayers in cell membranes, causing the occurrence of a distribution of local gaps or pores in the membrane. If the applied electric field at the membrane is larger than a threshold value, the electroporation is irreversible and the pores remain open, permitting exchange of material across the membrane and leading to necrosis and/or apoptosis (cell death). Subsequently the tissue heals in a natural process.
- While pulsed DC voltages are known to drive electroporation under the right circumstances, known approaches do not provide for ease of navigation, placement and therapy delivery from one or more devices and for safe energy delivery, especially in the context of ablation therapy for cardiac arrhythmias with epicardial catheter devices.
- Thus, there is a need for devices that can effectively deliver electroporation ablation therapy selectively to tissue in regions of interest while minimizing damage to healthy tissue. In particular, there is a need for devices that can efficiently deliver electroporation therapy to desired tissue regions while at the same time minimizing the occurrence of irreversible electroporation in undesired tissue regions. Such elective and effective electroporation delivery methods with enhanced safety of energy delivery can broaden the areas of clinical application of electroporation including therapeutic treatment of a variety of cardiac arrhythmias.
- Described here are systems, devices, and methods for ablating tissue through irreversible electroporation. An apparatus may include a first jaw including a plurality of first electrodes. A second jaw may include a plurality of second electrodes. The first jaw and the second jaw may be substantially rigid, elongate, and may collectively define a longitudinal axis. The first jaw and the second jaw may be further configured to engage tissue therebetween during use. Each electrode of the plurality of first electrodes may have a width orthogonal to the longitudinal axis that is less than a length of that electrode measured parallel to the longitudinal axis. The plurality of first electrodes may be spaced apart laterally with respect to the longitudinal axis. Each electrode of the plurality of second electrodes may have a width orthogonal to the longitudinal axis that is less than a length of that electrode measured parallel to the longitudinal axis. The plurality of second electrodes may be spaced apart laterally with respect to the longitudinal axis. Each electrode of the plurality of first electrodes and the plurality of second electrodes may be configured to deliver a pulse waveform of at least about 200 Volts.
- In some embodiments, each electrode of the plurality of first electrodes and the plurality of second electrodes may be independently addressable. In some embodiments, the longitudinal axis has one or more of a straight portion and curved portion. In some embodiments, an electrode of the plurality of first electrodes may be configured as an anode and an electrode from the plurality of second electrodes may be configured as a cathode, the anode being disposed directly across from the cathode. In some embodiments, an electrode from the plurality of first electrodes may be configured as an anode and another electrode from the plurality of first electrodes is configured as a cathode. The anode may be spaced apart laterally from the cathode. In some embodiments, at least two of the plurality of first electrodes may be spaced apart by a first measure. The first jaw and the second jaw may be spaced apart by a second measure. A ratio of the second measure to the first measure may be between about 0.1:1 and about 12:1. In some embodiments, a distance between a midpoint of at least two of the plurality of first electrodes in a cross-section orthogonal to the longitudinal axis may be between about 1 mm and about 10 mm.
- In some embodiments, any two adjacent electrodes of the plurality of first electrodes may be spaced apart by a first measure of between about 0.5 mm and about 10 mm and any two adjacent electrodes of the plurality of second electrodes may be spaced apart by a second measure of between about 0.5 mm and about 10 mm. In some embodiments, any two adjacent electrodes of the plurality of first electrodes may be spaced apart by a first measure and any two adjacent electrodes of the plurality of second electrodes are spaced apart by a second measure. A ratio of the first measure to the second measure may be between about 0.05:1 and about 20:1.
- In some embodiments, any two adjacent electrodes of the plurality of first electrodes may be spaced apart by a first measure and any two adjacent electrodes of the plurality of second electrodes may be spaced apart by a second measure. A ratio of the width of any electrode of the plurality of first electrodes to the width of any electrode of the plurality of second electrodes to the first measure may be between about 0.01:1 and about 10:1. In some embodiments, each electrode of the plurality of first electrodes and the plurality of second electrodes may have a length of between about 10 mm and about 120 mm.
- In some embodiments, the first and second jaws may be configured to transition between a first configuration for positioning the first and second jaws through or around a body cavity, organ system, or anatomical structure and a second configuration for engaging the tissue. In some embodiments, the first and second jaws may be spaced apart by a spacing distance in the second configuration. In some embodiments, the cross-section of each electrode of the plurality of first electrodes and the plurality of second electrodes may be substantially rectangular. In some embodiments, each electrode of the plurality of first electrodes and the plurality of second electrodes may include a curved portion. In some of these embodiments, the curved portion may have a radius of curvature of about 1 cm or larger. In some embodiments, the curved portion may have a J shape.
- In some embodiments, each electrode of the plurality of first electrodes and the plurality of second electrodes may include an exposed portion in electrical contact with the tissue during use. In some of these embodiments, the exposed portion of each electrode of the plurality of first electrodes and the plurality of second electrodes may be flat or convex. In some embodiments, the first and second jaws may be parallel. In some embodiments, a pulse generator may include a generator. The generator may be coupled to each electrode of the plurality of first electrodes and the plurality of second electrodes. The controller may include a processor and memory. The generator may be configured to generate a pulse waveform of at least about 200 Volts. A first set of electrodes of the plurality of first electrodes and the plurality of second electrodes may be configured for pulse waveform delivery. In some embodiments, the pulse waveform may be delivered to the first set of electrodes. In some of these embodiments, the generator may be further configured to configure a second set of electrodes of the plurality of first electrodes and the plurality of second electrodes for receiving electrical activity of tissue, and receive signal data corresponding to electrical activity of the tissue using the second set of electrodes. Electrocardiography data may be generated using the signal data.
- In some embodiments, a handle may be coupled to the first jaw and the second jaw. In some of these embodiments, the handle may include one or more of a jaw control, electrode selection control, and pulse waveform control. In some embodiments, a pivot may couple the first jaw to the second jaw. In some embodiments, a spring may be configured to bias the first and second jaws closed. In some embodiments, one or more lead wires may be coupled to the plurality of first electrodes and the plurality of second electrodes.
- In some embodiments, an apparatus may include a first jaw including a first electrode and a second electrode. A second jaw may include a third electrode and a fourth electrode. The first jaw and the second jaw may be substantially rigid, elongate, and collectively define a longitudinal axis. The first jaw and the second jaw may be further configured to engage tissue therebetween during use. The first electrode may be disposed directly across the third electrode. The second electrode may be disposed directly across the fourth electrode. A processor may be operably coupled to the first jaw and the second jaw. The processor may be configured to, during use, configure the first electrode as an anode and the third electrode as a cathode. Pulsed electric field ablative energy may be delivered via the first electrode and the third electrode.
- In some embodiments, each of the first electrode, second electrode, third electrode, and fourth electrode are independently addressable. In some embodiments, the longitudinal axis may have one or more of a straight portion and a curved portion. In some embodiments, the first electrode and the second electrode may be spaced apart by a first measure of between about 0.5 mm and about 10 mm, and the third electrode and the fourth electrode may be spaced apart by a second measure of between about 0.5 mm and about 10 mm. In some embodiments, the first electrode and the second electrode may be spaced apart by a first measure and the third electrode and the fourth electrode may be spaced apart by a second measure. A ratio of the first measure to the second measure may be between about 0.05:1 and about 20:1. In some embodiments, the first electrode and the second electrode may be spaced apart by a first measure. A ratio of a width of the first electrode to the first measure may be between about 0.01:1 and about 10:1. In some embodiments, the first, second, third, and fourth electrode may each have a length of between about 10 mm and about 120 mm.
- In some embodiments, the first and second jaws may be configured to transition between a first configuration for positioning the first and second jaws through or around a body cavity, organ system, or anatomical structure and a second configuration for engaging the tissue. In some of these embodiments, the first and second jaws may be spaced apart by a spacing distance in the second configuration. In some embodiments, the cross-section of the first, second, third, and fourth electrodes may be substantially rectangular. In some embodiments, the first, second, third, and fourth electrodes may include a curved portion.
- In some of these embodiments, the curved portion may have a radius of curvature of about 1 cm or larger. In some of these embodiments, the curved portion may have a J shape. In some embodiments, the first, second, third, and fourth electrodes may include an exposed portion in electrical contact with the tissue during use. In some of these embodiments, the exposed portion of each of the electrodes may be flat or convex. In some embodiments, the first and second jaws may be parallel.
- In some embodiments, a pulse generator may include a controller. The pulse generator may be coupled to the first, second, third, and fourth electrodes. The controller may include a processor and memory. The generator may be configured to generate a pulse waveform of at least about 200 Volts. A first set of electrodes of the first, second, third, and fourth electrodes may be configured for pulse waveform delivery. The pulse waveform may be delivered to the first set of electrodes.
- In some embodiments, the generator may be further configured to configure a second set of electrodes of the first, second, third, and fourth electrodes for receiving electrical activity of tissue. Signal data may be received corresponding to electrical activity of the tissue using the second set of electrodes. Electrocardiography data may be generated using the signal data.
- In some embodiments, a handle may be coupled to the first jaw and the second jaw. In some of these embodiments, the handle may include one or more of a jaw control, electrode selection control, and pulse waveform control. In some embodiments, a pivot may couple the first jaw to the second jaw. In some embodiments, a spring may be configured to bias the first and second jaws closed. In some embodiments, one or more lead wires may be coupled to the first, second, third, and fourth electrodes.
- In some embodiments, a method of ablating tissue via irreversible electroporation may include the steps of clamping tissue between a first jaw and a second jaw of an apparatus. The first jaw may include a plurality of first electrodes and the second jaw may include a plurality of second electrodes. The first jaw and the second jaw may be substantially rigid, elongate, and may collectively define a longitudinal axis. Each electrode of the plurality of first electrodes may have a width orthogonal to the longitudinal axis that is less than a length parallel to the longitudinal axis of that electrode. The plurality of first electrodes may be spaced apart laterally with respect to the longitudinal axis. Each electrode of the plurality of second electrodes may have a width orthogonal to the longitudinal axis that is less than a length parallel to the longitudinal axis of that electrode. The plurality of second electrodes may be spaced apart laterally with respect to the longitudinal axis. An electrode of the plurality of first electrodes may be configured as an anode. An electrode of the plurality of second electrodes may be configured as a cathode. The anode and the cathode may be disposed diagonally across the longitudinal axis and may be spaced apart laterally with respect to the longitudinal axis. Ablative energy may be delivered to the tissue via the anode and the cathode.
- In some embodiments, the longitudinal axis may have one or more of a straight portion and curved portion. In some embodiments, clamping the tissue may include transitioning the first and second jaws between a first configuration for advancing the apparatus and a second configuration for clamping the tissue. In some embodiments, the tissue may be a region of the atrial base of a pulmonary vein. In some embodiments, the pulse waveform may include a first level of a hierarchy of the pulsed waveform includes a first set of pulses, each pulse having a pulse time duration, and a first time interval separating successive pulses. A second level of the hierarchy of the pulsed waveform may include a plurality of first sets of pulses as a second set of pulses, a second time interval separating successive first sets of pulses, the second time interval being at least three times the duration of the first time interval. A third level of the hierarchy of the pulsed waveform may include a plurality of second sets of pulses as a third set of pulses, a third time interval separating successive second sets of pulses, the third time interval being at least thirty times the duration of the second level time interval.
- In some embodiments, signal data may be received corresponding to electrical activity of the tissue using one or more of the plurality of first electrodes and the plurality of second electrodes. Electrocardiography data may be generated using the signal data. In some embodiments, the first and second jaws may be positioned through or around a body cavity, organ system, or anatomical structure. In some embodiments, each electrode of the plurality of first electrodes and the plurality of second electrodes may be independently addressable.
-
FIG. 1A is a schematic perspective view of an ablation device, according to embodiments. -
FIG. 1B is a schematic cross-sectional side view of an ablation device, according to other embodiments. -
FIG. 2A is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device, according to other embodiments. -
FIG. 2B is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device with the electrodes spaced further apart than those inFIG. 2A , according to other embodiments. -
FIG. 2C is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device with the electrodes spaced further apart than those inFIG. 2B , according to other embodiments. -
FIG. 3A is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device, according to other embodiments. -
FIG. 3B is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device with the electrodes spaced further apart than those inFIG. 3A , according to other embodiments. -
FIG. 3C is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device with the electrodes spaced further apart than those inFIG. 3B , according to other embodiments. -
FIG. 4A is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device, according to other embodiments. -
FIG. 4B is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device with the jaws spaced further apart than those inFIG. 4A , according to other embodiments. -
FIG. 4C is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device with the jaws spaced further apart than those inFIG. 4B , according to other embodiments. -
FIG. 4D is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device with the jaws spaced further apart than those inFIG. 4C , according to other embodiments. -
FIG. 4E is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device with the jaws spaced further apart than those inFIG. 4D , according to other embodiments. -
FIG. 5A is a schematic cross-sectional side view of an ablation device generating an electric field, according to other embodiments. -
FIG. 5B is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device with the jaws spaced further apart than those inFIG. 5A , according to other embodiments. -
FIG. 5C is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device with the jaws spaced further apart than those inFIG. 5B , according to other embodiments. -
FIG. 5D is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device using a higher voltage than applied inFIG. 5C , according to other embodiments. -
FIG. 5E is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device with the jaws spaced further apart than those inFIG. 5D , according to other embodiments. -
FIG. 5F is a simulation result in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device using a higher voltage than applied inFIG. 5E , according to other embodiments. -
FIG. 6 is a block diagram of an electroporation system, according to embodiments. -
FIG. 7 is a side view of an ablation device, according to other embodiments. -
FIG. 8 is a perspective view of a distal end of an ablation device, according to embodiments. -
FIG. 9A is a perspective view of a distal end of an ablation device, according to embodiments.FIG. 9B is a perspective view of a distal end of an ablation device shown inFIG. 9A having tissue disposed in between the arms of the device, according to embodiments. -
FIG. 10 is a perspective view of a distal end of an ablation device having a pulmonary vein disposed between the arms of the device, according to embodiments. -
FIG. 11 illustrates a method for tissue ablation, according to embodiments. -
FIG. 12 is an example waveform showing a sequence of voltage pulses with a pulse width defined for each pulse, according to embodiments. -
FIG. 13 schematically illustrates a hierarchy of pulses showing pulse widths, intervals between pulses, and groupings of pulses, according to embodiments. -
FIG. 14 provides a schematic illustration of a nested hierarchy of monophasic pulses displaying different levels of nested hierarchy, according to embodiments. -
FIG. 15 is a schematic illustration of a nested hierarchy of biphasic pulses displaying different levels of nested hierarchy, according to embodiments. -
FIG. 16 illustrates schematically a time sequence of electrocardiograms and cardiac pacing signals together with atrial and ventricular refractory time periods and indicating a time window for irreversible electroporation ablation, according to embodiments. - Described herein are systems, devices, and methods for selective and rapid application of pulsed electric fields to ablate tissue by irreversible electroporation. Generally, the systems, devices, and methods described herein may be used to generate electric field magnitudes at desired regions of interest while tissue is clamped in order to treat atrial fibrillation via irreversible electroporation. An ablation device may include a set of jaws or arms each having a set of electrodes that may be configured to hold (e.g., clamp, grasp, compress) a portion of tissue therebetween and provide tissue ablation with reduced energy delivery. The set of electrodes may be configured to contact tissue during use. The jaws may transition from a closed configuration to an open configuration for grasping tissue such as a pulmonary vein. It is understood that the set of jaws may be transformed into any intermediate configuration between the open and closed configurations, continuously or in discrete steps. For example, the jaws may transition from a closed configuration to an open configuration to allow tissue to be placed between the jaws. Then, the jaws may be brought closer together to apply compression force to tissue disposed therebetween to target energy delivery to a desired portion of tissue.
- An irreversible electroporation system as described herein may include a signal generator and a processor configured to apply one or more voltage pulse waveforms to a selected set of electrodes of an ablation device (e.g., clamp, clip, forcep, hemostat) to deliver energy to a region of interest (e.g., portion of a pulmonary vein) and provide a highly configurable a set of electrode channels (e.g., allow independent and arbitrary electrode selection). The ablation device may generally include a pair of opposable members configured to hold tissue therebetween. In some embodiments, the opposable members may be movable relative to each other. The pulse waveforms disclosed herein may aid in therapeutic treatment of a variety of cardiac arrhythmias (e.g., atrial fibrillation). In order to deliver the pulse waveforms generated by the signal generator, the ablation device may comprise one or more elongate parallel electrodes. In some embodiments, the electrodes may be independently addressable such that each electrode may be controlled (e.g., deliver energy) independently of any other electrode of the device. For example, an anode-cathode energy delivery sequence may be selected to ablate desired regions of tissue and/or to reduce the possibility of shorting. In this manner, the electrodes may deliver different energy waveforms with different timing synergistically for electroporation of tissue.
- The term “electroporation” as used herein refers to the application of an electric field to a cell membrane to change the permeability of the cell membrane to the extracellular environment. The term “reversible electroporation” as used herein refers to the application of an electric field to a cell membrane to temporarily change the permeability of the cell membrane to the extracellular environment. For example, a cell undergoing reversible electroporation may observe the temporary and/or intermittent formation of one or more pores in its cell membrane that close up upon removal of the electric field. The term “irreversible electroporation” as used herein refers to the application of an electric field to a cell membrane to permanently change the permeability of the cell membrane to the extracellular environment. For example, a cell undergoing irreversible electroporation may observe the formation of one or more pores in its cell membrane that persist upon removal of the electric field.
- Pulse waveforms for electroporation energy delivery as disclosed herein may enhance the safety, efficiency, and effectiveness of energy delivery to tissue by reducing the electric field threshold associated with irreversible electroporation, thus yielding more effective ablative lesions with a reduction in total energy delivered. In some embodiments, the voltage pulse waveforms disclosed herein may be hierarchical and have a nested structure. For example, the pulse waveform may include hierarchical groupings of pulses having associated timescales. In some embodiments, the methods, systems, and devices disclosed herein may comprise one or more of the methods, systems, and devices described in International Application Serial No. PCT/US2016/057664, filed on Oct. 19, 2016, and titled “SYSTEMS, APPARATUSES AND METHODS FOR DELIVERY OF ABLATIVE ENERGY TO TISSUE,” the contents of which are hereby incorporated by reference in its entirety.
- In some embodiments, the systems may further include a cardiac stimulator used to synchronize the generation of the pulse waveform to a paced heartbeat. The cardiac stimulator may electrically pace the heart with a cardiac stimulator and ensure pacing capture to establish periodicity and predictability of the cardiac cycle. A time window within a refractory period of the periodic cardiac cycle may be selected for voltage pulse waveform delivery. Thus, voltage pulse waveforms may be delivered in the refractory period of the cardiac cycle to avoid disruption of the sinus rhythm of the heart. The ablation device may transform into different configurations (e.g., compact and expanded) to navigate and position the device within a body cavity. In some embodiments, the system may optionally include one or more return electrodes.
- Generally, to ablate tissue, the device may be surgically placed at a target location. In a cardiac application, the electrodes through which the voltage pulse waveform is delivered may be disposed on opposing sides of a pair of jaws of an ablation device. The methods described here may include placing tissue (e.g., pulmonary vein) between the jaws in contact with the electrodes. A pulse waveform may be generated and delivered to one or more electrodes of the device to ablate tissue. In some embodiments, the pulse waveform may be generated in synchronization with a pacing signal of the heart to avoid disruption of the sinus rhythm of the heart. In some embodiments, the electrodes may be configured in anode-cathode (e.g., bipole) subsets. The pulse waveform may include hierarchical waveforms to aid in tissue ablation and reduce damage to healthy tissue.
- Disclosed herein are systems and devices configured for tissue ablation via the selective and rapid application of voltage pulse waveforms to aid tissue ablation, resulting in irreversible electroporation. Generally, a system for ablating tissue described here may include a signal generator and an ablation device having one or more electrodes for the selective and rapid application of DC voltage to drive electroporation. Voltages may be applied to a selected subset of the electrodes, with independent subset selections for anode and cathode electrode selections. The ablation device may be coupled to one or more electrode channels of the signal generator. Each electrode channel may be independently configured as an anode or cathode and a voltage pulse waveform may be delivered through one or more of the electrode channels in a predetermined sequence. A pacing signal for cardiac stimulation may be generated and used to generate the pulse waveform by the signal generator in synchronization with the pacing signal.
- Generally, the systems and devices described herein include one or more ablation devices configured to ablate tissue held between jaws of the device.
FIG. 7 is a side view of an ablation device (700) configured to hold tissue and deliver energy for tissue ablation. The ablation device (700) may include a first jaw (710) and a second jaw (712) coupled to a distal end of a body (e.g., shaft, elongate member) (720). A proximal end of the body (720) may be coupled to a handle (730). In some embodiments, the handle (730) may include an actuator (740) that may be configured to control one or more of the jaws (710, 720) and energy delivery, as described in more detail herein. In some embodiments, the actuator (740) may include an input device such as one or more of a lever, trigger, button, slide, switch, and the like. For example, a user may engage the actuator to transition and hold the jaws in an open configuration to permit the release of tissue held therebetween. When a desired portion of tissue is positioned between the open jaws, the user may disengage the actuator to transition the jaws to a closed configuration suitable for tissue ablation. Alternatively, a user may engage the actuator to transition the jaws from an open configuration to a closed configuration to allow, for example, the device to be advanced into a body cavity. When the device is adjacent to a desired portion of tissue, the user may disengage the actuator to transition the jaws to an open configuration to allow the desired portion of tissue to be positioned between the open jaws. With the tissue disposed between the jaws, the user may then engage the actuator to transition the jaws to a closed configuration suitable for tissue ablation. - In some embodiments, the actuator may be configured for direct movement of the jaws such that when engaged, the actuator causes the jaws to move in a 1:1 ratio or some other ratio. That is, the actuator may be configured to limit, attenuate, and/or amplify a force applied by the jaws based on an amount of force applied to the actuator. In some embodiments, the ablation device (740) may include a spring configured to bias the jaws (710, 720) between different configurations. For example, a spring may be coupled to the jaws (710, 720) and be configured to bias the jaws (710, 720) towards the tissue ablation configuration in order to apply a compressive force to tissue held between the jaws (710, 720) when the ablation device is advanced into or retracted from a body cavity, the jaws may transition to a closed configuration where the jaws contact each other.
-
FIG. 6 illustrates an ablation system (600) configured to deliver voltage pulse waveforms for tissue ablation. The system (600) may include a signal generator (610), ablation device (640), and optionally a cardiac stimulator (650). The signal generator (610) may be coupled to at least one ablation device (640), and optionally to the cardiac stimulator (650). The ablation device (640) may include a first jaw (650 a) and a second jaw (650 b). The first jaw (650 a) may include a set of one or more electrodes (642 a, 642 b, . . . , 642 n). The second jaw (650 a) may include a set of one or more electrodes (644 a, 644 b, . . . , 644 n). - The signal generator (610) may be configured to generate pulse waveforms for irreversible electroporation of tissue, such as, for example, heart tissue. The signal generator (610) may be a voltage pulse waveform generator and deliver a pulse waveform to a set of electrodes (642 a, 642 b, . . . , 642 n, and 644 a, 644 b, . . . , 644 n) of the ablation device (640). The signal generator (610) may generate and deliver several types of signals including, but not limited to, radiofrequency (RF), direct current (DC) impulses (such as high-voltage, ultra-short pulses used in electroporation), stimulus range impulses, and/or hybrid electrical impulses. For example, the signal generator (610) may generate monophasic (DC) pulses or biphasic pulses (pulses of both polarities). The signal generator (610) may include a processor (620), memory (622), a set of electrode channels (624 a, 624 b, . . . , 624 n, and 625 a, 625 b, . . . , 625 n), energy source (626), sensing circuit (628), routing console (630), and user interface (632). One or more signal generator components may be coupled using a communication bus. The processor (620) may incorporate data received from one or more of memory (622), electrode channels (624 a, 624 b, . . . , 624 n, and 625 a, 625 b, . . . , 625 n), energy source (626), sensing circuit (628), routing console (630), user interface (632), ablation device (640), and cardiac stimulator (650) to determine the parameters (e.g., amplitude, width, duty cycle, timing, etc.) of the voltage pulse waveform to be generated by the signal generator (610). The memory (622) may further store instructions to cause the processor (620) to execute modules, processes and/or functions associated with the system (600), such as pulse waveform generation and delivery, electrode channel configuration, and/or cardiac pacing synchronization. For example, the memory (622) may be configured to store anode/cathode configuration data, electrode channel configuration data, pulse waveform data, fault data, energy discharge data, heart pacing data, patient data, clinical data, procedure data, electromyography data, sensor data, temperature data, and/or the like.
- In some embodiments, the ablation device (640) may include a catheter configured to receive and/or deliver the pulse waveforms described herein. For example, the ablation device (640) may be introduced into an epicardial space of the left atrium and positioned to align one or more electrodes (642 a, 642 b, . . . , 642 n, and 644 a, 644 b, . . . , 644 n) to heart tissue (e.g., pulmonary vein), and then deliver the pulse waveforms to ablate tissue. The ablation device (140) may include one or more electrodes (642 a, 642 b, . . . , 642 n, and 644 a, 644 b, . . . , 644 n), which may, in some embodiments, be a set of independently addressable electrodes. For example, the electrodes (642 a, 642 b, . . . , 642 n, and 644 a, 644 b, . . . , 644 n) may be grouped into one or more anode-cathode subsets such as, for example, a subset including one anode and one cathode, a subset including two anodes and two cathodes, a subset including two anodes and one cathode, a subset including one anode and two cathodes, a subset including three anodes and one cathode, a subset including three anodes and two cathodes, and/or the like. The set of electrodes (642 a, 642 b, . . . , 642 n, and 644 a, 644 b, . . . , 644 n) may include any number of electrodes, for example, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, or more electrodes. In some embodiments, the methods, systems, and devices disclosed herein may comprise one or more of the methods, systems, and devices described in U.S. patent application Ser. No. 15/499,804, filed on Apr. 27, 2017, and titled “SYSTEMS, DEVICES, AND METHODS FOR SIGNAL GENERATION,” and International Application Serial No. PCT/US17/12099, filed on Jan. 4, 2017, and titled “SYSTEMS, DEVICES, AND METHODS FOR DELIVERY OF PULSED ELECTRIC FIELD ABLATIVE ENERGY TO ENDOCARDIAL TISSUE,” and International Application Serial No. PCT/US2013/031252, filed on Mar. 14, 2013, and titled “CATHETERS, CATHETER SYSTEMS, AND METHODS FOR PUNCTURING THROUGH A TISSUE STRUCTURE AND ABLATING A TISSUE REGION,” the contents of which are hereby incorporated by reference in its entirety.
- In some embodiments, the processor (620) may be any suitable processing device configured to run and/or execute a set of instructions or code and may include one or more data processors, image processors, graphics processing units, physics processing units, digital signal processors, and/or central processing units. The processor (620) may be, for example, a general purpose processor, Field Programmable Gate Array (FPGA), an Application Specific Integrated Circuit (ASIC), and/or the like. The processor (620) may be configured to run and/or execute application processes and/or other modules, processes and/or functions associated with the system and/or a network associated therewith (not shown). In some embodiments, the processor may comprise both a microcontroller unit and an FPGA unit, with the microcontroller sending electrode sequence instructions to the FPGA. The underlying device technologies may be provided in a variety of component types, e.g., metal-oxide semiconductor field-effect transistor (MOSFET) technologies like complementary metal-oxide semiconductor (CMOS), bipolar technologies like emitter-coupled logic (ECL), polymer technologies (e.g., silicon-conjugated polymer and metal-conjugated polymer-metal structures), mixed analog and digital, and/or the like.
- In some embodiments, the memory (622) may include a database (not shown) and may be, for example, a random access memory (RAM), a memory buffer, a hard drive, an erasable programmable read-only memory (EPROM), an electrically erasable read-only memory (EEPROM), a read-only memory (ROM), Flash memory, etc. The memory (622) may store instructions to cause the processor (620) to execute modules, processes and/or functions associated with the system (600), such as pulse waveform generation, electrode channel configuration, and/or cardiac pacing.
- In some embodiments, a set of electrode channels (624 a, 624 b, . . . , 624 n, and 625 a, 625 b, . . . , 625 n) may include a set of active solid-state switches. The set of electrode channels (624 a, 624 b, . . . , 624 n, and 625 a, 625 b, . . . , 625 n) may be configured in a number of ways, including independent anode/cathode configuration for each electrode channel. For example, the electrode channels (624 a, 624 b, . . . , 624 n, and 625 a, 625 b, . . . , 625 n) may be grouped into one or more anode-cathode subsets such as, for example, a subset including one anode and one cathode, a subset including two anodes and two cathodes, a subset including two anodes and one cathode, a subset including one anode and two cathodes, a subset including three anodes and one cathode, a subset including three anodes and two cathodes, and/or the like. The set of electrode channels (624 a, 624 b, . . . , 624 n, and 625 a, 625 b, . . . , 625 n) may include any number of channels, for example, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, or more electrode channels. Energy delivery may use any combination of electrode channels (624 a, 624 b, . . . , 624 n, and 625 a, 625 b, . . . , 625 n) and any order for an energy delivery sequence.
- The set of electrode channels (624 a, 624 b, . . . , 624 n, and 625 a, 625 b, . . . , 625 n) may be coupled to a routing console (630) to deliver energy to a set of electrodes (642) coupled to the routing console (630). The set of electrode channels (624 a, 624 b, . . . , 624 n, and 625 a, 625 b, . . . , 625 n) may be coupled to an energy source (626) to receive energy (e.g., a pulse waveform). Processor (620) may be coupled to each electrode channel (624 a, 624 b, . . . , 624 n, and 625 a, 625 b, . . . , 625 n) to configure an anode/cathode configuration for each electrode channel (624), which may be configured on a per pulse basis, per operator input, and/or the like. The processor (620) and energy source (626) may be collectively configured to deliver a pulse waveform to the set of electrodes (642, 644) through the set of electrode channels (624 a, 624 b, . . . , 624 n, and 625 a, 625 b, . . . , 625 n). In some embodiments, each electrode channel (624 a, 624 b, . . . , 624 n, and 625 a, 625 b, . . . , 625 n) may include an electronic switch (e.g., bipolar transistor) and a drive circuit, as described in detail herein. In some embodiments, each electrode channel (624 a, 624 b, . . . , 624 n, and 625 a, 625 b, . . . , 625 n) may have a bootstrap configuration for low and high frequency operation. For example, the pulse duration of voltage pulses delivered through an electrode channel may be in the range of between about 1 microsecond and about 1000 microseconds. In biphasic mode, this corresponds to an approximate frequency range of between about 500 Hz and about 500 KHz for the frequency associated with the voltage pulses.
- In some embodiments, a controller including the processor (620) and memory (622) may be coupled to each electrode of the set of first electrodes (642) and the set of second electrodes (644). The controller may be configured to generate a pulse waveform, configure a first set of electrodes of the set of first electrodes (642) and the set of second electrodes (644) for pulse waveform delivery. The pulse waveform may be delivered to the first set of electrodes (642). In some embodiments, a second set of electrodes of the set of first electrodes (642) and the set of second electrodes (644) may be configured for receiving electrical activity of tissue. Signal data corresponding to the electrical activity of the tissue may be received using the second set of electrodes. Electrocardiography data may be generated using the signal data.
- In some embodiments, an energy source (626) may be configured to convert and supply energy to a set of electrodes (642, 644) coupled to the signal generator (610). The energy source (626) of the signal generator (610) may include a DC power supply and be configured as an AC/DC switcher. In some embodiments, an energy source (626) of the signal generator (610) may deliver rectangular-wave pulses with a voltage in the range between about 300 V and about 5000 V. In some of these embodiments, the energy source (626) may be configured to store energy. For example, the energy source (626) may include one or more capacitors to store energy from a power supply. While these examples are included for purely non-limiting illustrative purposes, it is noted that a variety of pulse waveforms with a range of pulse durations, intervals between pulses, pulse groupings, etc. may be generated depending on the clinical application.
- In some embodiments, a sensing circuit (628) may be configured to determine an amount of current being delivered to a device coupled to the signal generator (610) (e.g., electrode (642) coupled to the electrode channel (624)). As described in more detail herein, the sensing circuit (628) may also be used to classify an electrode channel fault, monitor capacitor discharge, and/or sense arcing. In some embodiments, the sensing circuit (628) may be a direct current sensing circuit and/or a low-side sensing circuit. The sensing circuit may include one or more operational amplifiers, difference amplifiers (DA), instrumentation amplifiers (IA), and/or current shunt monitors (CSM).
- In some embodiments, the routing console (630) may be configured to electrically couple a set of electrodes (642) of an ablation device (640) to a set of electrode channels (624 a, 624 b, . . . , 624 n, and 625 a, 625 b, . . . , 625 n). The routing console (630) may be configured to selectively deliver energy to the set of electrodes (642) using the set of electrode channels (624 a, 624 b, . . . , 624 n, and 625 a, 625 b, . . . , 625 n). One or more ablation devices (640) each having a set of electrodes (642, 644) may be coupled to the routing console (630). The set of electrodes (642, 644) may include any number of electrodes, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, or more electrodes. In some embodiments, an ablation device (640) may include three electrodes with a first jaw (650 a) having a first electrode (642 a) and a second jaw (650 b) having a second electrode (644 a) and a third electrode (644 b).
- In some embodiments, the electrode channels (624 a, 624 b, . . . , 624 n, and 625 a, 625 b, . . . , 625 n) configured for energy delivery (e.g., configured as an anode/cathode pair of electrode channels) may not be adjacent to each other. For example, the set of electrode channels (624 a, 624 b, . . . , 624 n, and 625 a, 625 b, . . . , 625 n) may include a set of N electrode channels (624 a, 624 b, . . . , 624 n, and 625 a, 625 b, . . . , 625 n) in a parallel array. In one embodiment, a first electrode channel may correspond to a first electrode channel (624 a) in the parallel array of N electrode channels (624 a, 624 b, . . . , 624 n, and 625 a, 625 b, . . . , 625 n). One or more of a second and third electrode channel (624 b, 624 c) may not be adjacent to the first electrode channel (624 a) in the parallel array of N electrode channels (624 a, 624 b, . . . , 624 n, and 625 a, 625 b, . . . , 625 n).
- A multi-electrode ablation device may allow targeted and precise energy delivery to tissue. In some embodiments, the electrodes (642, 644) of an ablation device (640) may be configured for energy delivery (e.g., as an anode/cathode pair of electrodes (642, 644)) and may be disposed on opposing jaws on respective parallel arrays of the ablation device (640). For example, an ablation device (640) may include a first jaw (650 a) having a set of first electrodes (642) as a parallel array of N electrodes (142 n) and a second jaw (650 b) having a set of second electrodes (644) as a parallel array of M electrodes (644 n). The signal generator (610) coupled to the ablation device (640) may include a set of electrode channels (624 a, 624 b, . . . , 624 n, and 625 a, 625 b, . . . , 625 n) having N electrode channels corresponding to the M electrodes (642 n, 644 n) of the ablation device (640). In one embodiment, the first electrode channel (624 a) of the N electrode channels (624 a, 624 b, . . . , 624 n, and 625 a, 625 b, . . . , 625 n) may correspond to a first electrode (642 a) in the parallel array of M electrodes (642 n) of the first jaw (650 a). One or more of second and third electrode channel (624 b, 624 c) of the N electrode channels (624 n) may not correspond to any of the electrodes adjacent to the first electrode (642 a) in the parallel array of M electrodes (642 n). For example, the second electrode channel (642 b) may correspond to a second electrode (644 a) in the parallel array of M electrodes (644 n) of the second jaw (650 b).
- Configurable electrode channel and electrode selection may provide flexibility in positioning the electrodes for ablating a desired region of interest, as described in more detail herein. In some embodiments, the routing console (630) may couple to a set of four or six electrodes (642, 644) of an ablation device (640). The routing console (630) may receive input from the processor (620) and/or user interface (632) for electrode channel selection and energy delivery to one or more electrodes (642, 644). Additionally or alternatively, the routing console (630) may couple to a cardiac stimulator (650) and be configured to receive data from devices (e.g., heart pacing data from a pacing device) used for synchronization of a pulse waveform with a patient cardiac cycle.
- In some embodiments, a user interface (632) may be configured as a communication interface between an operator and the system (600). The user interface (632) may include an input device and output device (e.g., touch surface and display). For example, patient data from memory (622) may be received by user interface (632) and output visually and/or audibly. Electric current data from sensing circuit (628) may be received and output on a display of user interface (632). As another example, operator control of an input device having one or more buttons, knobs, dials, switches, trackball, touch surface, and/or the like, may generate a control signal to the signal generator (610) and/or ablation device (640).
- In some embodiments, an input device of the user interface (632) may include a touch surface for operator input and may be configured to detect contact and movement on the touch surface using any of a plurality of touch sensitivity technologies including capacitive, resistive, infrared, optical imaging, dispersive signal, acoustic pulse recognition, and surface acoustic wave technologies. Additionally or alternatively, the user interface (632) may include a step switch or foot pedal.
- In some embodiments, an output device of the user interface (632) may include one or more of a display device and audio device. The display device may include at least one of a light emitting diode (LED), liquid crystal display (LCD), electroluminescent display (ELD), plasma display panel (PDP), thin film transistor (TFT), and organic light emitting diodes (OLED). An audio device may audibly output patient data, sensor data, system data, other data, alarms, warnings, and/or the like. The audio device may include at least one of a speaker, piezoelectric audio device, magnetostrictive speaker, and/or digital speaker. In one embodiment, the audio device may output an audible warning upon detection of a fault in the signal generator (610) and/or ablation device (640).
- In some embodiments, the signal generator (610) may be mounted on a trolley or cart. In some embodiments, the user interface (632) may be formed in the same or different housing as the signal generator (610). The user interface (632) may be mounted to any suitable object, such as furniture (e.g., a bed rail), a wall, a ceiling, or may be self-standing. In some embodiments, the input device may include a wired and/or wireless transmitter configured to transmit a control signal to a wired and/or wireless receiver of the signal generator (610).
- In some embodiments, a cardiac stimulator (650) including a pacing device may be configured to generate a heart pacing signal to be delivered to a patient via the pacing device. An indication of the pacing signal may be transmitted by the cardiac stimulator (650) to the signal generator (610). Based on the pacing signal, an indication of a voltage pulse waveform may be selected, computed, and/or otherwise identified by the processor (620) and generated by the signal generator (610). In some embodiments, the signal generator (610) may be configured to generate the voltage pulse waveform in synchronization with the indication of the pacing signal (e.g., within a common refractory window). For example, in some embodiments, the common refractory window may start substantially immediately following a ventricular pacing signal (or after a very small delay) and last for a duration of between about 150 ms and about 250 ms thereafter. In such embodiments, an entire pulse waveform may be delivered within this duration.
- In some embodiments, the systems described herein may include one or more sterile coverings configured to create a sterile barrier around portions of the system (600). In some embodiments, the system (600) may include one or more sterile coverings to form a sterile field. For example, a sterile covering may be placed over the user interface of the signal generator. The sterile covering may include, for example, a sterile drape configured to cover at least a portion of a system component. In one embodiment, a sterile covering (e.g., sterile drape) may be configured to create a sterile barrier with respect to a user interface (632) of the system (600). The sterile drape may be clear and allow an operator to visualize and manually manipulate the user interface (632). The sterile covering may conform tightly around one or more system components or may drape loosely to allow components to be adjusted within the sterile field.
- The systems described here may include one or more multi-electrode ablation devices configured to ablate tissue for treating atrial fibrillation. Generally, the ablation devices may include a first jaw and a second jaw sized and shaped to physically engage, hold, and (optionally) compress tissue therebetween for delivery of ablation energy. In some embodiments, a distal end of the first jaw and the second jaw may be generally atraumatic to decrease the risk of damage to tissue through laceration, puncture, and other damage when releasably coupled thereto. For example, the first jaw and second jaw may form atraumatic surfaces and edges (e.g., rounded, blunt) to contact and/or hold tissue without causing damage. A set of metallic electrodes disposed on each of the jaws and may also be generally atraumatic to decrease the risk of damage to tissue through laceration and puncture. For example, the edges of the electrodes may be rounded to reduce tissue damage and to increase the uniformity of the electric field generated at a central portion and a peripheral portion of the electrodes. The electrodes may generally form an elongate member (e.g., bar, strip) that extends generally parallel to a length of the jaws. The electrodes may have a length greater than a width or height/depth dimension of the electrode. The jaws as described in more detail herein may be composed of an electrically insulating material such as a polymeric or ceramic material.
- In order to deliver the pulse waveforms generated by the signal generator, one or more electrodes of the ablation device may have an insulated electrical lead configured for sustaining a voltage potential of at least about 300 V without dielectric breakdown of its corresponding insulation. In some embodiments, the insulation on each of the electrical leads may sustain an electrical potential difference of between about 200 V to about 3,000 V across its thickness without dielectric breakdown, including all values and sub-ranges in between. In some embodiments, the electrodes may be independently addressable such that each electrode may be controlled (e.g., deliver energy) independently of any other electrode of the device. In this manner, the electrodes may deliver different energy waveforms with different timing synergistically for electroporation of tissue. The electrodes may, for example, be connected to an insulated electrical lead leading to a handle to receive pulse waveforms generated by a signal generator as discussed above with respect to
FIG. 6 . -
FIG. 1A is a schematic perspective view of an exemplary ablation device (100) including a first jaw (102) and a second jaw (104) that may be structurally and/or functionally similar to the ablation device inFIG. 6 . The first jaw (102) may include a set of first electrodes (110 a, 110 b, . . . , 110 n) and the second jaw (104) may include a set of second electrodes (120 a, 120 b, . . . , 120 n), as shown inFIG. 1B . The first jaw (102) and the second jaw (104) may be spaced apart and substantially parallel and configured to engage tissue (130) therebetween during use. In some embodiments, the first jaw (102) and the second jaw (104) may transition between a set of configurations having different jaw measures (132) (e.g., spacing, distance). In some embodiments, the first jaw (102) and second jaw (104) may be configured to transition between a first configuration for passing the first and second jaws through a body cavity, organ system, or anatomical structure and a second configuration for engaging the tissue (130). The first jaw (102) and the second jaw (104) may be spaced apart by a spacing distance in the second configuration (e.g., third measure (132) as described in more detail herein). The first jaw (102) and the second jaw (104) may be collectively configured to define a longitudinal axis (140). The first jaw (102) and the second jaw (104) may be substantially rigid. - The set of first electrodes (110) and the set of second electrodes (120) may be arranged parallel to the longitudinal axis (140) of the jaws (102, 104). Each of the first electrodes (110) may be spaced apart from an adjacent first electrode (110) by a first measure (106) (e.g., spacing, distance) and each of the second electrodes (120) may be spaced apart from an adjacent second electrode (120) by a second measure (108). The set of first electrodes (110) may be disposed on a side of the first jaw (102) facing the second jaw (104) with each of the set of first electrodes (110) spaced apart laterally with respect to the longitudinal axis (140). Similarly, the set of second electrodes (120) may be disposed on a side of the second jaw (104) facing the first jaw (102) with each of the set of second electrodes (120) spaced apart laterally with respect to the longitudinal axis (140). As shown in
FIG. 1B , each electrode of the set of first electrodes (110) and the set of second electrodes (120) may include an exposed portion in electrical contact with tissue (130) during use. The exposed portion of each electrode of the set of first electrodes (110) and the set of second electrodes (120) may be flat or convex. - At least two of the set of first electrodes (110) may be spaced apart by a first measure (106), and at least two of the set of second electrodes (120) may be spaced apart by a second measure (108), as shown in
FIG. 1B . The first jaw (102) and the second jaw (104) may be spaced apart by a third measure (132). For example, the set of first electrodes may be spaced apart by a distance between about 1 mm and about 6 mm, while the set of second electrodes may be spaced apart by a distance between about 1 mm and about 4 mm. The first jaw and the second jaw may be spaced apart by a distance between about 1 mm and about 15 mm. - In some embodiments, each electrode of the set of first electrodes (110) and the set of second electrodes (120) may have a width orthogonal to the longitudinal axis that is less than a length of that electrode that is parallel to the longitudinal axis (140) where the set of first electrodes (110) are spaced apart laterally with respect to the longitudinal axis (140). In some embodiments, any two adjacent electrodes of the set of first electrodes (110) may have a first measure of between about 0.5 mm and about 10 mm and any two adjacent electrodes of the set of second electrodes (120) may have a second measure of between about 0.5 mm and about 10 mm.
- In some embodiments, each electrode of the set of first electrodes (110) and the set of second electrodes (120) may have a length of between about 1 cm and about 8 cm, a width of between about 1 mm and about 5 mm, and a height of between about 0.5 mm and about 3 mm. In some embodiments, the set of first electrodes (110) and the set of second electrodes (120) may have a length to width ratio of at least about 3:1.
- The set of first electrodes (110) and the set of second electrodes (120) may have a shape of an elongate electrode. In some embodiments, each electrode of the set of first electrodes (110) and the set of second electrodes (120) may be substantially rectangular. In other embodiments, each electrode of the set of first electrodes (110) and the set of second electrodes (120) may include a curved portion.
- In some embodiments, each electrode of the set of first electrodes (110) and the set of second electrodes (120) may be independently addressable. One or more lead wires may be coupled to the set of first electrodes (110) and the set of second electrodes (120). In some embodiments, the electrodes may comprise a generally elliptical or circular cross-section. A length of a semi-major axis of the electrode may be between about 0.5 mm and about 5 mm. In some of these embodiments, a length to width ratio of the electrode may be at least about 3:1.
- In some embodiments, an electrode of the set of first electrodes (110) may be configured as an anode and an electrode of the set of second electrodes (120) may be configured as a cathode. For example, the anode may be disposed directly across from the cathode. For example, a first electrode pairing may include electrodes (110 a, 120 a) directly across from each other on opposing jaws (102, 104), a second electrode pairing may include electrodes (110 b, 120 b) directly across from each other on opposing jaws (102, 104), and so forth for n electrodes.
- In other embodiments, the anode may be diagonal from the cathode. In some embodiments, the anode may generally be spaced apart laterally from the cathode. In some embodiments, a first electrode pairing may include electrodes (110 a, 120 b) spaced apart laterally from each other on opposing jaws (102, 104) and a second electrode pairing may include electrodes (110 b, 120 a) spaced apart laterally from each other on opposing jaws (102, 104), and so forth for n electrodes.
- In some embodiments, one electrode of the set of first electrodes (110) may be configured as an anode while another electrode of the set of first electrodes (110) may be configured as a cathode. In some embodiments, one electrode of one of the jaws may be configured as an anode while another electrode of the same jaw may be configured as a cathode. In some embodiments, a first electrode pairing may include electrodes (110 a, 110 b) adjacent to each other on the same first jaw (102), a second electrode pairing may include electrodes (120 a, 120 b) adjacent to each other on the same second jaw (104), and so forth for n electrodes.
- A pre-determined ablation sequence may include delivering ablation pulse waveforms over a sequence of pre-defined electrode pairings. In some embodiments, the sequenced delivery may be triggered from a cardiac stimulator and/or pacing device. In some embodiments, the ablation pulse waveforms may be applied in a refractory period of the cardiac cycle to avoid disruption of the sinus rhythm of the heart, as described in more detail herein. One or more of the electrodes may be configured to receive signal data corresponding to electrical activity of the tissue (e.g., electrocardiography data).
- In some embodiments, a handle such as the handle shown in
FIG. 7 may be coupled to the first jaw (102) and the second jaw (104). The handle may include one or more of a jaw control configured to control a spacing and/or angle between the first jaw (102) and the second jaw (104), electrode selection control, and pulse waveform control. In some embodiments, the first jaw (102) and the second jaw (104) may be coupled by a pivot (not shown) in which case, the jaws may form an angle with respect to each other. In some embodiments, the device (100) may include a spring (not shown) configured to bias the first jaw (102) and the second jaw (104) toward each other. In some embodiments, the first jaw (102) may be fixed relative to the handle while the second jaw (104) is configured to move relative to the first jaw (102). -
FIG. 8 is a perspective view of a distal end of an ablation device (800) that may be structurally and/or functionally similar to the ablation device inFIG. 6 . The ablation device (800) may include a body (830) having a lumen extending therethrough, a first jaw (810), and a second jaw (820). The first jaw (810) may include a first shaft (814) that extends through the lumen of the body (830). Likewise, the second jaw (820) may include a second shaft (824) that extends through the lumen of the body (830). In some embodiments, one or both of the jaws (810, 820) may move in a direction (840) relative to each other in order to modify a spacing between the first and second jaws (810, 820). In some embodiments, the jaws (810, 820) may be movable relative to the body (830) such that the jaws (810, 820) may advance and retract into and out of the body (830). Retraction of the jaws (810, 820) permits grasping a portion of tissue between the jaws. When the moveable jaw is released, the tissue may then be firmly held in place between the jaws.FIG. 8 shows a first jaw (810) and a second jaw (820) having a generally elliptical (e.g., arcuate) shape. The jaws (810, 820) may be substantially rigid and parallel to each other. - A distal end of the first jaw (810) may include a set of first electrodes such as the two electrodes (812 a, 812 b) shown in
FIG. 8 . Likewise, a distal end of the second jaw (812) may include a set of second electrodes such as the two electrodes (822 a, 822 b) shown inFIG. 8 . The pair of first electrodes (812 a, 812 b) and the pair of second electrodes (822 a, 822 b) may be arranged to be parallel, although they may be arcuate along their lengths. A set of tangent vectors to the elongate shape of each jaw may be defined, and a local longitudinal axis may, for example, pass through the center of the cross-section of either jaw such that the local longitudinal axis is parallel to the local tangent vector. Each of the first electrodes (812 a, 812 b) may be spaced apart from each other and each of the second electrodes (822 a, 822 b) may be spaced apart from each other. The local electrode cross-section may be generally perpendicular to the local longitudinal axis. The set of first electrodes (812) and the set of second electrodes (822) may be elongate electrodes. Some electrodes on opposite jaws may be directly across from each other, such that the normal to an electrode on one jaw points directly towards an electrode on the other jaw. In some embodiments, each electrode of the set of first electrodes (812) and the set of second electrodes (822) may be substantially rectangular. In other embodiments, each electrode of the set of first electrodes (812) and the set of second electrodes (822) may include a curved portion such as a generally arcuate shape or rounded edges. The electrodes may include a curvature that generally follows a curvature of its respective jaw. - The first electrodes (812 a, 812 b) may be disposed on a side of the first jaw (810) facing the second jaw (820). Similarly, the second electrodes (822 a, 822 b) may be disposed on a side of the second jaw (820) facing the first jaw (810). Each electrode of the first electrodes (812 a, 812 b) and the second electrodes (822 a, 822 b) may include an exposed portion in electrical contact with tissue during use. The exposed portion of each electrode of the first electrodes (812 a, 812 b) and the second electrodes (822 a, 822 b) may be flat or convex. Each electrode (812 a, 812 b, 822 a, 822 b) may have an insulated electrical lead associated therewith. The insulated electrical leads may be disposed in a corresponding shaft. In some embodiments, each electrode of the set of first electrodes (812) and the set of second electrodes (822) may be independently addressable. In some embodiments, the electrodes (812 a, 812 b, 822 a, 822 b) may have a length of between about 1 cm and about 8 cm, a width of between about 1 mm and about 5 mm, and a height of between about 0.5 mm and about 3 mm. In some embodiments the electrodes (812 a, 812 b, 822 a, 822 b) may have a length to width ratio of at least about 3:1.
- In some embodiments, an electrode of the set of first electrodes (812) may be configured as an anode and an electrode of the set of second electrodes (822) may be configured as a cathode. For example, the anode may be disposed directly across from the cathode. In some embodiments, a first electrode pairing may include electrodes (812 a, 822 a) directly across from each other on opposing jaws (810, 820) and a second electrode pairing may include electrodes (812 b, 822 b) directly across from each other on opposing jaws (810, 820).
- In other embodiments, the anode may be diagonal from the cathode such that the anode is laterally spaced apart from the cathode and/or does not intersect a line perpendicular to the cathode. In some embodiments, a first electrode pairing may include electrodes (812 a, 822 b) spaced apart laterally from each other on opposing jaws (810, 820) and a second electrode pairing may include electrodes (812 b, 822 a) spaced apart laterally from each other on opposing jaws (810, 820). This combination of electrode pairing may reduce, if not eliminate, the risk of the electrodes electrically shorting in cases where tissue is incompletely grasped between the jaws and/or portions of the jaws touch each other.
- In some embodiments, one electrode of one of the jaws may be configured as an anode while another electrode of the same jaw may be configured as a cathode. In some embodiments, a first electrode pairing may include electrodes (812 a, 812 b) adjacent to each other on the same jaw (810) and a second electrode pairing may include electrodes (822 a, 822 b) adjacent to each other on the same jaw (820).
- Generally in the embodiments described herein, pulsed electric field ablation is delivered in order to generate irreversible electroporation in the tissue between the jaws. A pre-determined ablation sequence may include delivering ablation pulse waveforms sequentially over a pre-defined set of electrode pairings, for example first and second electrode pairings when a set of two electrode pairings are configured. In some embodiments, the sequenced delivery may be triggered from a cardiac stimulator and/or pacing device. In some embodiments, the ablation pulse waveforms may be applied in a refractory period of the cardiac cycle to avoid disruption of the sinus rhythm of the heart, as described in more detail herein. One or more of the electrodes may be configured to receive signal data corresponding to electrical activity of the tissue (e.g., electrocardiography data).
- In some embodiments, a handle such as the handle shown in
FIG. 7 may be coupled to the first jaw (810) and the second jaw (820). The handle may include one or more of a jaw control configured to control a spacing and/or angle between the first jaw (810) and the second jaw (820), electrode selection control, and pulse waveform control. In some embodiments, the first jaw (810) and the second jaw (820) may be coupled by a pivot (not shown) in which case, the jaws may form an angle with respect to each other. In some embodiments, the device (800) may include a spring (not shown) configured to bias the first jaw (810) and the second jaw (820) toward each other. In some embodiments, the first jaw (810) may be fixed relative to the handle while the second jaw (820) is configured to move relative to the first jaw (810). -
FIGS. 9A-9B are perspective views of a distal end of an ablation device (900) that may be structurally and/or functionally similar to the ablation device inFIG. 6 . The ablation device (900) may include a first jaw (910) and a second jaw (920). In some embodiments, one or both of the jaws (910, 920) may move in a direction relative to each other in order to modify a spacing between the first and second jaws (910, 920).FIGS. 9A-9B show a first jaw (910) and a second jaw (920) having a generally elliptical (e.g., arcuate) shape. The jaws (910, 920) may be substantially rigid and parallel to each other. The jaws (910, 920) may collectively define a curved longitudinal axis (950). - A distal end of the first jaw (910) may include a set of first electrodes such as the three electrodes (912 a, 912 b, 912 c) shown in
FIGS. 9A-9B . Likewise, a distal end of the second jaw (912) may include a set of second electrodes such as the three electrodes (922 a, 922 b, 922 c) shown inFIGS. 9A-9B . The trio of first electrodes (912 a, 912 b, 912 c) and the trio of second electrodes (922 a, 922 b, 922 c) may be arranged parallel to the curve of a long edge of the jaws. - Each of the first electrodes (912 a, 912 b, 912 c) may be spaced apart from each other and each of the second electrodes (922 a, 922 b, 922 c) may be spaced apart from each other. The set of first electrodes (912) and the set of second electrodes (922) may be elongate electrodes. In some embodiments, each electrode of the set of first electrodes (912) and the set of second electrodes (922) may be substantially rectangular. In other embodiments, each electrode of the set of first electrodes (912) and the set of second electrodes (922) may include a curved portion such as a generally arcuate shape or rounded edges. The electrodes may include a curvature such that generally each electrode follows the curvature of its respective jaw.
- The first electrodes (912 a, 912 b, 912 c) may be disposed on a side of the first jaw (910) facing the second jaw (920). Similarly, the second electrodes (922 a, 922 b, 922 c) may be disposed on a side of the second jaw (920) facing the first jaw (910). Each electrode of the first electrodes (912 a, 912 b, 912 c) and the second electrodes (922 a, 922 b, 922 c) may include an exposed portion in electrical contact with tissue during use (
FIG. 9B ). The exposed portion of each electrode of the first electrodes (912 a, 912 b, 912 c) and the second electrodes (922 a, 922 b, 922 c) may be flat or convex. Each electrode (912 a, 912 b, 912 c, 922 a, 922 b, 922 c) may have an insulated electrical lead associated therewith. The insulated electrical leads may be disposed in a corresponding shaft. In some embodiments, each electrode of the set of first electrodes (912) and the set of second electrodes (922) may be independently addressable. In some embodiments, the electrodes (912 a, 912 b, 912 c, 922 a, 922 b, 922 c) may have a length of between about 1 cm and about 8 cm, a width of between about 1 mm and about 5 mm, and a height of between about 0.5 mm and about 3 mm. In some embodiments the electrodes (912 a, 912 b, 912 c, 922 a, 922 b, 922 c) may have a length to width ratio of at least about 3:1. - In some embodiments, an electrode of the set of first electrodes (912) may be configured as an anode and an electrode of the set of second electrodes (922) may be configured as a cathode. For example, the anode may be disposed directly across from the cathode. In some embodiments, a first electrode pairing may include electrodes (912 a, 922 a) directly across from each other on opposing jaws (910, 920), a second electrode pairing may include electrodes (912 b, 922 b) directly across from each other on opposing jaws (810, 820), and a third electrode pairing may include electrodes (912 c, 922 c) directly across from each other on opposing jaws (910, 920).
- In other embodiments, the anode may be diagonal from the cathode such that the anode is laterally spaced apart from the cathode and/or does not intersect a line perpendicular to the cathode. In some embodiments, a first electrode pairing may include electrodes (912 a, 922 b) spaced apart laterally from each other on opposing jaws (910, 920), a second electrode pairing may include electrodes (912 b, 922 a) spaced apart laterally from each other on opposing jaws (910, 920), a third electrode pairing may include electrodes (912 b, 922 c) spaced apart laterally from each other on opposing jaws (910, 920), and a fourth electrode pairing may include electrodes (912 c, 922 b) spaced apart laterally from each other on opposing jaws (910, 920).
- In some embodiments, one electrode of one of the jaws may be configured as an anode while another electrode of the same jaw may be configured as a cathode. In some embodiments, a first electrode pairing may include electrodes (912 a, 912 b) adjacent to each other on the same first jaw (910), a second electrode pairing may include electrodes (912 b, 912 c) adjacent to each other on the same first jaw (910), a third electrode pairing may include electrodes (922 a, 922 b) adjacent to each other on the same second jaw (920), and a fourth electrode pairing may include electrodes (922 b, 922 c) adjacent to each other on the same second jaw (920).
- A pre-determined ablation sequence may include delivering ablation pulse waveforms sequentially over a pre-defined set of electrode pairings. In some embodiments, the sequenced delivery may be triggered from a cardiac stimulator and/or pacing device. In some embodiments, the ablation pulse waveforms may be applied in a refractory period of the cardiac cycle to avoid disruption of the sinus rhythm of the heart, as described in more detail herein. One or more of the electrodes may be configured to receive signal data corresponding to electrical activity of the tissue (e.g., electrocardiography data).
-
FIG. 9B is a perspective view of the ablation device (900) coupled to tissue (930) after undergoing one or more ablation sequences as described herein. InFIG. 9B , at least a portion of tissue (930) is held between the jaws (910, 920) of the device (900). In some embodiments, a tissue ablation zone (932) may have a width (940) that substantially corresponds to at least an end-to-end width between the electrodes (912 a and 912 c, 922 a and 922 c) of a jaw (910, 920). In some embodiments, the tissue (930) may comprise a portion of a pulmonary vein as shown, for example, inFIG. 10 . Tissue between the jaws (910, 920) may be compressed relative to other portions of tissue (940). - In some embodiments, a handle such as the handle shown in
FIG. 7 may be coupled to the first jaw (910) and the second jaw (920). The handle may include one or more of a jaw control configured to control a spacing and/or angle between the first jaw (910) and the second jaw (920), electrode selection control, and pulse waveform control. In some embodiments, the first jaw (910) and the second jaw (920) may be coupled by a pivot (not shown) in which case, the jaws may form an angle with respect to each other. In some embodiments, the device (900) may include a spring (not shown) configured to bias the first jaw (910) and the second jaw (920) toward each other. In some embodiments, the first jaw (910) may be fixed relative to the handle while the second jaw (920) is configured to move relative to the first jaw (910). - The electrodes as described may be composed of any suitable biocompatible conductive material including, but not limited to, one or more of silver, palladium, stainless steel, platinum, titanium, platinum-iridium alloys, gold, copper, nickel, combinations thereof, and the like. In some embodiments, the electrode materials may be plated, coated, and/or otherwise applied in an appropriately thick layer on top of a different substrate material. In some embodiments, electrode portions may be coupled using annealing, soldering, welding, crimping, lamination, combinations thereof, and the like. The jaws and body of the ablation devices disclosed may be composed of any suitable electrically insulating biocompatible material including polymers, ceramics, glasses, combinations thereof, and the like.
- Also described here are methods for ablating tissue (e.g., pulmonary vein) using the systems and devices described above. The ablation devices described herein may be used for ablation of cardiac features/structures identified to cause arrhythmia. The pulmonary vein may be connected to the left atrium of the heart. Generally, the methods described here include introducing and disposing a device in contact with one or more pulmonary vein regions. A pulse waveform may be delivered by one or more electrodes of the device to ablate tissue. In some embodiments, a cardiac pacing signal may synchronize the delivered pulse waveforms with the cardiac cycle. Additionally or alternatively, the pulse waveforms may include a set of levels of a hierarchy. The tissue ablation thus performed may be delivered in synchrony with paced heartbeats. It should be appreciated that any of the ablation devices described herein may be used to ablate tissue using the methods discussed below as appropriate.
- As a non-limiting example, in some embodiments, a system may include any of the devices described in the disclosure herein.
FIG. 11 is a method (1100) for one embodiment of a tissue ablation process. In some embodiments, the voltage pulse waveforms described herein may be applied during a refractory period of the cardiac cycle to avoid disruption of the sinus rhythm of the heart. Generally, the method (1100) includes introduction of a device (e.g., ablation device, such as the ablation device (100), and/or any of the ablation devices (200, 300, 400, 500, 640, 700, 800, 900, 1000) into a chest cavity of a patient by any suitable means at step (1102). The chest of the patient may be surgically exposed to provide access to a desired ablation site, for example pulmonary vein in the region of the posterior left atrium. For example, the jaws/arms and body of the ablation device may enter the chest cavity at an oblique angle. It may be helpful to angle the jaws/arms in a manner that permits access to a posterior side of a patient's body (where the pulmonary veins may be located) through access from an anterior side of the patient's body. For example, a surgical excision may open and expose the chest cavity. In some embodiments, the ablation device may be advanced in a first configuration where the jaws/arms are closely spaced and/or in contact with each other to aid advancement of the ablation device towards a target tissue (e.g., pulmonary vein). For example,FIG. 10 is a perspective view of a distal end of an ablation device (1000) having a first jaw (1010) and a second jaw (1012) coupled to a pulmonary vein (1030) at a basal location (at the portion of tissue connecting the pulmonary vein to the left atrium) on a posterior side of the left atrium (1040). The ablation device (1000) may be transformed to contact tissue between the jaws/arms at step (1104). For example, the jaws of the ablation device (1000) may transition from a closed configuration to an open configuration to allow a portion of the pulmonary vein (1030) to be held between the jaws (1010, 1020). Saline may be introduced into the chest cavity to at least partially surround the electrodes and create an electrically conductive environment for optimal delivery of current to tissue. - Returning to
FIG. 11 , at step 1106, the electrodes of the device may be configured in one or more anode/cathode subsets using, for example, the signal generator as described with respect toFIG. 6 . For example, electrodes on opposing jaws and which are laterally spaced apart from each other may be configured in anode-cathode sets, as described with respect toFIGS. 8 and 9 . This configuration may reduce the risk of shorting and may help generate uniform ablation across the compressed portion of tissue. In some embodiments, one or more electrodes may be configured to receive signal data corresponding to electrocardiography data. Electrocardiography data may be generated for display from the recorded signal data. - In some embodiments, a pacing signal may be generated for cardiac stimulation of the heart. The pacing signal may then be applied to the heart. For example, the heart may be electrically paced with a cardiac stimulator to ensure pacing capture to establish periodicity and predictability of the cardiac cycle. One or more of atrial and ventricular pacing may be applied. An indication of the pacing signal may be transmitted to a signal generator. A time window within the refractory period of the cardiac cycle may then be defined within which one or more voltage pulse waveforms may be delivered. In some embodiments, a refractory time window may follow a pacing signal. For example, a common refractory time window may lie between both atrial and ventricular refractory time windows.
- A pulse waveform may be generated in synchronization with the pacing signal (1108). For example, a voltage pulse waveform may be applied in the common refractory time window. In some embodiments, the pulse waveform may be generated with a time offset with respect to the indication of the pacing signal. For example, the start of a refractory time window may be offset from the pacing signal by a time offset. The voltage pulse waveform(s) may be applied over a series of heartbeats over corresponding common refractory time windows.
- In some embodiments, hierarchical voltage pulse waveforms having a nested structure and a hierarchy of time intervals as described herein may be useful for irreversible electroporation, providing control and selectivity in different tissue types. A pulse waveform may be generated by a signal generator (e.g., the signal generator 610) and may include a set of levels in a hierarchy. A variety of hierarchical waveforms may be generated with a signal generator as disclosed herein. For example, the pulse waveform may include a first level of a hierarchy of the pulse waveform including a first set of pulses. Each pulse has a pulse time duration and a first time interval separating successive pulses. A second level of the hierarchy of the pulse waveform may include a plurality of first sets of pulses as a second set of pulses. A second time interval may separate successive first sets of pulses. The second time interval may be at least three times the duration of the first time interval. A third level of the hierarchy of the pulse waveform may include a plurality of second sets of pulses as a third set of pulses. A third time interval may separate successive second sets of pulses. The third time interval may be at least thirty times the duration of the second level time interval.
- It is understood that while the examples herein identify separate monophasic and biphasic waveforms, it should be appreciated that combination waveforms, where some portions of the waveform hierarchy are monophasic while other portions are biphasic, may also be generated. A voltage pulse waveform having a hierarchical structure may be applied across different anode-cathode subsets (optionally with a time delay). As discussed above, one or more of the waveforms applied across the anode-cathode subsets may be applied during the refractory period of a cardiac cycle. The generated pulse waveform may be delivered to tissue. Accordingly, in the embodiments described herein, a contiguous, transmural zone of ablated tissue may be generated to electrically isolate the pulmonary vein from a main body of the left atrium.
- In some embodiments, the pulse waveform may be delivered to pulmonary vein of a heart of a patient via one or more electrodes of a set of jaws of an ablation device. In other embodiments, voltage pulse waveforms as described herein may be selectively delivered to electrode subsets such as paired anode-cathode subsets for ablation and isolation of the pulmonary vein. For example, a first electrode of a first jaw may be configured as an anode and a second electrode of a second jaw may be configured as a cathode. These steps may be repeated for a desired number of pulmonary vein regions to be ablated.
-
FIGS. 2A-2C depict a set of simulation results in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device (200) that may be structurally and/or functionally similar to the ablation device inFIG. 6 . The ablation device (200) includes a first jaw (202) and a second jaw (204). The first jaw (202) may include a first electrode (210) and a second electrode (220). The second jaw (204) may include a third electrode (230) and a fourth electrode (240). The first jaw (202) and the second jaw (204) may be spaced apart and substantially parallel, and configured to engage tissue (260) therebetween during use. The first jaw (202) and the second jaw (204) may be spaced apart by a third measure (262, 264, 266). The first electrode (210) and the second electrode (220) may be may be disposed on a side of the first jaw (202) facing the second jaw (204). Similarly, the third electrode (230) and the fourth electrode (240) may be disposed on a side of the second jaw (204) facing the first jaw (202). Each electrode (210, 220, 230, 240) may include an exposed portion in electrical contact with tissue (260) during use. The first electrode (210) and the second electrode (220) may be spaced apart by a first measure (203, 206). The third electrode (230) and the fourth electrode (240) may be spaced apart by a second measure (205, 207). The electrodes (210, 220, 230, 240) may be elongate electrodes as described herein. In some embodiments, each electrode (210, 220, 230, 240) may be independently addressable. - In some embodiments, the electrodes configured to deliver energy to tissue (260) may be adjacent electrodes on the same jaw. For example, a first electrode (210) may be configured as an anode and a second electrode (220) may be configured as a cathode. In
FIGS. 2A-2C , the first jaw (202) may deliver 200 V to tissue (260) between first electrode (210) and second electrode (220) to generate respective ablation zones (270, 272, 274) having an electric field strength of about 460 V/cm. The first measure (203, 206) may be 1 mm inFIG. 2A , 2 mm inFIG. 2B , and 3 mm inFIG. 2C . As shown inFIGS. 2A-2C , decreasing separation between electrodes (210, 220) may generate an ablation zone of lesser width and greater depth. -
FIGS. 3A-3C depict a set of simulation results in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device (300). The plots inFIGS. 3A-3C simulate higher voltages and greater separation between electrodes than the plots inFIGS. 2A-2C . The ablation device (300) includes a first jaw (302) and a second jaw (304). The first jaw (302) may include a first electrode (310) and a second electrode (320). The second jaw (304) may include a third electrode (330) and a fourth electrode (340). The first jaw (302) and the second jaw (304) may be spaced apart and substantially parallel and configured to engage tissue (360) therebetween during use. The first jaw (302) and the second jaw (304) may be spaced apart by a third measure (360, 362, 364). The first electrode (310) and the second electrode (320) may be may be disposed on a side of the first jaw (302) facing the second jaw (304). Similarly, the third electrode (330) and the fourth electrode (340) may be disposed on a side of the second jaw (304) facing the first jaw (302). Each electrode (310, 320, 330, 340) may include an exposed portion in electrical contact with tissue (360) during use. The first electrode (310) and the second electrode (320) may be spaced apart by a first measure (303, 306, 308). The third electrode (330) and the fourth electrode (340) may be spaced apart by a second measure (305, 307, 309). The electrodes (310, 320, 330, 340) may be elongate electrodes as described herein. In some embodiments, each electrode (310, 320, 330, 340) may be independently addressable. - In some embodiments, the electrodes configured to deliver energy to tissue (360) may be adjacent electrodes on the same jaw. For example, a first electrode (310) may be configured as an anode and a second electrode (320) may be configured as a cathode. In
FIGS. 3A-3C , the first jaw (302) may deliver 300 V to tissue (360) between first electrode (310) and second electrode (320) to generate respective ablation zones (370, 372, 374) having an electric field strength of about 460 V/cm. The first measure (303, 306, 308) may be 3 mm inFIG. 3A , 4 mm inFIG. 3B , and 5 mm inFIG. 3C . As shown inFIGS. 3A-3C , decreasing separation between electrodes (310, 320) may generate an ablation zone of lesser width and greater depth. A separation of 5 mm inFIG. 3C may generate non-contiguous ablation zones (374). -
FIGS. 4A-4E depict a set of simulation results in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device (400). The plots inFIGS. 4A-4E generate electric fields using electrodes on opposing jaws rather than adjacent electrodes on the same jaw as shown inFIGS. 2A-3C . The ablation device (400) includes a first jaw (402) and a second jaw (404). The first jaw (402) may include a first electrode (410) and a second electrode (420). The second jaw (404) may include a third electrode (430) and a fourth electrode (440). The first jaw (402) and the second jaw (404) may be spaced apart and substantially parallel and configured to engage tissue (460) therebetween during use. The first jaw (402) and the second jaw (404) may be spaced apart by a third measure (460, 462, 464, 466, 468). The first electrode (410) and the second electrode (420) may be may be disposed on a side of the first jaw (402) facing the second jaw (404). Similarly, the third electrode (430) and the fourth electrode (440) may be disposed on a side of the second jaw (404) facing the first jaw (402). Each electrode (410, 420, 430, 440) may include an exposed portion in electrical contact with tissue (460) during use. The first electrode (410) and the second electrode (420) may be spaced apart by a first measure (403). The third electrode (430) and the fourth electrode (440) may be spaced apart by a second measure (405). The electrodes (410, 420, 430, 440) may be elongate electrodes as described herein. In some embodiments, each electrode (410, 420, 430, 440) may be independently addressable. - In some embodiments, the electrodes configured to deliver energy to tissue (460) may be electrodes that directly oppose each other on different jaws. For example, a second electrode (420) may be configured as an anode and a fourth electrode (440) may be configured as a cathode. In
FIG. 4A , the first jaw (402) may deliver 200 V to tissue (460) between second electrode (420) and fourth electrode (440) to generate ablation zones (470) having an electric field strength of about 460 V/cm across a depth of the tissue (460) held by between the jaws (402, 404). InFIGS. 4B-4E , the first jaw (402) may deliver 300 V to tissue (360) between second electrode (420) and fourth electrode (440) to generate respective ablation zones (470, 472, 474, 476, 478) having an electric field strength of about 460 V/cm. The third measure (460) may be 2 mm inFIG. 4A , third measure (462) may be 3 mm inFIG. 4B , third measure (464) may be and 4 mm inFIG. 4C , third measure (466) may be 5 mm inFIG. 4D , and third measure (468) may be 6 mm inFIG. 4E . As shown inFIGS. 4B-4E , decreasing separation between electrodes (420, 440) may generate an ablation zone of greater intensity. A separation of 6 mm inFIG. 4E may generate non-contiguous ablation zones (478). -
FIGS. 5A-5F depict a set of simulation results in the form of a shaded contour plot of the electric potential in a cross-sectional side view of an ablation device (500). The plots inFIGS. 5A-5F generate electric fields using electrodes disposed diagonally on opposing jaws rather than adjacent electrodes on the same jaw as shown inFIGS. 2A-3C . The ablation device (500) includes a first jaw (502) and a second jaw (504). The first jaw (502) may include a first electrode (510) and a second electrode (520). The second jaw (504) may include a third electrode (530) and a fourth electrode (540). The first jaw (502) and the second jaw (504) may be spaced apart and substantially parallel and configured to engage tissue (560) therebetween during use. The first jaw (502) and the second jaw (504) may be spaced apart by a third measure (560, 562, 564, 566, 568, 569). The first electrode (510) and the second electrode (520) may be disposed on a side of the first jaw (502) facing the second jaw (504). Similarly, the third electrode (530) and the fourth electrode (540) may be disposed on a side of the second jaw (504) facing the first jaw (502). Each electrode (510, 520, 530, 540) may include an exposed portion in electrical contact with tissue (560) during use. The first electrode (510) and the second electrode (520) may be spaced apart by a first measure (503). The third electrode (530) and the fourth electrode (540) may be spaced apart by a second measure (505). The electrodes (510, 520, 530, 540) may be elongate electrodes as described herein. In some embodiments, each electrode (510, 520, 530, 540) may be independently addressable. - In some embodiments, the electrodes configured to deliver energy to tissue (560) may be electrodes that are laterally spaced apart and adjacent on opposing different jaws. For example, a second electrode (520) may be configured as an anode and a third electrode (530) may be configured as a cathode. This anode-cathode configuration of the electrodes reduces the risk of electrical shorting since the anode and cathode will not contact each other even if the jaws are brought into contact with each other. In
FIG. 5A , the first jaw (502) may deliver 200 V to tissue (560) between second electrode (520) and third electrode (540) to generate ablation zone (560) having an electric field strength of about 460 V/cm across a depth of the tissue (460) held between the jaws (502, 504). InFIGS. 5B-5C , the first jaw (502) may deliver 300 V to tissue (560) between second electrode (520) and third electrode (530) to generate respective ablation zones (572, 574) having an electric field strength of about 460 V/cm. InFIGS. 5D-5E , the first jaw (502) may deliver 400 V to tissue (560) between second electrode (520) and third electrode (530) to generate respective ablation zones (576, 578) having an electric field strength of about 460 V/cm). InFIG. 5F , the first jaw (502) may deliver 500 V to tissue (560) between second electrode (520) and third electrode (530) to generate ablation zone (579) having an electric field strength of about 460 V/cm. Thus, by increasing the applied voltage, deeper ablation zones may be produced which may be useful when the tissue between the clamps is relatively thicker. As a set of non-limiting examples, the third measure (560) may be 2 mm inFIG. 5A , third measure (562) may be 4 mm inFIG. 5B , third measure (564) may be and 5 mm inFIG. 5C , third measure (566) may be 5 mm inFIG. 5D , third measure (568) may be 6 mm inFIG. 5E , and third measure (569) may be 6 mm inFIG. 5F . - Disclosed herein are methods, systems and apparatuses for the selective and rapid application of pulsed electric fields/waveforms to effect tissue ablation with irreversible electroporation. The pulse waveform(s) as disclosed herein are usable with any of the systems (600), devices (e.g., 200, 300, 400, 500, 640, 700, 800, 900, 1000), and methods (e.g., 1100) described herein. Some embodiments are directed to pulsed high voltage waveforms together with a sequenced delivery scheme for delivering energy to tissue via sets of electrodes. In some embodiments, peak electric field values may be reduced and/or minimized while at the same time sufficiently large electric field magnitudes may be maintained in regions where tissue ablation is desired. This also reduces the likelihood of excessive tissue damage or the generation of electrical arcing, and locally high temperature increases. In some embodiments, a system useful for irreversible electroporation includes a signal generator and a processor capable of being configured to apply pulsed voltage waveforms to a selected plurality or a subset of electrodes of an ablation device. In some embodiments, the processor is configured to control inputs whereby selected pairs of anode-cathode subsets of electrodes may be sequentially triggered based on a pre-determined sequence, and in one embodiment the sequenced delivery may be triggered from a cardiac stimulator and/or pacing device. In some embodiments, the ablation pulse waveforms are applied in a refractory period of the cardiac cycle to avoid disruption of the sinus rhythm of the heart. One example method of enforcing this is to electrically pace the heart with a cardiac stimulator and ensure pacing capture to establish periodicity and predictability of the cardiac cycle, and then to define a time window well within the refractory period of this periodic cycle within which the ablation waveform is delivered.
- In some embodiments, the pulsed voltage waveforms disclosed herein are hierarchical in organization and have a nested structure. In some embodiments, the pulsed waveform includes hierarchical groupings of pulses with a variety of associated timescales. Furthermore, the associated timescales and pulse widths, and the numbers of pulses and hierarchical groupings, may be selected to satisfy one or more of a set of Diophantine inequalities involving the frequency of cardiac pacing.
- Pulsed waveforms for electroporation energy delivery as disclosed herein may enhance the safety, efficiency and effectiveness of the energy delivery by reducing the electric field threshold associated with irreversible electroporation, yielding more effective ablative lesions with reduced total energy delivered. This in turn may broaden the areas of clinical application of electroporation including therapeutic treatment of a variety of cardiac arrhythmias.
-
FIG. 12 illustrates a pulsed voltage waveform in the form of a sequence of rectangular double pulses, with each pulse, such as the pulse (1200) being associated with a pulse width or duration. The pulse width/duration may be about 0.5 microseconds, about 1 microsecond, about 5 microseconds, about 10 microseconds, about 25 microseconds, about 50 microseconds, about 100 microseconds, about 125 microseconds, about 140 microseconds, about 150 microseconds, including all values and sub-ranges in between. The pulsed waveform ofFIG. 12 illustrates a set of monophasic pulses where the polarities of all the pulses are the same (all positive inFIG. 12 , as measured from a zero baseline). In some embodiments, such as for irreversible electroporation applications, the height of each pulse (1200) or the voltage amplitude of the pulse (1200) may be in the range of about 300 volts, about 1,000 volts, or about 5,000 volts, including all values and sub ranges in between. As illustrated inFIG. 12 , the pulse (1200) is separated from a neighboring pulse by a time interval (1202), also sometimes referred to as a first time interval. The first time interval may be about 10 microseconds, about 50 microseconds, about 100 microseconds, about 200 microseconds, about 500 microseconds, about 800 microseconds, about 1 millisecond including all values and sub ranges in between, in order to generate irreversible electroporation. -
FIG. 13 introduces a pulse waveform with the structure of a hierarchy of nested pulses.FIG. 13 shows a series of monophasic pulses such as pulse (1300) with pulse width/pulse time duration w, separated by a time interval (also sometimes referred to as a first time interval) such as (1302) of duration t1 between successive pulses, a number m1 of which are arranged to form a group of pulses (1310) (also sometimes referred to as a first set of pulses). Furthermore, the waveform has a number m2 of such groups of pulses (also sometimes referred to as a second set of pulses) separated by a time interval (1312) (also sometimes referred to as a second time interval) of duration t2 between successive groups. The collection of m2 such pulse groups, marked by (1320) inFIG. 13 , constitutes the next level of the hierarchy, which may be referred to as a packet and/or as a third set of pulses. The pulse width and the time interval t1 between pulses may both be in the range of microseconds to hundreds of microseconds, including all values and sub ranges in between. In some embodiments, the time interval t2 may be at least three times larger than the time interval t1. In some embodiments, the ratio t2/t1 may be in the range between about 3 and about 300, including all values and sub-ranges in between. -
FIG. 14 further elaborates the structure of a nested pulse hierarchy waveform. In this figure, a series of m1 pulses (individual pulses not shown) form a group of pulses (1400) (e.g., a first set of pulses). A series of m2 such groups separated by an inter-group time interval (1410) of duration t2 (e.g., a second time interval) between one group and the next form a packet 132 (e.g., a second set of pulses). A series of m3 such packets separated by time intervals (1412) of duration t3 (e.g., a third time interval) between one packet and the next form the next level in the hierarchy, a super-packet labeled (1420) (e.g., a third set of pulses) in the figure. In some embodiments, the time interval t3 may be at least about thirty times larger than the time interval t2. In some embodiments, the time interval t3 may be at least fifty times larger than the time interval t2. In some embodiments, the ratio t3/t2 may be in the range between about 30 and about 800, including all values and sub-ranges in between. The amplitude of the individual voltage pulses in the pulse hierarchy may be anywhere in the range from 300 volts to 7,000 volts or higher, including all values and sub ranges in between. -
FIG. 15 provides an example of a biphasic waveform sequence with a hierarchical structure. In the example shown in the figure, biphasic pulses such as (1500) have a positive voltage portion as well as a negative voltage portion to complete one cycle of the pulse. There is a time delay (1502) (e.g., a first time interval) between adjacent cycles of duration t1, and n1 such cycles form a group of pulses (1510) (e.g., a first set of pulses). A series of n2 such groups separated by an inter-group time interval (1512) (e.g., a second time interval) of duration t2 between one group and the next form a packet (1520) (e.g., a second set of pulses). The figure also shows a second packet (1530), with a time delay (1532) (e.g., a third time interval) of duration t3 between the packets. Just as for monophasic pulses, higher levels of the hierarchical structure may be formed as well. The amplitude of each pulse or the voltage amplitude of the biphasic pulse may be anywhere in the range from 300 volts to 7,000 volts or higher, including all values and sub ranges in between. The pulse width/pulse time duration may be in the range from nanoseconds or even sub-nanoseconds to tens of microseconds, while the delays t1 may be in the range from zero to several microseconds. The inter-group time interval t2 may be at least ten times larger than the pulse width. In some embodiments, the time interval t3 may be at least about twenty times larger than the time interval t2. In some embodiments, the time interval t3 may be at least fifty times larger than the time interval t2. - Embodiments disclosed herein include waveforms structured as hierarchical waveforms that include waveform elements/pulses at various levels of the hierarchy. The individual pulses such as (1300) in
FIG. 13 includes the first level of the hierarchy, and have an associated pulse time duration and a first time interval between successive pulses. A set of pulses, or elements of the first level structure, form a second level of the hierarchy such as the group of pulses/second set of pulses (1310) inFIG. 13 . Among other parameters, associated with the waveform are parameters such as a total time duration of the second set of pulses (not shown), a total number of first level elements/first set of pulses, and second time intervals between successive first level elements that describe the second level structure/second set of pulses. In some embodiments, the total time duration of the second set of pulses may be between about 20 microseconds and about 10 milliseconds, including all values and subranges in between. A set of groups, second set of pulses, or elements of the second level structure, form a third level of the hierarchy such as the packet of groups/third set of pulses (1320) inFIG. 13 . Among other parameters, there is a total time duration of the third set of pulses (not shown), a total number of second level elements/second set of pulses, and third time intervals between successive second level elements that describe the third level structure/third set of pulses. In some embodiments, the total time duration of the third set of pulses may be between about 60 microseconds and about 200 milliseconds, including all values and sub ranges in between. The generally iterative or nested structure of the waveforms may continue to a higher plurality of levels, such as ten levels of structure, or more. - In some embodiments, hierarchical waveforms with a nested structure and hierarchy of time intervals as described herein are useful for irreversible electroporation ablation energy delivery, providing a good degree of control and selectivity for applications in different tissue types. A variety of hierarchical waveforms may be generated with a suitable pulse generator. It is understood that while the examples herein identify separate monophasic and biphasic waveforms for clarity, it should be noted that combination waveforms, where some portions of the waveform hierarchy are monophasic while other portions are biphasic, may also be generated/implemented.
- In some embodiments, the ablation pulse waveforms described herein are applied during the refractory period of the cardiac cycle to avoid disruption of the sinus rhythm of the heart. In some embodiments, a method of treatment includes electrically pacing the heart with a cardiac stimulator to ensure pacing capture to establish periodicity and predictability of the cardiac cycle, and then defining a time window within the refractory period of the cardiac cycle within which one or more pulsed ablation waveforms may be delivered.
FIG. 16 illustrates an example where both atrial and ventricular pacing is applied (for instance, with pacing leads or catheters situated in the right atrium and right ventricle respectively). With time represented on the horizontal axis,FIG. 16 illustrates a series of ventricular pacing signals such as (1600) and (1610), and a series of atrial pacing signals (1620, 1630), along with a series of ECG waveforms (1640, 1642) that are driven by the pacing signals. As indicated inFIG. 16 by the thick arrows, there is an atrial refractory time window (1622) and a ventricular refractory time window (1602) that respectively follow the atrial pacing signal (1622) and the ventricular pacing signal (1600). As shown inFIG. 16 , a common refractory time window (1650) of duration Tr may be defined that lies within both atrial and ventricular refractory time windows (1622, 1602). In some embodiments, the electroporation ablation waveform(s) may be applied in this common refractory time window (1650). The start of this refractory time window (1622) is offset from the pacing signal (1600) by a time offset (1604) as indicated inFIG. 16 . The time offset (1604) may be smaller than about 25 milliseconds, in some embodiments. At the next heartbeat, a similarly defined common refractory time window (1652) is the next time window available for application of the ablation waveform(s). In this manner, the ablation waveform(s) may be applied over a series of heartbeats, at each heartbeat remaining within the common refractory time window. In one embodiment, each packet of pulses as defined above in the pulse waveform hierarchy may be applied over a heartbeat, so that a series of packets is applied over a series of heartbeats, for a given electrode set. - It should be understood that the examples and illustrations in this disclosure serve exemplary purposes and departures and variations such as the shape and size of the jaws and electrodes, number of electrodes, and so on may be built and deployed according to the teachings herein without departing from the scope of this invention.
- As used herein, the terms “about” and/or “approximately” when used in conjunction with numerical values and/or ranges generally refer to those numerical values and/or ranges near to a recited numerical value and/or range. In some instances, the terms “about” and “approximately” may mean within ±10% of the recited value. For example, in some instances, “about 100 [units]” may mean within ±10% of 100 (e.g., from 90 to 110). The terms “about” and “approximately” may be used interchangeably.
- Some embodiments described herein relate to a computer storage product with a non-transitory computer-readable medium (also may be referred to as a non-transitory processor-readable medium) having instructions or computer code thereon for performing various computer-implemented operations. The computer-readable medium (or processor-readable medium) is non-transitory in the sense that it does not include transitory propagating signals per se (e.g., a propagating electromagnetic wave carrying information on a transmission medium such as space or a cable). The media and computer code (also may be referred to as code or algorithm) may be those designed and constructed for the specific purpose or purposes. Examples of non-transitory computer-readable media include, but are not limited to, magnetic storage media such as hard disks, floppy disks, and magnetic tape; optical storage media such as Compact Disc/Digital Video Discs (CD/DVDs), Compact Disc-Read Only Memories (CD-ROMs), and holographic devices; magneto-optical storage media such as optical disks; carrier wave signal processing modules; and hardware devices that are specially configured to store and execute program code, such as Application-Specific Integrated Circuits (ASICs), Programmable Logic Devices (PLDs), Read-Only Memory (ROM) and Random-Access Memory (RAM) devices. Other embodiments described herein relate to a computer program product, which may include, for example, the instructions and/or computer code disclosed herein.
- The systems, devices, and/or methods described herein may be performed by software (executed on hardware), hardware, or a combination thereof. Hardware modules may include, for example, a general-purpose processor (or microprocessor or microcontroller), a field programmable gate array (FPGA), and/or an application specific integrated circuit (ASIC). Software modules (executed on hardware) may be expressed in a variety of software languages (e.g., computer code), including C, C++, Java®, Ruby, Visual Basic®, and/or other object-oriented, procedural, or other programming language and development tools. Examples of computer code include, but are not limited to, micro-code or micro-instructions, machine instructions, such as produced by a compiler, code used to produce a web service, and files containing higher-level instructions that are executed by a computer using an interpreter. Additional examples of computer code include, but are not limited to, control signals, encrypted code, and compressed code.
- The specific examples and descriptions herein are exemplary in nature and embodiments may be developed by those skilled in the art based on the material taught herein without departing from the scope of the present invention, which is limited only by the attached claims.
Claims (35)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/970,404 US20190336198A1 (en) | 2018-05-03 | 2018-05-03 | Systems, devices, and methods for ablation using surgical clamps |
| EP19734941.8A EP3787541A1 (en) | 2018-05-03 | 2019-04-24 | Systems, devices, and methods for ablation using surgical clamps |
| CN202410595815.2A CN118285903A (en) | 2018-05-03 | 2019-04-24 | Systems, devices, and methods for ablation using surgical clips |
| PCT/US2019/028943 WO2019212827A1 (en) | 2018-05-03 | 2019-04-24 | Systems, devices, and methods for ablation using surgical clamps |
| CN201980031108.8A CN112087979A (en) | 2018-05-03 | 2019-04-24 | Systems, devices, and methods for ablation using surgical clips |
| JP2020561052A JP7483628B2 (en) | 2018-05-03 | 2019-04-24 | Systems, devices and methods for ablation using surgical clamps - Patents.com |
| US17/087,433 US12042208B2 (en) | 2018-05-03 | 2020-11-02 | Systems, devices, and methods for ablation using surgical clamps |
| JP2024030025A JP2024069277A (en) | 2018-05-03 | 2024-02-29 | Systems, devices and methods for ablation using surgical clamps - Patents.com |
| US18/753,828 US20240341834A1 (en) | 2018-05-03 | 2024-06-25 | Systems, devices, and methods for ablation using surgical clamps |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/970,404 US20190336198A1 (en) | 2018-05-03 | 2018-05-03 | Systems, devices, and methods for ablation using surgical clamps |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2019/028943 Continuation WO2019212827A1 (en) | 2018-05-03 | 2019-04-24 | Systems, devices, and methods for ablation using surgical clamps |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20190336198A1 true US20190336198A1 (en) | 2019-11-07 |
Family
ID=67138010
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/970,404 Abandoned US20190336198A1 (en) | 2018-05-03 | 2018-05-03 | Systems, devices, and methods for ablation using surgical clamps |
| US17/087,433 Active US12042208B2 (en) | 2018-05-03 | 2020-11-02 | Systems, devices, and methods for ablation using surgical clamps |
| US18/753,828 Pending US20240341834A1 (en) | 2018-05-03 | 2024-06-25 | Systems, devices, and methods for ablation using surgical clamps |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US17/087,433 Active US12042208B2 (en) | 2018-05-03 | 2020-11-02 | Systems, devices, and methods for ablation using surgical clamps |
| US18/753,828 Pending US20240341834A1 (en) | 2018-05-03 | 2024-06-25 | Systems, devices, and methods for ablation using surgical clamps |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US20190336198A1 (en) |
| EP (1) | EP3787541A1 (en) |
| JP (2) | JP7483628B2 (en) |
| CN (2) | CN118285903A (en) |
| WO (1) | WO2019212827A1 (en) |
Cited By (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10617467B2 (en) | 2017-07-06 | 2020-04-14 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
| US10624693B2 (en) | 2014-06-12 | 2020-04-21 | Farapulse, Inc. | Method and apparatus for rapid and selective tissue ablation with cooling |
| US10625080B1 (en) | 2019-09-17 | 2020-04-21 | Farapulse, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
| US10660702B2 (en) | 2016-01-05 | 2020-05-26 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
| US10709502B2 (en) | 2018-05-07 | 2020-07-14 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
| US10709891B2 (en) | 2016-01-05 | 2020-07-14 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
| US10835314B2 (en) | 2014-10-14 | 2020-11-17 | Farapulse, Inc. | Method and apparatus for rapid and safe pulmonary vein cardiac ablation |
| US10842561B2 (en) | 2016-01-05 | 2020-11-24 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
| US10842572B1 (en) | 2019-11-25 | 2020-11-24 | Farapulse, Inc. | Methods, systems, and apparatuses for tracking ablation devices and generating lesion lines |
| US10893905B2 (en) | 2017-09-12 | 2021-01-19 | Farapulse, Inc. | Systems, apparatuses, and methods for ventricular focal ablation |
| US20210106374A1 (en) * | 2019-10-15 | 2021-04-15 | Boston Scientific Scimed, Inc. | Control system and user interface for an ablation system |
| US11020180B2 (en) | 2018-05-07 | 2021-06-01 | Farapulse, Inc. | Epicardial ablation catheter |
| US20210169568A1 (en) * | 2019-12-09 | 2021-06-10 | Biosense Webster (Israel) Ltd. | Oriented irreversible-electroporation (ire) pulses to compensate for cell size and orientation |
| US11033236B2 (en) | 2018-05-07 | 2021-06-15 | Farapulse, Inc. | Systems, apparatuses, and methods for filtering high voltage noise induced by pulsed electric field ablation |
| US11065047B2 (en) | 2019-11-20 | 2021-07-20 | Farapulse, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
| US20210228261A1 (en) * | 2019-12-03 | 2021-07-29 | Biosense Webster (Israel) Ltd. | Pulse generator for irreversible electroporation with switchable pulse application |
| US20220039855A1 (en) * | 2020-08-10 | 2022-02-10 | Gyrus Acmi, Inc. D/B/A Olympus Surgical Technologies America | Bipolar forceps with vessel seal testing |
| US11259869B2 (en) | 2014-05-07 | 2022-03-01 | Farapulse, Inc. | Methods and apparatus for selective tissue ablation |
| US20220061884A1 (en) * | 2020-08-25 | 2022-03-03 | Cross Vascular, Inc. | Depth sensing dilator system |
| EP4018950A1 (en) * | 2020-12-22 | 2022-06-29 | Biosense Webster (Israel) Ltd | Improving lesion uniformity in bipolar cardiac ablation |
| US11426573B2 (en) | 2012-08-09 | 2022-08-30 | University Of Iowa Research Foundation | Catheters, catheter systems, and methods for puncturing through a tissue structure and ablating a tissue region |
| US11497541B2 (en) | 2019-11-20 | 2022-11-15 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
| US11589919B2 (en) | 2014-01-06 | 2023-02-28 | Boston Scientific Scimed, Inc. | Apparatus and methods for renal denervation ablation |
| US11678928B2 (en) | 2019-01-10 | 2023-06-20 | Atricure, Inc. | Surgical clamp |
| US12016619B2 (en) | 2020-05-14 | 2024-06-25 | Circa Scientific, Inc. | Transseptal crossing system for single pass large bore access |
| US12042208B2 (en) | 2018-05-03 | 2024-07-23 | Boston Scientific Scimed, Inc. | Systems, devices, and methods for ablation using surgical clamps |
| US12137968B2 (en) | 2014-05-16 | 2024-11-12 | Boston Scientific Scimed, Inc. | Methods and apparatus for multi-catheter tissue ablation |
| US12144541B2 (en) | 2016-01-05 | 2024-11-19 | Boston Scientific Scimed, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
| US12295637B2 (en) | 2018-02-08 | 2025-05-13 | Boston Scientific Scimed, Inc. | Method and apparatus for controlled delivery of pulsed electric field ablative energy to tissue |
| CN120227138A (en) * | 2025-04-01 | 2025-07-01 | 苏州赛纳思医疗技术有限公司 | Pulse ablation system and control method of pulse ablation system |
| US12349964B2 (en) | 2020-09-30 | 2025-07-08 | Boston Scientific Scimed, Inc. | Pretreatment waveform for irreversible electroporation |
| US12426944B2 (en) | 2020-07-28 | 2025-09-30 | Biosense Webster (Israel) Ltd. | Automatically performing irreversible electroporation ablation during heart refractory period |
| US12496128B2 (en) | 2024-05-24 | 2025-12-16 | Boston Scientific Scimed, Inc. | Methods and apparatus for selective tissue ablation |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12076071B2 (en) | 2020-08-14 | 2024-09-03 | Kardium Inc. | Systems and methods for treating tissue with pulsed field ablation |
| MX2023011506A (en) | 2021-04-07 | 2023-12-07 | Btl Medical Dev A S | DEVICE AND METHOD OF PULSED FIELD ABLATION. |
| HRP20250794T1 (en) | 2021-07-06 | 2025-08-29 | Btl Medical Development A.S. | PULSE FIELD ABLATION DEVICE |
| JP2025533070A (en) | 2022-10-05 | 2025-10-03 | ビーティーエル メディカル デベロップメント エー.エス. | Pulsed field ablation device and method |
| WO2025117526A1 (en) * | 2023-11-28 | 2025-06-05 | Medtronic, Inc. | Surgical instrument for pulsed field ablation |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030125729A1 (en) * | 2000-04-27 | 2003-07-03 | Hooven Michael D. | Transmural ablation device |
| US20050251130A1 (en) * | 2005-04-22 | 2005-11-10 | Boveja Birinder R | Method and system of stopping energy delivery of an ablation procedure with a computer based device for increasing safety of ablation procedures |
| US20080172048A1 (en) * | 2007-01-12 | 2008-07-17 | Keith Edward Martin | Ablation system, clamp and method of use |
| US20100274238A1 (en) * | 2009-04-22 | 2010-10-28 | Klimovitch Gleb V | Method and apparatus for radiofrequency ablation with increased depth and/or decreased volume of ablated tissue |
| US20120095459A1 (en) * | 2010-10-13 | 2012-04-19 | Peter Callas | System and Method for Electrically Ablating Tissue of a Patient |
| US20120310237A1 (en) * | 2011-05-31 | 2012-12-06 | Estech, Inc. (Endoscopic Technologies, Inc.) | High-voltage pulse ablation systems and methods |
| US20140052126A1 (en) * | 2012-08-15 | 2014-02-20 | Ethicon Endo-Surgery, Inc. | Electrosurgical devices and methods |
| US20140148804A1 (en) * | 2012-11-29 | 2014-05-29 | Zane R. Ward | Quadripolar forceps |
Family Cites Families (557)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4200104A (en) | 1977-11-17 | 1980-04-29 | Valleylab, Inc. | Contact area measurement apparatus for use in electrosurgery |
| US4470407A (en) | 1982-03-11 | 1984-09-11 | Laserscope, Inc. | Endoscopic device |
| US4739759A (en) | 1985-02-26 | 1988-04-26 | Concept, Inc. | Microprocessor controlled electrosurgical generator |
| US5547467A (en) | 1988-01-21 | 1996-08-20 | Massachusettes Institute Of Technology | Method for rapid temporal control of molecular transport across tissue |
| US5344435A (en) | 1988-07-28 | 1994-09-06 | Bsd Medical Corporation | Urethral inserted applicator prostate hyperthermia |
| FR2639238B1 (en) | 1988-11-21 | 1991-02-22 | Technomed Int Sa | APPARATUS FOR SURGICAL TREATMENT OF TISSUES BY HYPERTHERMIA, PREFERABLY THE PROSTATE, COMPRISING MEANS OF THERMAL PROTECTION COMPRISING PREFERABLY RADIOREFLECTIVE SCREEN MEANS |
| US5257635A (en) | 1988-11-25 | 1993-11-02 | Sensor Electronics, Inc. | Electrical heating catheter |
| US5749914A (en) | 1989-01-06 | 1998-05-12 | Advanced Coronary Intervention | Catheter for obstructed stent |
| US5342301A (en) | 1992-08-13 | 1994-08-30 | Advanced Polymers Incorporated | Multi-lumen balloons and catheters made therewith |
| WO1992021285A1 (en) | 1991-05-24 | 1992-12-10 | Ep Technologies, Inc. | Combination monophasic action potential/ablation catheter and high-performance filter system |
| US6029671A (en) | 1991-07-16 | 2000-02-29 | Heartport, Inc. | System and methods for performing endovascular procedures |
| US5697281A (en) | 1991-10-09 | 1997-12-16 | Arthrocare Corporation | System and method for electrosurgical cutting and ablation |
| US5524338A (en) | 1991-10-22 | 1996-06-11 | Pi Medical Corporation | Method of making implantable microelectrode |
| US5304214A (en) | 1992-01-21 | 1994-04-19 | Med Institute, Inc. | Transurethral ablation catheter |
| US5306296A (en) | 1992-08-21 | 1994-04-26 | Medtronic, Inc. | Annuloplasty and suture rings |
| US5242441A (en) | 1992-02-24 | 1993-09-07 | Boaz Avitall | Deflectable catheter with rotatable tip electrode |
| US5281213A (en) | 1992-04-16 | 1994-01-25 | Implemed, Inc. | Catheter for ice mapping and ablation |
| US5443463A (en) | 1992-05-01 | 1995-08-22 | Vesta Medical, Inc. | Coagulating forceps |
| WO2003097159A1 (en) | 2002-05-17 | 2003-11-27 | Obino Stan F | Device and method for the treatment of cardiac disorders |
| US5341807A (en) | 1992-06-30 | 1994-08-30 | American Cardiac Ablation Co., Inc. | Ablation catheter positioning system |
| US5313943A (en) | 1992-09-25 | 1994-05-24 | Ep Technologies, Inc. | Catheters and methods for performing cardiac diagnosis and treatment |
| US5700243A (en) | 1992-10-30 | 1997-12-23 | Pdt Systems, Inc. | Balloon perfusion catheter |
| US5334193A (en) | 1992-11-13 | 1994-08-02 | American Cardiac Ablation Co., Inc. | Fluid cooled ablation catheter |
| US6068653A (en) | 1992-11-13 | 2000-05-30 | Scimed Life Systems, Inc. | Electrophysiology catheter device |
| US5545161A (en) | 1992-12-01 | 1996-08-13 | Cardiac Pathways Corporation | Catheter for RF ablation having cooled electrode with electrically insulated sleeve |
| US6749604B1 (en) | 1993-05-10 | 2004-06-15 | Arthrocare Corporation | Electrosurgical instrument with axially-spaced electrodes |
| US5531685A (en) | 1993-06-11 | 1996-07-02 | Catheter Research, Inc. | Steerable variable stiffness device |
| FR2708860B1 (en) | 1993-08-11 | 1995-10-13 | Ela Medical Sa | Protection circuit for implantable electronic device. |
| US5545193A (en) | 1993-10-15 | 1996-08-13 | Ep Technologies, Inc. | Helically wound radio-frequency emitting electrodes for creating lesions in body tissue |
| US5722400A (en) | 1995-02-16 | 1998-03-03 | Daig Corporation | Guiding introducers for use in the treatment of left ventricular tachycardia |
| US5921924A (en) | 1993-12-03 | 1999-07-13 | Avitall; Boaz | Mapping and ablation catheter system utilizing multiple control elements |
| US5454370A (en) | 1993-12-03 | 1995-10-03 | Avitall; Boaz | Mapping and ablation electrode configuration |
| US5928269A (en) | 1994-04-04 | 1999-07-27 | Alt; Eckhard | Apparatus and method for temporary atrial defibrillation with external defibrillator and implanted transvenous catheter and electrodes |
| US5578040A (en) | 1994-06-14 | 1996-11-26 | Smith; Albert C. | Ocular repair system and apparatus |
| US5617854A (en) | 1994-06-22 | 1997-04-08 | Munsif; Anand | Shaped catheter device and method |
| US5836947A (en) | 1994-10-07 | 1998-11-17 | Ep Technologies, Inc. | Flexible structures having movable splines for supporting electrode elements |
| US6071274A (en) | 1996-12-19 | 2000-06-06 | Ep Technologies, Inc. | Loop structures for supporting multiple electrode elements |
| US5885278A (en) | 1994-10-07 | 1999-03-23 | E.P. Technologies, Inc. | Structures for deploying movable electrode elements |
| US5876336A (en) | 1994-10-11 | 1999-03-02 | Ep Technologies, Inc. | Systems and methods for guiding movable electrode elements within multiple-electrode structure |
| US5722402A (en) | 1994-10-11 | 1998-03-03 | Ep Technologies, Inc. | Systems and methods for guiding movable electrode elements within multiple-electrode structures |
| US5624430A (en) | 1994-11-28 | 1997-04-29 | Eton; Darwin | Magnetic device to assist transcorporeal guidewire placement |
| US5647871A (en) | 1995-03-10 | 1997-07-15 | Microsurge, Inc. | Electrosurgery with cooled electrodes |
| US5810762A (en) * | 1995-04-10 | 1998-09-22 | Genetronics, Inc. | Electroporation system with voltage control feedback for clinical applications |
| US20060024359A1 (en) | 1995-06-07 | 2006-02-02 | Walker Jeffrey P | Drug delivery system and method |
| US6090104A (en) | 1995-06-07 | 2000-07-18 | Cordis Webster, Inc. | Catheter with a spirally wound flat ribbon electrode |
| US5702438A (en) | 1995-06-08 | 1997-12-30 | Avitall; Boaz | Expandable recording and ablation catheter system |
| US5788692A (en) | 1995-06-30 | 1998-08-04 | Fidus Medical Technology Corporation | Mapping ablation catheter |
| US6023638A (en) | 1995-07-28 | 2000-02-08 | Scimed Life Systems, Inc. | System and method for conducting electrophysiological testing using high-voltage energy pulses to stun tissue |
| US5706823A (en) | 1995-08-18 | 1998-01-13 | Quinton Instrument Company | Electrophysiology filtering system |
| CA2233963C (en) | 1995-10-06 | 2005-06-21 | Cordis Webster, Inc. | Split tip electrode catheter |
| DE29519651U1 (en) | 1995-12-14 | 1996-02-01 | Muntermann, Axel, 35583 Wetzlar | Device for linear radio frequency catheter ablation of endomyocardial tissue |
| BR9612395A (en) | 1995-12-29 | 1999-07-13 | Gyrus Medical Ltd | Electrosurgical instrument and an electrosurgical electrode set |
| US7141049B2 (en) | 1999-03-09 | 2006-11-28 | Thermage, Inc. | Handpiece for treatment of tissue |
| JP2000504242A (en) | 1996-01-19 | 2000-04-11 | イーピー・テクノロジーズ・インコーポレイテッド | Multifunctional electrode structure for electrically analyzing and heating body tissue |
| US5868736A (en) | 1996-04-12 | 1999-02-09 | Ep Technologies, Inc. | Systems and methods to control tissue heating or ablation with porous electrode structures |
| US5836874A (en) | 1996-04-08 | 1998-11-17 | Ep Technologies, Inc. | Multi-function electrode structures for electrically analyzing and heating body tissue |
| US5800482A (en) | 1996-03-06 | 1998-09-01 | Cardiac Pathways Corporation | Apparatus and method for linear lesion ablation |
| US5830224A (en) | 1996-03-15 | 1998-11-03 | Beth Israel Deaconess Medical Center | Catheter apparatus and methodology for generating a fistula on-demand between closely associated blood vessels at a pre-chosen anatomic site in-vivo |
| US5779699A (en) | 1996-03-29 | 1998-07-14 | Medtronic, Inc. | Slip resistant field focusing ablation catheter electrode |
| US5836942A (en) | 1996-04-04 | 1998-11-17 | Minnesota Mining And Manufacturing Company | Biomedical electrode with lossy dielectric properties |
| US5863291A (en) | 1996-04-08 | 1999-01-26 | Cardima, Inc. | Linear ablation assembly |
| US5904709A (en) | 1996-04-17 | 1999-05-18 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Microwave treatment for cardiac arrhythmias |
| US5672170A (en) | 1996-06-20 | 1997-09-30 | Cynosure, Inc. | Laser transmyocardial revascularization arrangement |
| US6006131A (en) | 1996-08-13 | 1999-12-21 | Uab Research Foundation | Dual current pathway atrial defibrillation apparatus |
| EP0832602B1 (en) | 1996-09-27 | 2004-03-17 | Sulzer Osypka GmbH | Device for carrying out diagnostic and/or therapeutic heart procedures with a catheter |
| US6464697B1 (en) | 1998-02-19 | 2002-10-15 | Curon Medical, Inc. | Stomach and adjoining tissue regions in the esophagus |
| US6311692B1 (en) | 1996-10-22 | 2001-11-06 | Epicor, Inc. | Apparatus and method for diagnosis and therapy of electrophysiological disease |
| US6805128B1 (en) | 1996-10-22 | 2004-10-19 | Epicor Medical, Inc. | Apparatus and method for ablating tissue |
| US7052493B2 (en) | 1996-10-22 | 2006-05-30 | Epicor Medical, Inc. | Methods and devices for ablation |
| US6096036A (en) | 1998-05-05 | 2000-08-01 | Cardiac Pacemakers, Inc. | Steerable catheter with preformed distal shape and method for use |
| US6002955A (en) | 1996-11-08 | 1999-12-14 | Medtronic, Inc. | Stabilized electrophysiology catheter and method for use |
| US6035238A (en) | 1997-08-13 | 2000-03-07 | Surx, Inc. | Noninvasive devices, methods, and systems for shrinking of tissues |
| US6076012A (en) | 1996-12-19 | 2000-06-13 | Ep Technologies, Inc. | Structures for supporting porous electrode elements |
| US5913854A (en) | 1997-02-04 | 1999-06-22 | Medtronic, Inc. | Fluid cooled ablation catheter and method for making |
| US5916213A (en) | 1997-02-04 | 1999-06-29 | Medtronic, Inc. | Systems and methods for tissue mapping and ablation |
| US6039757A (en) | 1997-03-12 | 2000-03-21 | Cardiosynopsis, Inc. | In situ formed fenestrated stent |
| US6223085B1 (en) | 1997-05-06 | 2001-04-24 | Urologix, Inc. | Device and method for preventing restenosis |
| US6012457A (en) | 1997-07-08 | 2000-01-11 | The Regents Of The University Of California | Device and method for forming a circumferential conduction block in a pulmonary vein |
| US5849028A (en) | 1997-05-16 | 1998-12-15 | Irvine Biomedical, Inc. | Catheter and method for radiofrequency ablation of cardiac tissue |
| US5978704A (en) | 1997-06-03 | 1999-11-02 | Uab Research Foundation | Method and apparatus for treating cardiac arrhythmia |
| US5938660A (en) | 1997-06-27 | 1999-08-17 | Daig Corporation | Process and device for the treatment of atrial arrhythmia |
| US6245064B1 (en) | 1997-07-08 | 2001-06-12 | Atrionix, Inc. | Circumferential ablation device assembly |
| US6966908B2 (en) | 1997-07-08 | 2005-11-22 | Atrionix, Inc. | Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall |
| US6164283A (en) | 1997-07-08 | 2000-12-26 | The Regents Of The University Of California | Device and method for forming a circumferential conduction block in a pulmonary vein |
| CN1161081C (en) | 1997-07-08 | 2004-08-11 | 加利福尼亚大学董事会 | Peripheral ablation device assemblies and methods |
| US6009351A (en) | 1997-07-14 | 1999-12-28 | Urologix, Inc. | System and method for transurethral heating with rectal cooling |
| US6014579A (en) | 1997-07-21 | 2000-01-11 | Cardiac Pathways Corp. | Endocardial mapping catheter with movable electrode |
| JP2002512552A (en) | 1997-07-22 | 2002-04-23 | イーメッド コーポレイション | Delivery of drugs into heart tissue by iontophoresis. |
| US6216034B1 (en) | 1997-08-01 | 2001-04-10 | Genetronics, Inc. | Method of programming an array of needle electrodes for electroporation therapy of tissue |
| US5895404A (en) | 1997-09-29 | 1999-04-20 | Ruiz; Carlos E. | Apparatus and methods for percutaneously forming a passageway between adjacent vessels or portions of a vessel |
| US6464699B1 (en) | 1997-10-10 | 2002-10-15 | Scimed Life Systems, Inc. | Method and apparatus for positioning a diagnostic or therapeutic element on body tissue and mask element for use with same |
| US6071281A (en) | 1998-05-05 | 2000-06-06 | Ep Technologies, Inc. | Surgical method and apparatus for positioning a diagnostic or therapeutic element within the body and remote power control unit for use with same |
| US6645200B1 (en) | 1997-10-10 | 2003-11-11 | Scimed Life Systems, Inc. | Method and apparatus for positioning a diagnostic or therapeutic element within the body and tip electrode for use with same |
| JP2001521774A (en) | 1997-10-31 | 2001-11-13 | シー・アール・バード・インコーポレーテッド | Ring-shaped electrode structure for diagnostic and ablation catheters |
| US6120500A (en) | 1997-11-12 | 2000-09-19 | Daig Corporation | Rail catheter ablation and mapping system |
| US5928270A (en) | 1997-12-02 | 1999-07-27 | Cardiocommand, Inc. | Method and apparatus for incremental cardioversion or defibrillation |
| US6447505B2 (en) | 1998-02-11 | 2002-09-10 | Cosman Company, Inc. | Balloon catheter method for intra-urethral radio-frequency urethral enlargement |
| US6517534B1 (en) | 1998-02-11 | 2003-02-11 | Cosman Company, Inc. | Peri-urethral ablation |
| US20020087148A1 (en) | 1998-02-24 | 2002-07-04 | Brock David L. | Flexible instrument |
| US6167291A (en) | 1998-03-12 | 2000-12-26 | Cardima, Inc. | Protected pin connector for an electrophysiology catheter |
| DE19817553A1 (en) | 1998-04-15 | 1999-10-21 | Biotronik Mess & Therapieg | Ablation arrangement |
| US6030384A (en) * | 1998-05-01 | 2000-02-29 | Nezhat; Camran | Bipolar surgical instruments having focused electrical fields |
| US6146381A (en) | 1998-05-05 | 2000-11-14 | Cardiac Pacemakers, Inc. | Catheter having distal region for deflecting axial forces |
| US6171305B1 (en) | 1998-05-05 | 2001-01-09 | Cardiac Pacemakers, Inc. | RF ablation apparatus and method having high output impedance drivers |
| US6045550A (en) | 1998-05-05 | 2000-04-04 | Cardiac Peacemakers, Inc. | Electrode having non-joined thermocouple for providing multiple temperature-sensitive junctions |
| US6592581B2 (en) | 1998-05-05 | 2003-07-15 | Cardiac Pacemakers, Inc. | Preformed steerable catheter with movable outer sleeve and method for use |
| US6527767B2 (en) | 1998-05-20 | 2003-03-04 | New England Medical Center | Cardiac ablation system and method for treatment of cardiac arrhythmias and transmyocardial revascularization |
| US6231518B1 (en) | 1998-05-26 | 2001-05-15 | Comedicus Incorporated | Intrapericardial electrophysiological procedures |
| US6287306B1 (en) | 1998-06-22 | 2001-09-11 | Daig Corporation | Even temperature linear lesion ablation catheter |
| US6251107B1 (en) | 1998-06-25 | 2001-06-26 | Cardima, Inc. | Ep catheter |
| US6322559B1 (en) | 1998-07-06 | 2001-11-27 | Vnus Medical Technologies, Inc. | Electrode catheter having coil structure |
| US6623480B1 (en) | 1998-07-24 | 2003-09-23 | University Of Kentucky Research Foundation | Flexible recording/high energy electrode catheter with anchor for ablation of atrial flutter by radio frequency energy |
| US7435247B2 (en) | 1998-08-11 | 2008-10-14 | Arthrocare Corporation | Systems and methods for electrosurgical tissue treatment |
| US6251128B1 (en) | 1998-09-01 | 2001-06-26 | Fidus Medical Technology Corporation | Microwave ablation catheter with loop configuration |
| US8308719B2 (en) | 1998-09-21 | 2012-11-13 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Apparatus and method for ablating tissue |
| US6807447B2 (en) | 1998-09-25 | 2004-10-19 | Ep Medsystems, Inc. | Triple array defibrillation catheter and method of using the same |
| US6033403A (en) | 1998-10-08 | 2000-03-07 | Irvine Biomedical, Inc. | Long electrode catheter system and methods thereof |
| US6638278B2 (en) | 1998-11-23 | 2003-10-28 | C. R. Bard, Inc. | Intracardiac grasp catheter |
| IT1302900B1 (en) | 1998-12-04 | 2000-10-10 | Riccardo Fenici | AMAGNETIC CATHETER FOR THE SINGLE-CATHETER REGISTRATION OF MULTIPLE SINGLE-PHASE ACTION POTENTIALS, LOCABLE THREE-DIMENSIONALLY AND |
| US20070066972A1 (en) | 2001-11-29 | 2007-03-22 | Medwaves, Inc. | Ablation catheter apparatus with one or more electrodes |
| US6219582B1 (en) | 1998-12-30 | 2001-04-17 | Daig Corporation | Temporary atrial cardioversion catheter |
| US6206831B1 (en) | 1999-01-06 | 2001-03-27 | Scimed Life Systems, Inc. | Ultrasound-guided ablation catheter and methods of use |
| US6702811B2 (en) | 1999-04-05 | 2004-03-09 | Medtronic, Inc. | Ablation catheter assembly with radially decreasing helix and method of use |
| US6325797B1 (en) | 1999-04-05 | 2001-12-04 | Medtronic, Inc. | Ablation catheter and method for isolating a pulmonary vein |
| US20010007070A1 (en) | 1999-04-05 | 2001-07-05 | Medtronic, Inc. | Ablation catheter assembly and method for isolating a pulmonary vein |
| US6270476B1 (en) | 1999-04-23 | 2001-08-07 | Cryocath Technologies, Inc. | Catheter |
| US6272384B1 (en) | 1999-05-27 | 2001-08-07 | Urologix, Inc. | Microwave therapy apparatus |
| US7171263B2 (en) | 1999-06-04 | 2007-01-30 | Impulse Dynamics Nv | Drug delivery device |
| US6391024B1 (en) | 1999-06-17 | 2002-05-21 | Cardiac Pacemakers, Inc. | RF ablation apparatus and method having electrode/tissue contact assessment scheme and electrocardiogram filtering |
| US6300108B1 (en) | 1999-07-21 | 2001-10-09 | The Regents Of The University Of California | Controlled electroporation and mass transfer across cell membranes |
| DE19938558A1 (en) | 1999-08-17 | 2001-02-22 | Axel Muntermann | Catheters with improved electrical properties and treatment methods for improving the electrical properties of catheters |
| US6607520B2 (en) | 1999-09-15 | 2003-08-19 | The General Hospital Corporation | Coiled ablation catheter system |
| US6370412B1 (en) | 1999-10-07 | 2002-04-09 | Massachusetts Institute Of Technology | Method and apparatus for guiding ablative therapy of abnormal biological electrical excitation |
| US6613062B1 (en) | 1999-10-29 | 2003-09-02 | Medtronic, Inc. | Method and apparatus for providing intra-pericardial access |
| US6529756B1 (en) | 1999-11-22 | 2003-03-04 | Scimed Life Systems, Inc. | Apparatus for mapping and coagulating soft tissue in or around body orifices |
| US6892091B1 (en) | 2000-02-18 | 2005-05-10 | Biosense, Inc. | Catheter, method and apparatus for generating an electrical map of a chamber of the heart |
| DE10008918A1 (en) | 2000-02-25 | 2001-08-30 | Biotronik Mess & Therapieg | Ablation catheter to create linear lesions in cardiac muscle tissue |
| DE60119503T2 (en) | 2000-03-31 | 2007-04-19 | Medtronic, Inc., Minneapolis | steering mechanism |
| US7497844B2 (en) | 2000-03-31 | 2009-03-03 | Medtronic, Inc. | System and method for positioning implantable medical devices within coronary veins |
| US6652517B1 (en) | 2000-04-25 | 2003-11-25 | Uab Research Foundation | Ablation catheter, system, and method of use thereof |
| US20020107514A1 (en) | 2000-04-27 | 2002-08-08 | Hooven Michael D. | Transmural ablation device with parallel jaws |
| US6932811B2 (en) | 2000-04-27 | 2005-08-23 | Atricure, Inc. | Transmural ablation device with integral EKG sensor |
| US6743239B1 (en) | 2000-05-25 | 2004-06-01 | St. Jude Medical, Inc. | Devices with a bendable tip for medical procedures |
| US7419487B2 (en) | 2000-07-25 | 2008-09-02 | Angiodynamics, Inc. | Apparatus for detecting and treating tumors using localized impedance measurement |
| US8251986B2 (en) | 2000-08-17 | 2012-08-28 | Angiodynamics, Inc. | Method of destroying tissue cells by eletroporation |
| US6728563B2 (en) | 2000-11-29 | 2004-04-27 | St. Jude Medical, Daig Division, Inc. | Electrophysiology/ablation catheter having “halo” configuration |
| US7081114B2 (en) | 2000-11-29 | 2006-07-25 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Electrophysiology/ablation catheter having lariat configuration of variable radius |
| EP1349510A4 (en) | 2000-12-15 | 2005-07-13 | Tony R Brown | Atrial fibrillation rf treatment device and method |
| US6620157B1 (en) | 2000-12-28 | 2003-09-16 | Senorx, Inc. | High frequency power source |
| DE10102089C1 (en) | 2001-01-18 | 2002-07-25 | Wolf Gmbh Richard | Surgical instrument |
| DE10102254A1 (en) | 2001-01-19 | 2002-08-08 | Celon Ag Medical Instruments | Device for the electrothermal treatment of the human or animal body |
| US6743226B2 (en) | 2001-02-09 | 2004-06-01 | Cosman Company, Inc. | Adjustable trans-urethral radio-frequency ablation |
| US7229402B2 (en) | 2001-02-09 | 2007-06-12 | Cardiac Output Technologies, Inc. | Minimally invasive ventricular assist technology and method |
| US7137975B2 (en) | 2001-02-13 | 2006-11-21 | Aciont, Inc. | Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent |
| US6666862B2 (en) | 2001-03-01 | 2003-12-23 | Cardiac Pacemakers, Inc. | Radio frequency ablation system and method linking energy delivery with fluid flow |
| US6666863B2 (en) | 2001-03-01 | 2003-12-23 | Scimed Life Systems, Inc. | Device and method for percutaneous myocardial revascularization |
| US6743225B2 (en) | 2001-03-27 | 2004-06-01 | Uab Research Foundation | Electrophysiologic measure of endpoints for ablation lesions created in fibrillating substrates |
| US6619291B2 (en) | 2001-04-24 | 2003-09-16 | Edwin J. Hlavka | Method and apparatus for catheter-based annuloplasty |
| JP4279559B2 (en) | 2001-04-27 | 2009-06-17 | シー・アール・バード・インコーポレーテッド | Electrophysiological catheter for mapping and / or ablation |
| US6972016B2 (en) | 2001-05-01 | 2005-12-06 | Cardima, Inc. | Helically shaped electrophysiology catheter |
| US6771996B2 (en) | 2001-05-24 | 2004-08-03 | Cardiac Pacemakers, Inc. | Ablation and high-resolution mapping catheter system for pulmonary vein foci elimination |
| US6685702B2 (en) | 2001-07-06 | 2004-02-03 | Rodolfo C. Quijano | Device for treating tissue and methods thereof |
| US20030018374A1 (en) | 2001-07-16 | 2003-01-23 | Paulos Lonnie E. | Treatment probe using RF energy |
| US6994706B2 (en) | 2001-08-13 | 2006-02-07 | Minnesota Medical Physics, Llc | Apparatus and method for treatment of benign prostatic hyperplasia |
| US8623012B2 (en) | 2001-08-15 | 2014-01-07 | Nuortho Surgical, Inc. | Electrosurgical plenum |
| EP1429649A4 (en) | 2001-09-24 | 2008-08-20 | Best Vascular Inc | Methods and apparatus employing ionizing radiation for treatment of cardiac arrhythmia |
| JP4450622B2 (en) | 2001-09-28 | 2010-04-14 | アンジオ ダイナミクス インコーポレイテッド | Impedance-controlled tissue peeling device and method |
| US7285116B2 (en) | 2004-05-15 | 2007-10-23 | Irvine Biomedical Inc. | Non-contact tissue ablation device and methods thereof |
| US8175680B2 (en) | 2001-11-09 | 2012-05-08 | Boston Scientific Scimed, Inc. | Systems and methods for guiding catheters using registered images |
| US6669693B2 (en) | 2001-11-13 | 2003-12-30 | Mayo Foundation For Medical Education And Research | Tissue ablation device and methods of using |
| US7542807B2 (en) | 2001-12-04 | 2009-06-02 | Endoscopic Technologies, Inc. | Conduction block verification probe and method of use |
| US6740084B2 (en) | 2001-12-18 | 2004-05-25 | Ethicon, Inc. | Method and device to enhance RF electrode performance |
| JP4230915B2 (en) | 2001-12-21 | 2009-02-25 | シムチャ ミロ | Annuloplasty ring transplantation system |
| US7493156B2 (en) | 2002-01-07 | 2009-02-17 | Cardiac Pacemakers, Inc. | Steerable guide catheter with pre-shaped rotatable shaft |
| US8062251B2 (en) | 2002-02-01 | 2011-11-22 | Vascular Designs, Inc. | Multi-function catheter and use thereof |
| US6926714B1 (en) | 2002-02-05 | 2005-08-09 | Jasbir S. Sra | Method for pulmonary vein isolation and catheter ablation of other structures in the left atrium in atrial fibrillation |
| US6932816B2 (en) | 2002-02-19 | 2005-08-23 | Boston Scientific Scimed, Inc. | Apparatus for converting a clamp into an electrophysiology device |
| US6733499B2 (en) | 2002-02-28 | 2004-05-11 | Biosense Webster, Inc. | Catheter having circular ablation assembly |
| US6869414B2 (en) | 2002-03-22 | 2005-03-22 | Cardiac Pacemakers, Inc. | Pre-shaped catheter with proximal articulation and pre-formed distal end |
| US8774913B2 (en) | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for intravasculary-induced neuromodulation |
| US7756583B2 (en) | 2002-04-08 | 2010-07-13 | Ardian, Inc. | Methods and apparatus for intravascularly-induced neuromodulation |
| US8347891B2 (en) | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
| US7653438B2 (en) | 2002-04-08 | 2010-01-26 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
| US7617005B2 (en) | 2002-04-08 | 2009-11-10 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
| DE10218427A1 (en) | 2002-04-24 | 2003-11-06 | Biotronik Mess & Therapieg | Ablation device for cardiac tissue, in particular for creating a circular lesion around a vascular mouth in the heart |
| US6764486B2 (en) | 2002-04-24 | 2004-07-20 | Biotronik Mess- und Therapieger{haeck over (a)}te GmbH & Co. Ingenieurbüro Berlin | Ablation device for cardiac tissue, especially for forming a circular lesion around a vessel orifice in the heart |
| US20030204161A1 (en) | 2002-04-25 | 2003-10-30 | Bozidar Ferek-Petric | Implantable electroporation therapy device and method for using same |
| US6780178B2 (en) | 2002-05-03 | 2004-08-24 | The Board Of Trustees Of The Leland Stanford Junior University | Method and apparatus for plasma-mediated thermo-electrical ablation |
| JP4338631B2 (en) | 2002-05-27 | 2009-10-07 | セロン アクチエンゲゼルシャフト メディカル インスツルメンツ | Device for hardening body tissue by electrosurgery (thermal scrosis) |
| US20030229379A1 (en) | 2002-06-06 | 2003-12-11 | Maynard Ramsey | Method for cardioversion or defibrillation using electrical impulses at pacing strength |
| US7367974B2 (en) | 2004-09-20 | 2008-05-06 | Wisconsin Alumni Research Foundation | Electrode array for tissue ablation |
| US20040082859A1 (en) | 2002-07-01 | 2004-04-29 | Alan Schaer | Method and apparatus employing ultrasound energy to treat body sphincters |
| US7001383B2 (en) | 2002-10-21 | 2006-02-21 | Biosense, Inc. | Real-time monitoring and mapping of ablation lesion formation in the heart |
| US20040082947A1 (en) | 2002-10-25 | 2004-04-29 | The Regents Of The University Of Michigan | Ablation catheters |
| US9730100B2 (en) | 2002-10-28 | 2017-08-08 | MeshDynamics | Terse message networks |
| US9819747B2 (en) | 2008-11-24 | 2017-11-14 | MeshDynamics | Chirp networks |
| DE60327650D1 (en) | 2002-11-15 | 2009-06-25 | Bard Inc C R | ELECTROPHYSIOLOGY CATHETER WITH ABLATION ELECTRODE |
| AU2003290806A1 (en) | 2002-11-15 | 2004-06-15 | The Government Of The United States As Represented By The Secretary Of The Department Of Health And Human Services | Variable curve catheter |
| US7195628B2 (en) | 2002-12-11 | 2007-03-27 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Atrial fibrillation therapy with pulmonary vein support |
| WO2004058326A2 (en) | 2002-12-20 | 2004-07-15 | Cardiac Inventions Unlimited, Inc. | Left ventricular pacing lead and implantation method |
| US6984232B2 (en) | 2003-01-17 | 2006-01-10 | St. Jude Medical, Daig Division, Inc. | Ablation catheter assembly having a virtual electrode comprising portholes |
| US8192425B2 (en) | 2006-09-29 | 2012-06-05 | Baylis Medical Company Inc. | Radiofrequency perforation apparatus |
| US7387629B2 (en) | 2003-01-21 | 2008-06-17 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Catheter design that facilitates positioning at tissue to be diagnosed or treated |
| US6960207B2 (en) | 2003-01-21 | 2005-11-01 | St Jude Medical, Daig Division, Inc. | Ablation catheter having a virtual electrode comprising portholes and a porous conductor |
| US7622172B2 (en) | 2003-02-19 | 2009-11-24 | Erick Keenan | Composite flexible and conductive catheter electrode |
| WO2004086995A1 (en) | 2003-03-28 | 2004-10-14 | C.R. Bard, Inc. | Method and apparatus for selecting operating parameter values in electrophysiology procedures |
| US6985776B2 (en) | 2003-04-25 | 2006-01-10 | Medtronic, Inc. | Method and apparatus for coronary sinus cannulation |
| US6980843B2 (en) | 2003-05-21 | 2005-12-27 | Stereotaxis, Inc. | Electrophysiology catheter |
| US7163537B2 (en) | 2003-06-02 | 2007-01-16 | Biosense Webster, Inc. | Enhanced ablation and mapping catheter and method for treating atrial fibrillation |
| US7044946B2 (en) | 2003-06-10 | 2006-05-16 | Cryocath Technologies Inc. | Surgical clamp having treatment elements |
| US7540853B2 (en) | 2003-06-30 | 2009-06-02 | Cardiac Pacemakers, Inc. | Method and apparatus for diverting blood flow during ablation procedures |
| US6973339B2 (en) | 2003-07-29 | 2005-12-06 | Biosense, Inc | Lasso for pulmonary vein mapping and ablation |
| US20060009755A1 (en) | 2003-09-04 | 2006-01-12 | Sra Jasbir S | Method and system for ablation of atrial fibrillation and other cardiac arrhythmias |
| US7229437B2 (en) | 2003-09-22 | 2007-06-12 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Medical device having integral traces and formed electrodes |
| US8147486B2 (en) | 2003-09-22 | 2012-04-03 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Medical device with flexible printed circuit |
| US7435248B2 (en) | 2003-09-26 | 2008-10-14 | Boston Scientific Scimed, Inc. | Medical probes for creating and diagnosing circumferential lesions within or around the ostium of a vessel |
| US7179256B2 (en) | 2003-10-24 | 2007-02-20 | Biosense Webster, Inc. | Catheter with ablation needle and mapping assembly |
| US7207989B2 (en) | 2003-10-27 | 2007-04-24 | Biosense Webster, Inc. | Method for ablating with needle electrode |
| FR2861997A1 (en) | 2003-11-06 | 2005-05-13 | Fred Zacouto | Cardiac muscle stimulation device e.g. defibrillator, for use during tachycardia treatment, has impulse generator that sends stimulation pulse without delay at end of refractory period |
| US7666203B2 (en) | 2003-11-06 | 2010-02-23 | Nmt Medical, Inc. | Transseptal puncture apparatus |
| WO2005053555A1 (en) | 2003-12-01 | 2005-06-16 | Biotronik Crm Patent Ag | Electrode catheter for the electrotherapy of cardiac tissue |
| EP1696812B1 (en) | 2003-12-24 | 2015-07-22 | The Regents of The University of California | Tissue ablation with irreversible electroporation |
| US20050187545A1 (en) | 2004-02-20 | 2005-08-25 | Hooven Michael D. | Magnetic catheter ablation device and method |
| US7850642B2 (en) | 2004-03-05 | 2010-12-14 | Hansen Medical, Inc. | Methods using a robotic catheter system |
| US7972298B2 (en) | 2004-03-05 | 2011-07-05 | Hansen Medical, Inc. | Robotic catheter system |
| WO2006119467A2 (en) | 2005-05-04 | 2006-11-09 | Impulse Dynamics Nv | Protein activity modification |
| US20050261672A1 (en) | 2004-05-18 | 2005-11-24 | Mark Deem | Systems and methods for selective denervation of heart dysrhythmias |
| US7250049B2 (en) | 2004-05-27 | 2007-07-31 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation catheter with suspension system incorporating rigid and flexible components |
| EP1750607A2 (en) | 2004-06-02 | 2007-02-14 | Medtronic, Inc. | Loop ablation apparatus and method |
| US7527625B2 (en) | 2004-08-04 | 2009-05-05 | Olympus Corporation | Transparent electrode for the radiofrequency ablation of tissue |
| US7556627B2 (en) | 2004-09-13 | 2009-07-07 | Ethicon Endo-Surgery, Inc. | Mucosal ablation device |
| US7282049B2 (en) | 2004-10-08 | 2007-10-16 | Sherwood Services Ag | Electrosurgical system employing multiple electrodes and method thereof |
| US20060089637A1 (en) | 2004-10-14 | 2006-04-27 | Werneth Randell L | Ablation catheter |
| FR2877207B1 (en) | 2004-10-29 | 2007-02-23 | Jacques Hamou | DEVICE FOR RESECTING ORGANIC TISSUE USED IN PARTICULAR IN UROLOGY OR HYSTEROSCOPY |
| US8409191B2 (en) | 2004-11-04 | 2013-04-02 | Boston Scientific Scimed, Inc. | Preshaped ablation catheter for ablating pulmonary vein ostia within the heart |
| US7468062B2 (en) | 2004-11-24 | 2008-12-23 | Ablation Frontiers, Inc. | Atrial ablation catheter adapted for treatment of septal wall arrhythmogenic foci and method of use |
| US7429261B2 (en) | 2004-11-24 | 2008-09-30 | Ablation Frontiers, Inc. | Atrial ablation catheter and method of use |
| US7731715B2 (en) | 2004-12-10 | 2010-06-08 | Edwards Lifesciences Corporation | Ablative treatment of atrial fibrillation via the coronary sinus |
| US7869865B2 (en) | 2005-01-07 | 2011-01-11 | Biosense Webster, Inc. | Current-based position sensing |
| US20070225589A1 (en) | 2005-01-11 | 2007-09-27 | Viswanathan Raju R | Single catheter diagnosis, navigation and treatment of arrhythmias |
| WO2006079965A2 (en) | 2005-01-31 | 2006-08-03 | Koninklijke Philips Electronics N.V. | System and method for the guidance of a catheter in electrophysiologic interventions |
| US9821158B2 (en) | 2005-02-17 | 2017-11-21 | Metacure Limited | Non-immediate effects of therapy |
| US7578816B2 (en) | 2005-04-22 | 2009-08-25 | Abl Technologies, Llc | Method and system of increasing safety of cardiac ablation procedures |
| US7512447B2 (en) | 2005-04-25 | 2009-03-31 | Medtronic, Inc. | Medical electrical electrodes with conductive polymer |
| US20060264752A1 (en) | 2005-04-27 | 2006-11-23 | The Regents Of The University Of California | Electroporation controlled with real time imaging |
| US8571635B2 (en) | 2005-04-28 | 2013-10-29 | Boston Scientific Scimed, Inc. | Automated activation/deactivation of imaging device based on tracked medical device position |
| US20060270900A1 (en) | 2005-05-26 | 2006-11-30 | Chin Albert K | Apparatus and methods for performing ablation |
| US8932208B2 (en) | 2005-05-26 | 2015-01-13 | Maquet Cardiovascular Llc | Apparatus and methods for performing minimally-invasive surgical procedures |
| US9861836B2 (en) | 2005-06-16 | 2018-01-09 | Biosense Webster, Inc. | Less invasive methods for ablation of fat pads |
| EP1895927A4 (en) | 2005-06-20 | 2011-03-09 | Medtronic Ablation Frontiers | Ablation catheter |
| US20060293730A1 (en) | 2005-06-24 | 2006-12-28 | Boris Rubinsky | Methods and systems for treating restenosis sites using electroporation |
| US20060293731A1 (en) | 2005-06-24 | 2006-12-28 | Boris Rubinsky | Methods and systems for treating tumors using electroporation |
| US20070005053A1 (en) | 2005-06-30 | 2007-01-04 | Dando Jeremy D | Ablation catheter with contoured openings in insulated electrodes |
| DE602006005674D1 (en) | 2005-07-06 | 2009-04-23 | Vascular Pathways Inc | DEVICE FOR INTRAVENOUS CATHETER INTRODUCTION AND USE METHOD |
| US20070021744A1 (en) | 2005-07-07 | 2007-01-25 | Creighton Francis M Iv | Apparatus and method for performing ablation with imaging feedback |
| CA2615267A1 (en) | 2005-07-11 | 2007-01-18 | Ablation Frontiers, Inc. | Low power tissue ablation system |
| US20070191826A1 (en) | 2005-07-15 | 2007-08-16 | Park Christopher J | Matrix router |
| US20160374747A9 (en) * | 2005-07-15 | 2016-12-29 | Atricure, Inc. | Ablation Device with Sensor |
| ITBO20050495A1 (en) | 2005-07-22 | 2007-01-23 | Fiab Spa | EXOGUE PIPELINE |
| US7681579B2 (en) | 2005-08-02 | 2010-03-23 | Biosense Webster, Inc. | Guided procedures for treating atrial fibrillation |
| US7416552B2 (en) | 2005-08-22 | 2008-08-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Multipolar, multi-lumen, virtual-electrode catheter with at least one surface electrode and method for ablation |
| US8657814B2 (en) | 2005-08-22 | 2014-02-25 | Medtronic Ablation Frontiers Llc | User interface for tissue ablation system |
| JP2009506873A (en) | 2005-09-07 | 2009-02-19 | ザ ファウンドリー, インコーポレイテッド | Apparatus and method for disrupting subcutaneous structures |
| US7623899B2 (en) | 2005-09-16 | 2009-11-24 | Biosense Webster, Inc. | Catheter with flexible pre-shaped tip section |
| US20080300588A1 (en) | 2005-12-02 | 2008-12-04 | Koninklijke Philips Electronics, N.V. | Automating the Ablation Procedure to Minimize the Need for Manual Intervention |
| US10362959B2 (en) | 2005-12-06 | 2019-07-30 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing the proximity of an electrode to tissue in a body |
| US8406866B2 (en) | 2005-12-06 | 2013-03-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing coupling between an electrode and tissue |
| US9492226B2 (en) | 2005-12-06 | 2016-11-15 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Graphical user interface for real-time RF lesion depth display |
| US8603084B2 (en) | 2005-12-06 | 2013-12-10 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing the formation of a lesion in tissue |
| US8449535B2 (en) | 2005-12-06 | 2013-05-28 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing coupling between an electrode and tissue |
| US8403925B2 (en) | 2006-12-06 | 2013-03-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing lesions in tissue |
| WO2007076045A2 (en) | 2005-12-24 | 2007-07-05 | Crossman Arthur W | Circumferential ablation guide wire system and related method of using the same |
| US20070167740A1 (en) | 2005-12-30 | 2007-07-19 | Grunewald Debby E | Magnetic stabilization of catheter location sensor |
| US7857809B2 (en) | 2005-12-30 | 2010-12-28 | Biosense Webster, Inc. | Injection molded irrigated tip electrode and catheter having the same |
| WO2007079268A2 (en) | 2005-12-30 | 2007-07-12 | C.R. Bard, Inc. | Methods and apparatus for ablation of cardiac tissue |
| US20070156135A1 (en) | 2006-01-03 | 2007-07-05 | Boris Rubinsky | System and methods for treating atrial fibrillation using electroporation |
| US7513896B2 (en) | 2006-01-24 | 2009-04-07 | Covidien Ag | Dual synchro-resonant electrosurgical apparatus with bi-directional magnetic coupling |
| US7374567B2 (en) | 2006-01-25 | 2008-05-20 | Heuser Richard R | Catheter system for connecting adjacent blood vessels |
| US7918850B2 (en) | 2006-02-17 | 2011-04-05 | Biosense Wabster, Inc. | Lesion assessment by pacing |
| WO2007123770A2 (en) | 2006-03-31 | 2007-11-01 | Automated Medical Instruments, Inc. | System and method for advancing, orienting, and immobilizing on internal body tissue a catheter or therapeutic device |
| US7615044B2 (en) | 2006-05-03 | 2009-11-10 | Greatbatch Ltd. | Deflectable sheath handle assembly and method therefor |
| WO2007134039A2 (en) | 2006-05-08 | 2007-11-22 | Medeikon Corporation | Interferometric characterization of ablated tissue |
| US20140276782A1 (en) | 2013-03-15 | 2014-09-18 | Larry D. Paskar | Catheter system |
| US7729752B2 (en) | 2006-06-13 | 2010-06-01 | Rhythmia Medical, Inc. | Non-contact cardiac mapping, including resolution map |
| US7515954B2 (en) | 2006-06-13 | 2009-04-07 | Rhythmia Medical, Inc. | Non-contact cardiac mapping, including moving catheter and multi-beat integration |
| US7783352B1 (en) | 2006-06-23 | 2010-08-24 | Pacesetter, Inc. | Optimizing anti-tachycardia pacing for terminating atrial fibrillation |
| US8920411B2 (en) | 2006-06-28 | 2014-12-30 | Kardium Inc. | Apparatus and method for intra-cardiac mapping and ablation |
| WO2008134245A1 (en) | 2007-04-27 | 2008-11-06 | Cvdevices, Llc | Devices, systems, and methods for promotion of infarct healing and reinforcement of border zone |
| JP2009545338A (en) | 2006-07-12 | 2009-12-24 | レ オピトー ユニヴェルシテール ド ジュネーヴ | Medical device for tissue resection |
| US20080033426A1 (en) | 2006-07-27 | 2008-02-07 | Machell Charles H | Catheter system and method of use thereof |
| US8273081B2 (en) | 2006-09-08 | 2012-09-25 | Stereotaxis, Inc. | Impedance-based cardiac therapy planning method with a remote surgical navigation system |
| EP2478931B1 (en) | 2006-10-13 | 2015-12-30 | Cyberonics, Inc. | Obstructive sleep apnea treatment device |
| AU2007231704B2 (en) | 2006-11-29 | 2011-02-24 | Cathrx Ltd | Heat treating a biological site in a patient's body |
| US20080132885A1 (en) | 2006-12-01 | 2008-06-05 | Boris Rubinsky | Methods for treating tissue sites using electroporation |
| US20080132884A1 (en) | 2006-12-01 | 2008-06-05 | Boris Rubinsky | Systems for treating tissue sites using electroporation |
| US8228065B2 (en) | 2006-12-22 | 2012-07-24 | Koninklijke Philips Electronics N.V. | Transmission line for use in magnetic resonance system |
| US8226648B2 (en) | 2007-12-31 | 2012-07-24 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Pressure-sensitive flexible polymer bipolar electrode |
| US7883508B2 (en) | 2006-12-29 | 2011-02-08 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Contact-sensitive pressure-sensitive conductive composite electrode and method for ablation |
| US8449537B2 (en) | 2006-12-29 | 2013-05-28 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation catheter with thermally mediated catheter body for mitigating blood coagulation and creating larger lesion |
| US8108069B2 (en) | 2007-01-10 | 2012-01-31 | Hansen Medical, Inc. | Robotic catheter system and methods |
| US20080200913A1 (en) | 2007-02-07 | 2008-08-21 | Viswanathan Raju R | Single Catheter Navigation for Diagnosis and Treatment of Arrhythmias |
| US7655004B2 (en) | 2007-02-15 | 2010-02-02 | Ethicon Endo-Surgery, Inc. | Electroporation ablation apparatus, system, and method |
| WO2008118737A1 (en) | 2007-03-22 | 2008-10-02 | University Of Virginia Patent Foundation | Electrode catheter for ablation purposes and related method thereof |
| US9468396B2 (en) | 2007-03-19 | 2016-10-18 | University Of Virginia Patent Foundation | Systems and methods for determining location of an access needle in a subject |
| US11058354B2 (en) | 2007-03-19 | 2021-07-13 | University Of Virginia Patent Foundation | Access needle with direct visualization and related methods |
| EP2136702B1 (en) | 2007-03-26 | 2015-07-01 | Boston Scientific Limited | High resolution electrophysiology catheter |
| US8597288B2 (en) | 2008-10-01 | 2013-12-03 | St. Jude Medical, Artial Fibrillation Division, Inc. | Vacuum-stabilized ablation system |
| EP2532320A3 (en) | 2007-04-19 | 2013-04-03 | Miramar Labs, Inc. | Apparatus for reducing sweat production |
| US8588885B2 (en) | 2007-05-09 | 2013-11-19 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Bendable catheter arms having varied flexibility |
| EP2139416B1 (en) | 2007-05-09 | 2015-08-19 | Irvine Biomedical, Inc. | Basket catheter having multiple electrodes |
| US8641704B2 (en) | 2007-05-11 | 2014-02-04 | Medtronic Ablation Frontiers Llc | Ablation therapy system and method for treating continuous atrial fibrillation |
| US8100900B2 (en) | 2007-05-11 | 2012-01-24 | Board Of Trustees Of The Leland Stanford Junior University | System for delivering therapy |
| US8216221B2 (en) | 2007-05-21 | 2012-07-10 | Estech, Inc. | Cardiac ablation systems and methods |
| US7742810B2 (en) | 2007-05-23 | 2010-06-22 | Boston Scientific Neuromodulation Corporation | Short duration pre-pulsing to reduce stimulation-evoked side-effects |
| US10220187B2 (en) | 2010-06-16 | 2019-03-05 | St. Jude Medical, Llc | Ablation catheter having flexible tip with multiple flexible electrode segments |
| US8160690B2 (en) | 2007-06-14 | 2012-04-17 | Hansen Medical, Inc. | System and method for determining electrode-tissue contact based on amplitude modulation of sensed signal |
| US20090024084A1 (en) | 2007-07-16 | 2009-01-22 | Peritec Biosciences Ltd. | Multi-lumen catheter assembly and method of providing relative motion thereto |
| US20090062788A1 (en) | 2007-08-31 | 2009-03-05 | Long Gary L | Electrical ablation surgical instruments |
| US8568410B2 (en) | 2007-08-31 | 2013-10-29 | Ethicon Endo-Surgery, Inc. | Electrical ablation surgical instruments |
| US8579897B2 (en) | 2007-11-21 | 2013-11-12 | Ethicon Endo-Surgery, Inc. | Bipolar forceps |
| WO2009036459A1 (en) | 2007-09-14 | 2009-03-19 | Lazure Technologies, Llc | Multi-tine probe and treatment by activation of opposing tines |
| CA2699782C (en) | 2007-09-14 | 2017-04-11 | Lazure Technologies, Llc | Prostate cancer ablation |
| WO2009046441A1 (en) | 2007-10-05 | 2009-04-09 | Coaptus Medical Corporation | Systems and methods for transeptal cardiac procedures |
| US8500697B2 (en) | 2007-10-19 | 2013-08-06 | Pressure Products Medical Supplies, Inc. | Transseptal guidewire |
| WO2009061860A1 (en) | 2007-11-05 | 2009-05-14 | Stereotaxis, Inc. | Magnetically guided energy delivery apparatus |
| US20100241185A1 (en) | 2007-11-09 | 2010-09-23 | University Of Virginia Patent Foundation | Steerable epicardial pacing catheter system placed via the subxiphoid process |
| US8906011B2 (en) | 2007-11-16 | 2014-12-09 | Kardium Inc. | Medical device for use in bodily lumens, for example an atrium |
| US9717501B2 (en) | 2007-11-21 | 2017-08-01 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Methods and systems for occluding vessels during cardiac ablation including optional electroanatomical guidance |
| US9452288B2 (en) | 2007-12-06 | 2016-09-27 | Boston Scientific Neuromodulation Corporation | Multimodal neurostimulation systems and methods |
| US8353907B2 (en) | 2007-12-21 | 2013-01-15 | Atricure, Inc. | Ablation device with internally cooled electrodes |
| EP2231029B1 (en) | 2007-12-21 | 2023-08-16 | GT Metabolic Solutions, Inc. | Devices for endoscopically creating an anastomosis |
| US8562600B2 (en) | 2007-12-27 | 2013-10-22 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Integration of control software with a medical device and system |
| US9204927B2 (en) | 2009-05-13 | 2015-12-08 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for presenting information representative of lesion formation in tissue during an ablation procedure |
| EP2231002A1 (en) | 2008-01-09 | 2010-09-29 | Mayo Foundation for Medical Education and Research | Mapping and ablation catheter system |
| EP2231253B1 (en) | 2008-01-16 | 2019-06-12 | Catheter Precision, Inc. | Remotely controlled catheter insertion system |
| US8235988B2 (en) | 2008-01-24 | 2012-08-07 | Coherex Medical, Inc. | Systems and methods for reduction of atrial fibrillation |
| US8617145B2 (en) | 2008-01-25 | 2013-12-31 | Intrepid Medical, Inc. | Methods of treating a cardiac arrhythmia by thoracoscopic production of a Cox maze III lesion set |
| US20090228003A1 (en) | 2008-03-04 | 2009-09-10 | Prorhythm, Inc. | Tissue ablation device using radiofrequency and high intensity focused ultrasound |
| WO2009112269A2 (en) | 2008-03-12 | 2009-09-17 | Afreeze Gmbh | Ablation system |
| US20100004623A1 (en) | 2008-03-27 | 2010-01-07 | Angiodynamics, Inc. | Method for Treatment of Complications Associated with Arteriovenous Grafts and Fistulas Using Electroporation |
| US8538509B2 (en) | 2008-04-02 | 2013-09-17 | Rhythmia Medical, Inc. | Intracardiac tracking system |
| US8926606B2 (en) | 2009-04-09 | 2015-01-06 | Virginia Tech Intellectual Properties, Inc. | Integration of very short electric pulses for minimally to noninvasive electroporation |
| US10702326B2 (en) | 2011-07-15 | 2020-07-07 | Virginia Tech Intellectual Properties, Inc. | Device and method for electroporation based treatment of stenosis of a tubular body part |
| US9198733B2 (en) | 2008-04-29 | 2015-12-01 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for electroporation-based therapies |
| US8992517B2 (en) | 2008-04-29 | 2015-03-31 | Virginia Tech Intellectual Properties Inc. | Irreversible electroporation to treat aberrant cell masses |
| US9867652B2 (en) | 2008-04-29 | 2018-01-16 | Virginia Tech Intellectual Properties, Inc. | Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds |
| US10448989B2 (en) | 2009-04-09 | 2019-10-22 | Virginia Tech Intellectual Properties, Inc. | High-frequency electroporation for cancer therapy |
| WO2009137800A2 (en) | 2008-05-09 | 2009-11-12 | Angiodynamics, Inc. | Electroporation device and method |
| US9474574B2 (en) | 2008-05-21 | 2016-10-25 | Atricure, Inc. | Stabilized ablation systems and methods |
| US20090306651A1 (en) | 2008-06-09 | 2009-12-10 | Clint Schneider | Catheter assembly with front-loaded tip |
| US8206385B2 (en) | 2008-06-09 | 2012-06-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Catheter assembly with front-loaded tip and multi-contact connector |
| US20110288544A1 (en) | 2008-07-17 | 2011-11-24 | Maestroheart Sa | Medical device for tissue ablation |
| US8585695B2 (en) | 2008-07-22 | 2013-11-19 | Hue-Teh Shih | Systems and methods for noncontact ablation |
| US8221411B2 (en) | 2008-07-28 | 2012-07-17 | Medtronic, Inc. | Systems and methods for cardiac tissue electroporation ablation |
| JP4545210B2 (en) | 2008-09-11 | 2010-09-15 | 日本ライフライン株式会社 | Defibrillation catheter |
| US9119533B2 (en) | 2008-10-07 | 2015-09-01 | Mc10, Inc. | Systems, methods, and devices having stretchable integrated circuitry for sensing and delivering therapy |
| CN107898498B (en) | 2008-10-21 | 2021-06-11 | 微立方有限责任公司 | Method and apparatus for applying energy to body tissue |
| US8167876B2 (en) | 2008-10-27 | 2012-05-01 | Rhythmia Medical, Inc. | Tracking system using field mapping |
| US9220924B2 (en) | 2008-10-30 | 2015-12-29 | Vytronus, Inc. | System and method for energy delivery to tissue while monitoring position, lesion depth, and wall motion |
| US8414508B2 (en) | 2008-10-30 | 2013-04-09 | Vytronus, Inc. | System and method for delivery of energy to tissue while compensating for collateral tissue |
| US9192789B2 (en) | 2008-10-30 | 2015-11-24 | Vytronus, Inc. | System and method for anatomical mapping of tissue and planning ablation paths therein |
| US9192769B2 (en) | 2008-10-31 | 2015-11-24 | Medtronic, Inc. | Shunt-current reduction techniques for an implantable therapy system |
| US9795442B2 (en) | 2008-11-11 | 2017-10-24 | Shifamed Holdings, Llc | Ablation catheters |
| US8475445B2 (en) | 2008-12-01 | 2013-07-02 | Daniel Soroff | Spectral analysis of intracardiac electrograms to predict identification of radiofrequency ablation sites |
| US8475450B2 (en) | 2008-12-30 | 2013-07-02 | Biosense Webster, Inc. | Dual-purpose lasso catheter with irrigation |
| US9610118B2 (en) | 2008-12-31 | 2017-04-04 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Method and apparatus for the cancellation of motion artifacts in medical interventional navigation |
| US8361066B2 (en) | 2009-01-12 | 2013-01-29 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
| WO2010088301A1 (en) | 2009-01-27 | 2010-08-05 | Boveda Marco Medical Llc | Catheters and methods for performing electrophysiological interventions |
| WO2010093692A2 (en) | 2009-02-10 | 2010-08-19 | Hobbs Eamonn P | Irreversible electroporation and tissue regeneration |
| EP2395934B1 (en) | 2009-02-11 | 2019-04-17 | Boston Scientific Scimed, Inc. | Insulated ablation catheter devices |
| JP2012517306A (en) | 2009-02-12 | 2012-08-02 | イューエムセー ユトレヒト ホールディング ベースローテン フェンノートシャップ | Ablation catheter and method for electrically insulating heart tissue |
| EP2398543A1 (en) | 2009-02-20 | 2011-12-28 | Boston Scientific Scimed, Inc. | Asymmetric dual directional steerable catheter sheath |
| US8747297B2 (en) | 2009-03-02 | 2014-06-10 | Olympus Corporation | Endoscopic heart surgery method |
| JP2012521863A (en) | 2009-03-31 | 2012-09-20 | アンジオダイナミツクス・インコーポレイテツド | System and method for treatment area estimation and interactive patient treatment planning of treatment devices |
| US8632534B2 (en) | 2009-04-03 | 2014-01-21 | Angiodynamics, Inc. | Irreversible electroporation (IRE) for congestive obstructive pulmonary disease (COPD) |
| US8287532B2 (en) | 2009-04-13 | 2012-10-16 | Biosense Webster, Inc. | Epicardial mapping and ablation catheter |
| US8709006B2 (en) | 2009-04-14 | 2014-04-29 | Old Dominion Research Foundation | System and method for applying plasma sparks to tissue |
| CN104605928B (en) | 2009-05-08 | 2018-01-05 | 圣犹达医疗用品国际控股有限公司 | System for controlling lesion size in catheter-based ablation therapy |
| US8103338B2 (en) | 2009-05-08 | 2012-01-24 | Rhythmia Medical, Inc. | Impedance based anatomy generation |
| US8571647B2 (en) | 2009-05-08 | 2013-10-29 | Rhythmia Medical, Inc. | Impedance based anatomy generation |
| US8551096B2 (en) | 2009-05-13 | 2013-10-08 | Boston Scientific Scimed, Inc. | Directional delivery of energy and bioactives |
| US8430875B2 (en) | 2009-05-19 | 2013-04-30 | Estech, Inc. (Endoscopic Technologies, Inc.) | Magnetic navigation systems and methods |
| US8903488B2 (en) | 2009-05-28 | 2014-12-02 | Angiodynamics, Inc. | System and method for synchronizing energy delivery to the cardiac rhythm |
| WO2010144405A2 (en) | 2009-06-08 | 2010-12-16 | Surgivision, Inc. | Mri-guided surgical systems with proximity alerts |
| US20100331838A1 (en) * | 2009-06-25 | 2010-12-30 | Estech, Inc. (Endoscopic Technologies, Inc.) | Transmurality clamp systems and methods |
| GB2472216A (en) | 2009-07-28 | 2011-02-02 | Gyrus Medical Ltd | Bipolar electrosurgical instrument with four electrodes |
| US20110028962A1 (en) | 2009-07-31 | 2011-02-03 | Randell Werneth | Adjustable pulmonary vein ablation catheter |
| IN2012DN00989A (en) | 2009-08-05 | 2015-04-10 | Scr Inc | |
| US9042969B2 (en) | 2009-08-12 | 2015-05-26 | Angel Medical Systems, Inc. | Heart rate correction system and methods for the detection of cardiac events |
| US20110054487A1 (en) | 2009-09-02 | 2011-03-03 | Circulite, Inc. | Coaxial transseptal guide-wire and needle assembly |
| US20150321021A1 (en) | 2009-09-03 | 2015-11-12 | The Johns Hopkins University | Method and device for treating cardiac arrhythmias |
| US9642534B2 (en) | 2009-09-11 | 2017-05-09 | University Of Virginia Patent Foundation | Systems and methods for determining location of an access needle in a subject |
| US20110098694A1 (en) | 2009-10-28 | 2011-04-28 | Ethicon Endo-Surgery, Inc. | Methods and instruments for treating cardiac tissue through a natural orifice |
| US9861438B2 (en) | 2009-12-11 | 2018-01-09 | Biosense Webster (Israel), Ltd. | Pre-formed curved ablation catheter |
| US8608735B2 (en) | 2009-12-30 | 2013-12-17 | Biosense Webster (Israel) Ltd. | Catheter with arcuate end section |
| US9005198B2 (en) | 2010-01-29 | 2015-04-14 | Ethicon Endo-Surgery, Inc. | Surgical instrument comprising an electrode |
| US20110190727A1 (en) | 2010-02-02 | 2011-08-04 | Boston Scientific Scimed, Inc. | Intervascular catheter, system and method |
| US9743980B2 (en) | 2010-02-24 | 2017-08-29 | Safepass Vascular Ltd | Method and system for assisting a wire guide to cross occluded ducts |
| US8556891B2 (en) | 2010-03-03 | 2013-10-15 | Medtronic Ablation Frontiers Llc | Variable-output radiofrequency ablation power supply |
| US20120046570A1 (en) | 2010-03-08 | 2012-02-23 | Alpha Orthopaedics, Inc. | Methods and devices for real time monitoring of collagen content and for altering collagen status |
| BR112012025470A2 (en) | 2010-04-08 | 2019-09-24 | Univ California | cardiac information reconstruction system, assembly to facilitate cardiac information reconstruction, and cardiac information reconstruction method |
| AU2011239637B2 (en) | 2010-04-13 | 2014-12-11 | Atricure, Inc. | Methods and devices for pericardial access |
| AU2011241103A1 (en) | 2010-04-13 | 2012-11-08 | Sentreheart, Inc. | Methods and devices for treating atrial fibrillation |
| US9943363B2 (en) | 2010-04-28 | 2018-04-17 | Biosense Webster, Inc. | Irrigated ablation catheter with improved fluid flow |
| US9510894B2 (en) | 2010-04-28 | 2016-12-06 | Biosense Webster (Israel) Ltd. | Irrigated ablation catheter having irrigation ports with reduced hydraulic resistance |
| WO2011140331A1 (en) | 2010-05-05 | 2011-11-10 | Automated Medical Instruments, Inc. | Anchored cardiac ablation catheter |
| US9924997B2 (en) | 2010-05-05 | 2018-03-27 | Ablacor Medical Corporation | Anchored ablation catheter |
| US9655677B2 (en) | 2010-05-12 | 2017-05-23 | Shifamed Holdings, Llc | Ablation catheters including a balloon and electrodes |
| US9131897B2 (en) | 2010-06-08 | 2015-09-15 | Toray Industries, Inc. | Catheter for measuring electric potential |
| ITRM20100314A1 (en) | 2010-06-09 | 2011-12-10 | Luca Viviana De | CATHETER WITH REVERSIBLE STABILITY, FOR STABILIZATION DURING THE ABLATION TRANSCATETERE BY MEANS OF RADIO FREQUENCY. |
| CN103153384B (en) | 2010-06-28 | 2016-03-09 | 科利柏心脏瓣膜有限责任公司 | For the device of device in the delivery of vascular of chamber |
| US20120029512A1 (en) | 2010-07-30 | 2012-02-02 | Willard Martin R | Balloon with surface electrodes and integral cooling for renal nerve ablation |
| US10080602B2 (en) | 2010-07-30 | 2018-09-25 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Generator, combination of a generator and a catheter, and method for providing an electrical pulse |
| JP2012050538A (en) | 2010-08-31 | 2012-03-15 | Terumo Corp | Ablation device |
| US9289606B2 (en) | 2010-09-02 | 2016-03-22 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System for electroporation therapy |
| US20120078320A1 (en) | 2010-09-29 | 2012-03-29 | Medtronic, Inc. | Prioritized programming of multi-electrode pacing leads |
| US20120089089A1 (en) | 2010-10-12 | 2012-04-12 | Ethicon Endo-Surgery, Inc. | Methods of magnetically guiding and axially aligning distal ends of surgical devices |
| JP2013544565A (en) | 2010-10-20 | 2013-12-19 | メドトロニック アーディアン ルクセンブルク ソシエテ ア レスポンサビリテ リミテ | Catheter device with expandable mesh structure for renal nerve modulation and related systems and methods |
| AU2011329669B2 (en) | 2010-11-19 | 2016-07-28 | Boston Scientific Scimed, Inc. | Renal nerve detection and ablation apparatus and method |
| US9877781B2 (en) | 2010-11-19 | 2018-01-30 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Electrode catheter device with indifferent electrode for direct current tissue therapies |
| US20120158021A1 (en) | 2010-12-19 | 2012-06-21 | Mitralign, Inc. | Steerable guide catheter having preformed curved shape |
| US9308041B2 (en) | 2010-12-22 | 2016-04-12 | Biosense Webster (Israel) Ltd. | Lasso catheter with rotating ultrasound transducer |
| DE102010064101B4 (en) | 2010-12-23 | 2017-02-23 | Siemens Healthcare Gmbh | Pair of endocardial and epicardial catheters and catheters |
| US20120303019A1 (en) | 2010-12-25 | 2012-11-29 | Xue Zhao | Kind of cardiac ablation catheter with guide-wire |
| CN103429183B (en) | 2010-12-27 | 2016-01-06 | 圣犹达医疗用品卢森堡控股有限公司 | Prediction system of atrial wall electrical reconnection based on contact force measured during radiofrequency ablation |
| US9149327B2 (en) | 2010-12-27 | 2015-10-06 | St. Jude Medical Luxembourg Holding S.À.R.L. | Prediction of atrial wall electrical reconnection based on contact force measured during RF ablation |
| US9572620B2 (en) | 2010-12-29 | 2017-02-21 | Kyungmoo Ryu | System and method for treating arrhythmias in the heart using information obtained from heart wall motion |
| US9044245B2 (en) | 2011-01-05 | 2015-06-02 | Medtronic Ablation Frontiers Llc | Multipolarity epicardial radiofrequency ablation |
| US9095262B2 (en) | 2011-01-05 | 2015-08-04 | Mehdi Razavi | Guided ablation devices, systems, and methods |
| GB201100443D0 (en) * | 2011-01-11 | 2011-02-23 | Creo Medical Ltd | Electrosurgical instrument |
| US9002442B2 (en) | 2011-01-13 | 2015-04-07 | Rhythmia Medical, Inc. | Beat alignment and selection for cardiac mapping |
| US9486273B2 (en) | 2011-01-21 | 2016-11-08 | Kardium Inc. | High-density electrode-based medical device system |
| CA2764494A1 (en) | 2011-01-21 | 2012-07-21 | Kardium Inc. | Enhanced medical device for use in bodily cavities, for example an atrium |
| US9314620B2 (en) | 2011-02-28 | 2016-04-19 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices and methods |
| US9937002B2 (en) | 2011-03-08 | 2018-04-10 | Nexus Control Systems, Llc | Ablation catheter system with safety features |
| JP6066935B2 (en) | 2011-03-08 | 2017-01-25 | コーエン,トッド,ジェイ. | Ablation catheter system with safety function |
| CN106510679A (en) | 2011-04-13 | 2017-03-22 | 维特罗纳斯有限公司 | Integrated ablation and mapping system |
| CN103718191B (en) | 2011-05-02 | 2018-02-02 | 加利福尼亚大学董事会 | Systems and methods for targeting cardiac rhythm disorders using shaping ablation |
| KR101248959B1 (en) | 2011-05-12 | 2013-04-01 | 신경민 | Electrode device having flexible tube for high frequency thermotherapy |
| US20120310230A1 (en) | 2011-06-01 | 2012-12-06 | Angiodynamics, Inc. | Coaxial dual function probe and method of use |
| US20120316557A1 (en) | 2011-06-08 | 2012-12-13 | Tyco Healthcare Group Lp | Septoplasty Instrument |
| CN104623807B (en) | 2011-06-15 | 2017-04-12 | 马克思-普朗克科学促进协会 | Apparatus and method for terminating a high frequency arrhythmic electric state of a biological tissue |
| US10506948B2 (en) | 2011-07-05 | 2019-12-17 | Cardioinsight Technologies, Inc. | Localization for electrocardiographic mapping |
| WO2013013099A1 (en) | 2011-07-19 | 2013-01-24 | Adagio Medical, Inc. | Methods and devices for the treatment of atrial fibrillation |
| US20130030430A1 (en) | 2011-07-29 | 2013-01-31 | Stewart Mark T | Intracardiac tools and methods for delivery of electroporation therapies |
| WO2013055815A1 (en) | 2011-10-11 | 2013-04-18 | Boston Scientific Scimed, Inc. | Off -wall electrode device for nerve modulation |
| US20130158621A1 (en) | 2011-12-20 | 2013-06-20 | Jiang Ding | Ectopic-triggered para-his stimulation |
| US8825130B2 (en) | 2011-12-30 | 2014-09-02 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Electrode support structure assemblies |
| US9687289B2 (en) | 2012-01-04 | 2017-06-27 | Biosense Webster (Israel) Ltd. | Contact assessment based on phase measurement |
| AU2013207994B2 (en) | 2012-01-10 | 2015-05-07 | Boston Scientific Scimed, Inc. | Electrophysiology system |
| US9414881B2 (en) | 2012-02-08 | 2016-08-16 | Angiodynamics, Inc. | System and method for increasing a target zone for electrical ablation |
| US8808273B2 (en) | 2012-02-10 | 2014-08-19 | Biosense Webster (Israel) Ltd. | Electrophysiology catheter with mechanical use limiter |
| US9095350B2 (en) | 2012-05-01 | 2015-08-04 | Medtronic Ablation Frontiers Llc | Impedance detection of venous placement of multi-electrode catheters |
| WO2013165584A1 (en) | 2012-05-04 | 2013-11-07 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for controlling delivery of ablation energy to tissue |
| US9693832B2 (en) | 2012-05-21 | 2017-07-04 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
| US9554847B2 (en) | 2012-07-02 | 2017-01-31 | Biosense Webster (Israel) Ltd. | Real time assessment of ablation from electrocardiogram signals |
| WO2014008489A1 (en) | 2012-07-04 | 2014-01-09 | Cibiem, Inc. | Devices and systems for carotid body ablation |
| US9101374B1 (en) | 2012-08-07 | 2015-08-11 | David Harris Hoch | Method for guiding an ablation catheter based on real time intracardiac electrical signals and apparatus for performing the method |
| CA2881462C (en) | 2012-08-09 | 2020-07-14 | University Of Iowa Research Foundation | Catheters, catheter systems, and methods for puncturing through a tissue structure |
| US20140052216A1 (en) | 2012-08-15 | 2014-02-20 | Ethicon Endo-Surgery, Inc. | Methods for promoting wound healing |
| US9801681B2 (en) | 2012-08-17 | 2017-10-31 | Medtronic Ablation Frontiers Llc | Catheters and methods for intracardiac electrical mapping |
| US9168004B2 (en) | 2012-08-20 | 2015-10-27 | Biosense Webster (Israel) Ltd. | Machine learning in determining catheter electrode contact |
| WO2014031800A1 (en) | 2012-08-22 | 2014-02-27 | Energize Medical Llc | Therapeutic energy systems |
| US10004459B2 (en) | 2012-08-31 | 2018-06-26 | Acutus Medical, Inc. | Catheter system and methods of medical uses of same, including diagnostic and treatment uses for the heart |
| JP2014054430A (en) | 2012-09-13 | 2014-03-27 | Nippon Koden Corp | Catheter |
| US11096741B2 (en) | 2012-10-10 | 2021-08-24 | Biosense Webster (Israel) Ltd. | Ablation power control based on contact force |
| US9827036B2 (en) | 2012-11-13 | 2017-11-28 | Pulnovo Medical (Wuxi) Co., Ltd. | Multi-pole synchronous pulmonary artery radiofrequency ablation catheter |
| WO2014089373A1 (en) | 2012-12-05 | 2014-06-12 | University Of Rochester | Catheter with integrated transeptal puncture needle |
| US9023036B2 (en) | 2012-12-07 | 2015-05-05 | Biosense Webster (Israel) Ltd. | Lasso catheter with tip electrode |
| US9474850B2 (en) | 2012-12-11 | 2016-10-25 | Biosense Webster (Israel) Ltd. | Lasso catheter with guide wire |
| US9078667B2 (en) | 2012-12-11 | 2015-07-14 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Catheter having reduced force concentration at tissue contact site |
| WO2014100579A1 (en) | 2012-12-21 | 2014-06-26 | David Anderson | Functional gain measurement technique and representation |
| US9204820B2 (en) | 2012-12-31 | 2015-12-08 | Biosense Webster (Israel) Ltd. | Catheter with combined position and pressure sensing structures |
| US10537286B2 (en) | 2013-01-08 | 2020-01-21 | Biosense Webster (Israel) Ltd. | Catheter with multiple spines of different lengths arranged in one or more distal assemblies |
| WO2014118734A2 (en) | 2013-01-31 | 2014-08-07 | David Prutchi | Unipolar and/or bipolar ablation catheter |
| US9031642B2 (en) | 2013-02-21 | 2015-05-12 | Medtronic, Inc. | Methods for simultaneous cardiac substrate mapping using spatial correlation maps between neighboring unipolar electrograms |
| US9474486B2 (en) | 2013-03-08 | 2016-10-25 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Basket for a multi-electrode array catheter |
| US9519021B2 (en) | 2013-03-11 | 2016-12-13 | Covidien Lp | Systems and methods for detecting abnormalities within a circuit of an electrosurgical generator |
| US9486272B2 (en) | 2013-03-12 | 2016-11-08 | Biosense Webster (Israel) Ltd. | Force feedback device and method for catheters |
| CN105142558A (en) | 2013-03-15 | 2015-12-09 | 美敦力阿迪安卢森堡有限公司 | Treatment device with electrode contact surface configured for enhancing uniformity of electrical energy distribution and associated devices and methods |
| AU2014241205B2 (en) | 2013-03-27 | 2019-01-17 | Autonomix Medical, Inc. | Neurological traffic and receptor evaluation and modification: systems and methods |
| KR20150140760A (en) | 2013-04-08 | 2015-12-16 | 아파마 메디칼, 인크. | Cardiac ablation catheters and methods of use thereof |
| US10575743B2 (en) | 2013-04-11 | 2020-03-03 | Biosense Webster (Israel) Ltd. | High electrode density basket catheter |
| WO2014195933A1 (en) | 2013-06-05 | 2014-12-11 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Myocardial ablation by irreversible electroporation |
| WO2015021113A1 (en) | 2013-08-06 | 2015-02-12 | Memorial Sloan Kettering Cancer Center | System, method and computer-accessible medium for in-vivo tissue ablation and/or damage |
| US9616233B2 (en) | 2013-08-29 | 2017-04-11 | Boston Scientific Neuromodulation Corporation | Systems and method of adjusting the compliance voltage in a neuromodulation device |
| US9931046B2 (en) | 2013-10-25 | 2018-04-03 | Ablative Solutions, Inc. | Intravascular catheter with peri-vascular nerve activity sensors |
| WO2015066322A1 (en) | 2013-11-01 | 2015-05-07 | Boston Scientific Scimed, Inc. | Cardiac mapping using latency interpolation |
| US20150141978A1 (en) | 2013-11-20 | 2015-05-21 | Boston Scientific Scimed, Inc. | Ablation medical devices and methods for making and using ablation medical devices |
| US20150173828A1 (en) | 2013-12-23 | 2015-06-25 | Boaz Avitall | Small loop ablation catheter |
| US20160324564A1 (en) | 2013-12-27 | 2016-11-10 | Empire Technology Development Llc | Devices and techniques for ablative treatment |
| CN105939686A (en) | 2014-01-06 | 2016-09-14 | 衣阿华方法股份有限公司 | Devices and methods for delivering therapeutic electrical impulses |
| WO2015103574A1 (en) | 2014-01-06 | 2015-07-09 | Iowa Approach Inc. | Apparatus and methods for renal denervation ablation |
| EP3089687B1 (en) | 2014-02-11 | 2018-06-06 | St. Jude Medical, Cardiology Division, Inc. | Ablation catheter |
| CA2940086C (en) | 2014-02-17 | 2022-07-26 | Children's National Medical Center | Delivery tool and method for devices in the pericardial space |
| US10470682B2 (en) | 2014-02-25 | 2019-11-12 | St. Jude Medical, Cardiology Division, Inc. | System and method for local electrophysiological characterization of cardiac substrate using multi-electrode catheters |
| WO2015140741A1 (en) | 2014-03-20 | 2015-09-24 | Atricath S.P.A. | Ablation catheter and ablation apparatus |
| EP3119470B1 (en) | 2014-03-21 | 2021-09-15 | Mayo Foundation for Medical Education and Research | Multi-electrode epicardial pacing |
| US9956035B2 (en) | 2014-03-27 | 2018-05-01 | Biosense Webster (Israel) Ltd. | Temperature measurement in catheter |
| US20150289923A1 (en) | 2014-04-14 | 2015-10-15 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for electrical-energy based therapies based on cell characteristics |
| US10111703B2 (en) | 2014-05-06 | 2018-10-30 | Cosman Instruments, Llc | Electrosurgical generator |
| WO2015171921A2 (en) | 2014-05-07 | 2015-11-12 | Mickelson Steven R | Methods and apparatus for selective tissue ablation |
| WO2015175944A1 (en) | 2014-05-16 | 2015-11-19 | Gary Long | Methods and apparatus for multi-catheter tissue ablation |
| WO2015187430A2 (en) | 2014-06-04 | 2015-12-10 | Boston Scientific Scimed, Inc. | Electrode assembly |
| WO2015192027A1 (en) | 2014-06-12 | 2015-12-17 | Iowa Approach Inc. | Method and apparatus for rapid and selective transurethral tissue ablation |
| EP3154464B1 (en) * | 2014-06-12 | 2025-03-12 | Boston Scientific Scimed, Inc. | Apparatus for rapid and selective tissue ablation with cooling |
| US12114911B2 (en) | 2014-08-28 | 2024-10-15 | Angiodynamics, Inc. | System and method for ablating a tissue site by electroporation with real-time pulse monitoring |
| JP2017529169A (en) | 2014-10-13 | 2017-10-05 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Tissue diagnosis and treatment using mini-electrodes |
| WO2016059027A1 (en) | 2014-10-13 | 2016-04-21 | Dr Philippe Debruyne Bvba | Limited ablation for the treatment of sick sinus syndrome and other inappropriate sinus bradycardias |
| WO2016060983A1 (en) | 2014-10-14 | 2016-04-21 | Iowa Approach Inc. | Method and apparatus for rapid and safe pulmonary vein cardiac ablation |
| US10231778B2 (en) | 2014-10-20 | 2019-03-19 | Biosense Webster (Israel) Ltd. | Methods for contemporaneous assessment of renal denervation |
| WO2016065337A1 (en) | 2014-10-24 | 2016-04-28 | Boston Scientific Scimed Inc. | Medical devices with a flexible electrode assembly coupled to an ablation tip |
| KR20170107428A (en) | 2014-11-19 | 2017-09-25 | 어드밴스드 카디악 테라퓨틱스, 인크. | Ablation devices, systems and methods of using a high-resolution electrode assembly |
| WO2016090175A1 (en) | 2014-12-03 | 2016-06-09 | Metavention, Inc. | Systems and methods for modulating nerves or other tissue |
| US10271893B2 (en) | 2014-12-15 | 2019-04-30 | Medtronic Ablation Frontiers Llc | Timed energy delivery |
| US9743854B2 (en) | 2014-12-18 | 2017-08-29 | Boston Scientific Scimed, Inc. | Real-time morphology analysis for lesion assessment |
| US9782099B2 (en) | 2014-12-31 | 2017-10-10 | Biosense Webster (Israel) Ltd. | Basket catheter with improved spine flexibility |
| EP3190961B1 (en) | 2014-12-31 | 2019-11-13 | St. Jude Medical, Cardiology Division, Inc. | Ablation generator comprising filter circuit for electrophysiology system |
| EP3294172B9 (en) | 2015-05-12 | 2023-04-05 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Asymmetric balanced waveform for ac cardiac irreversible electroporation |
| US11026746B2 (en) | 2015-05-12 | 2021-06-08 | National University Of Ireland, Galway | Devices for therapeutic nasal neuromodulation and associated methods and systems |
| US20160361109A1 (en) | 2015-06-11 | 2016-12-15 | Massachusetts Institute Of Technology | Methods for inducing electroporation and tissue ablation |
| US9949656B2 (en) | 2015-06-29 | 2018-04-24 | Biosense Webster (Israel) Ltd. | Catheter with stacked spine electrode assembly |
| US10583294B2 (en) | 2015-07-02 | 2020-03-10 | Dirk De Ridder | Methods and apparatus for sensing cross-frequency coupling and neuromodulation |
| US10398498B2 (en) | 2015-08-04 | 2019-09-03 | Lc Therapeutics, Inc. | Tissue ablation devices and methods of using the same |
| DE202016009215U1 (en) | 2015-08-06 | 2024-04-29 | Medtronic, Inc. | Cardiac ablation using pulsed field |
| US9931487B2 (en) | 2015-08-06 | 2018-04-03 | Boston Scientific Scimed, Inc. | Bidirectional steering control apparatus for a catheter |
| US20170071543A1 (en) | 2015-09-14 | 2017-03-16 | Biosense Webster (Israel) Ltd. | Convertible basket catheter |
| CN108472481A (en) | 2015-10-06 | 2018-08-31 | 哈尔西恩医疗有限公司 | Aortorenal ganglions detects |
| US20170105793A1 (en) | 2015-10-15 | 2017-04-20 | Boston Scientific Scimed, Inc. | Energy delivery devices and related methods of use |
| KR102799892B1 (en) | 2015-12-01 | 2025-04-23 | 사이맵 메디컬 (쑤저우), 엘티디 | Systems and methods for functional neural mapping and 3D mapping stimulating arterial walls and catheters therefor |
| US10660702B2 (en) | 2016-01-05 | 2020-05-26 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
| CN108778172B (en) | 2016-01-05 | 2021-08-13 | 法拉普尔赛股份有限公司 | Systems, devices and methods for delivering ablation energy to tissue |
| US10130423B1 (en) | 2017-07-06 | 2018-11-20 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
| EP4606419A3 (en) | 2016-01-05 | 2025-11-05 | Boston Scientific Scimed, Inc. | System for delivery of pulsed electric field ablative energy to endocardial tissue |
| US10512505B2 (en) | 2018-05-07 | 2019-12-24 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
| US20170189097A1 (en) | 2016-01-05 | 2017-07-06 | Iowa Approach Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
| US10172673B2 (en) | 2016-01-05 | 2019-01-08 | Farapulse, Inc. | Systems devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
| US10548665B2 (en) | 2016-02-29 | 2020-02-04 | Pulse Biosciences, Inc. | High-voltage analog circuit pulser with feedback control |
| US10874451B2 (en) | 2016-02-29 | 2020-12-29 | Pulse Biosciences, Inc. | High-voltage analog circuit pulser and pulse generator discharge circuit |
| WO2017192542A2 (en) | 2016-05-02 | 2017-11-09 | Affera, Inc. | Catheter sensing and irrigating |
| EP3471631A4 (en) | 2016-06-16 | 2020-03-04 | Farapulse, Inc. | GUIDE WIRE DISTRIBUTION SYSTEMS, APPARATUSES AND METHODS |
| AU2017289267B2 (en) | 2016-06-27 | 2021-08-12 | Galvanize Therapeutics, Inc. | Generator and a catheter with an electrode and a method for treating a lung passageway |
| IT201600068691A1 (en) * | 2016-07-01 | 2018-01-01 | Igea S P A | HANDLING AND CONTROL SYSTEM FOR EXPANDABLE ELECTRODES OF A HANDPIECE USED IN AN ELECTRO-PORTION PROCESS |
| EP3537954B1 (en) | 2016-11-11 | 2021-07-21 | National University of Ireland, Galway | Devices, systems, and methods for specializing, monitoring, and/or evaluating therapeutic nasal neuromodulation |
| US20180154142A1 (en) * | 2016-12-05 | 2018-06-07 | Old Dominion University Research Foundation | Methods and devices for treatment of tumors with nano-pulse stimulation |
| CN110087572A (en) | 2016-12-19 | 2019-08-02 | 波士顿科学医学有限公司 | The electrod-array towards distal end with longitudinally mounted spline |
| US20180184982A1 (en) | 2017-01-05 | 2018-07-05 | Biosense Webster (Israel) Ltd. | Hybrid balloon basket catheter |
| US10912609B2 (en) | 2017-01-06 | 2021-02-09 | St. Jude Medical, Cardiology Division, Inc. | Pulmonary vein isolation balloon catheter |
| EP3612103B1 (en) | 2017-04-20 | 2022-02-09 | Medtronic, Inc. | Stabilization of a transseptal delivery device |
| US9987081B1 (en) | 2017-04-27 | 2018-06-05 | Iowa Approach, Inc. | Systems, devices, and methods for signal generation |
| US10617867B2 (en) | 2017-04-28 | 2020-04-14 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue |
| EP3634284A1 (en) | 2017-06-06 | 2020-04-15 | Cardiac Pacemakers, Inc. | Ablation delivery using a catheter having a semi-permeable inflatable balloon structure |
| US20180360534A1 (en) | 2017-06-19 | 2018-12-20 | St. Jude Medical, Cardiology Division, Inc. | Apparatuses and methods for high-density sensing and ablation during a medical procedure |
| CN111479497B (en) | 2017-12-19 | 2023-06-09 | 圣犹达医疗用品心脏病学部门有限公司 | Method for Assessing Contact Between Electrodes and Tissue Using Complex Impedance Measurements |
| EP3731772B1 (en) | 2017-12-26 | 2024-04-17 | Galvanize Therapeutics, Inc. | Systems for the treatment of disease states and disorders |
| US20190336198A1 (en) | 2018-05-03 | 2019-11-07 | Farapulse, Inc. | Systems, devices, and methods for ablation using surgical clamps |
| EP3790485B1 (en) | 2018-05-07 | 2024-06-26 | Boston Scientific Scimed, Inc. | Epicardial ablation catheter |
-
2018
- 2018-05-03 US US15/970,404 patent/US20190336198A1/en not_active Abandoned
-
2019
- 2019-04-24 JP JP2020561052A patent/JP7483628B2/en active Active
- 2019-04-24 CN CN202410595815.2A patent/CN118285903A/en active Pending
- 2019-04-24 CN CN201980031108.8A patent/CN112087979A/en active Pending
- 2019-04-24 WO PCT/US2019/028943 patent/WO2019212827A1/en not_active Ceased
- 2019-04-24 EP EP19734941.8A patent/EP3787541A1/en active Pending
-
2020
- 2020-11-02 US US17/087,433 patent/US12042208B2/en active Active
-
2024
- 2024-02-29 JP JP2024030025A patent/JP2024069277A/en active Pending
- 2024-06-25 US US18/753,828 patent/US20240341834A1/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030125729A1 (en) * | 2000-04-27 | 2003-07-03 | Hooven Michael D. | Transmural ablation device |
| US20050251130A1 (en) * | 2005-04-22 | 2005-11-10 | Boveja Birinder R | Method and system of stopping energy delivery of an ablation procedure with a computer based device for increasing safety of ablation procedures |
| US20080172048A1 (en) * | 2007-01-12 | 2008-07-17 | Keith Edward Martin | Ablation system, clamp and method of use |
| US20100274238A1 (en) * | 2009-04-22 | 2010-10-28 | Klimovitch Gleb V | Method and apparatus for radiofrequency ablation with increased depth and/or decreased volume of ablated tissue |
| US20120095459A1 (en) * | 2010-10-13 | 2012-04-19 | Peter Callas | System and Method for Electrically Ablating Tissue of a Patient |
| US20120310237A1 (en) * | 2011-05-31 | 2012-12-06 | Estech, Inc. (Endoscopic Technologies, Inc.) | High-voltage pulse ablation systems and methods |
| US20140052126A1 (en) * | 2012-08-15 | 2014-02-20 | Ethicon Endo-Surgery, Inc. | Electrosurgical devices and methods |
| US20140148804A1 (en) * | 2012-11-29 | 2014-05-29 | Zane R. Ward | Quadripolar forceps |
Cited By (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11426573B2 (en) | 2012-08-09 | 2022-08-30 | University Of Iowa Research Foundation | Catheters, catheter systems, and methods for puncturing through a tissue structure and ablating a tissue region |
| US11589919B2 (en) | 2014-01-06 | 2023-02-28 | Boston Scientific Scimed, Inc. | Apparatus and methods for renal denervation ablation |
| US12408979B2 (en) | 2014-05-07 | 2025-09-09 | Boston Scientific Scimed, Inc. | Methods and apparatus for selective tissue ablation |
| US12390272B2 (en) | 2014-05-07 | 2025-08-19 | Boston Scientific Scimed, Inc. | Methods and apparatus for selective tissue ablation |
| US11259869B2 (en) | 2014-05-07 | 2022-03-01 | Farapulse, Inc. | Methods and apparatus for selective tissue ablation |
| US12137968B2 (en) | 2014-05-16 | 2024-11-12 | Boston Scientific Scimed, Inc. | Methods and apparatus for multi-catheter tissue ablation |
| US10624693B2 (en) | 2014-06-12 | 2020-04-21 | Farapulse, Inc. | Method and apparatus for rapid and selective tissue ablation with cooling |
| US11622803B2 (en) | 2014-06-12 | 2023-04-11 | Boston Scientific Scimed, Inc. | Method and apparatus for rapid and selective tissue ablation with cooling |
| US12295648B2 (en) | 2014-10-14 | 2025-05-13 | Boston Scientific Scimed, Inc. | Method and apparatus for rapid and safe pulmonary vein cardiac ablation |
| US10835314B2 (en) | 2014-10-14 | 2020-11-17 | Farapulse, Inc. | Method and apparatus for rapid and safe pulmonary vein cardiac ablation |
| US10842561B2 (en) | 2016-01-05 | 2020-11-24 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
| US12144541B2 (en) | 2016-01-05 | 2024-11-19 | Boston Scientific Scimed, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
| US11020179B2 (en) | 2016-01-05 | 2021-06-01 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
| US11589921B2 (en) | 2016-01-05 | 2023-02-28 | Boston Scientific Scimed, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
| US10709891B2 (en) | 2016-01-05 | 2020-07-14 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
| US10660702B2 (en) | 2016-01-05 | 2020-05-26 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
| US10617467B2 (en) | 2017-07-06 | 2020-04-14 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
| US12150698B2 (en) | 2017-09-12 | 2024-11-26 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for ventricular focal ablation |
| US10893905B2 (en) | 2017-09-12 | 2021-01-19 | Farapulse, Inc. | Systems, apparatuses, and methods for ventricular focal ablation |
| US12295637B2 (en) | 2018-02-08 | 2025-05-13 | Boston Scientific Scimed, Inc. | Method and apparatus for controlled delivery of pulsed electric field ablative energy to tissue |
| US12042208B2 (en) | 2018-05-03 | 2024-07-23 | Boston Scientific Scimed, Inc. | Systems, devices, and methods for ablation using surgical clamps |
| US12274491B2 (en) | 2018-05-07 | 2025-04-15 | Boston Scientific Scimed, Inc. | Epicardial ablation catheter |
| US11033236B2 (en) | 2018-05-07 | 2021-06-15 | Farapulse, Inc. | Systems, apparatuses, and methods for filtering high voltage noise induced by pulsed electric field ablation |
| US10709502B2 (en) | 2018-05-07 | 2020-07-14 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
| US11020180B2 (en) | 2018-05-07 | 2021-06-01 | Farapulse, Inc. | Epicardial ablation catheter |
| US12257080B2 (en) | 2018-05-07 | 2025-03-25 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for filtering high voltage noise induced by pulsed electric field ablation |
| US11678928B2 (en) | 2019-01-10 | 2023-06-20 | Atricure, Inc. | Surgical clamp |
| US10625080B1 (en) | 2019-09-17 | 2020-04-21 | Farapulse, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
| US10688305B1 (en) | 2019-09-17 | 2020-06-23 | Farapulse, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
| US11738200B2 (en) | 2019-09-17 | 2023-08-29 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
| US11931094B2 (en) * | 2019-10-15 | 2024-03-19 | Boston Scientific Scimed, Inc. | Control system and user interface for an ablation system |
| US20210106374A1 (en) * | 2019-10-15 | 2021-04-15 | Boston Scientific Scimed, Inc. | Control system and user interface for an ablation system |
| US11684408B2 (en) | 2019-11-20 | 2023-06-27 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
| US11065047B2 (en) | 2019-11-20 | 2021-07-20 | Farapulse, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
| US11497541B2 (en) | 2019-11-20 | 2022-11-15 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
| US12349953B2 (en) | 2019-11-20 | 2025-07-08 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
| US11931090B2 (en) | 2019-11-20 | 2024-03-19 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
| US10842572B1 (en) | 2019-11-25 | 2020-11-24 | Farapulse, Inc. | Methods, systems, and apparatuses for tracking ablation devices and generating lesion lines |
| US12102374B2 (en) * | 2019-12-03 | 2024-10-01 | Biosense Webster (Israel) Ltd. | Pulse generator for irreversible electroporation with switchable pulse application |
| US20210228261A1 (en) * | 2019-12-03 | 2021-07-29 | Biosense Webster (Israel) Ltd. | Pulse generator for irreversible electroporation with switchable pulse application |
| CN114786600A (en) * | 2019-12-09 | 2022-07-22 | 伯恩森斯韦伯斯特(以色列)有限责任公司 | Directed irreversible electroporation (IRE) pulses to compensate for cell size and orientation |
| US20210169568A1 (en) * | 2019-12-09 | 2021-06-10 | Biosense Webster (Israel) Ltd. | Oriented irreversible-electroporation (ire) pulses to compensate for cell size and orientation |
| US12213727B2 (en) | 2020-05-14 | 2025-02-04 | Circa Scientific, Inc. | Method for single pass large bore transseptal crossing |
| US12016619B2 (en) | 2020-05-14 | 2024-06-25 | Circa Scientific, Inc. | Transseptal crossing system for single pass large bore access |
| US12426944B2 (en) | 2020-07-28 | 2025-09-30 | Biosense Webster (Israel) Ltd. | Automatically performing irreversible electroporation ablation during heart refractory period |
| US20220039855A1 (en) * | 2020-08-10 | 2022-02-10 | Gyrus Acmi, Inc. D/B/A Olympus Surgical Technologies America | Bipolar forceps with vessel seal testing |
| US12089871B2 (en) * | 2020-08-25 | 2024-09-17 | Cross Vascular, Inc. | Depth sensing dilator system |
| US20220061884A1 (en) * | 2020-08-25 | 2022-03-03 | Cross Vascular, Inc. | Depth sensing dilator system |
| US12349964B2 (en) | 2020-09-30 | 2025-07-08 | Boston Scientific Scimed, Inc. | Pretreatment waveform for irreversible electroporation |
| EP4018950A1 (en) * | 2020-12-22 | 2022-06-29 | Biosense Webster (Israel) Ltd | Improving lesion uniformity in bipolar cardiac ablation |
| US12496128B2 (en) | 2024-05-24 | 2025-12-16 | Boston Scientific Scimed, Inc. | Methods and apparatus for selective tissue ablation |
| CN120227138A (en) * | 2025-04-01 | 2025-07-01 | 苏州赛纳思医疗技术有限公司 | Pulse ablation system and control method of pulse ablation system |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024069277A (en) | 2024-05-21 |
| US12042208B2 (en) | 2024-07-23 |
| CN118285903A (en) | 2024-07-05 |
| CN112087979A (en) | 2020-12-15 |
| JP2021522893A (en) | 2021-09-02 |
| US20240341834A1 (en) | 2024-10-17 |
| EP3787541A1 (en) | 2021-03-10 |
| US20210045798A1 (en) | 2021-02-18 |
| WO2019212827A1 (en) | 2019-11-07 |
| JP7483628B2 (en) | 2024-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240341834A1 (en) | Systems, devices, and methods for ablation using surgical clamps | |
| US12121720B2 (en) | Systems, devices, and methods for signal generation | |
| US20250261985A1 (en) | Method and apparatus for controlled delivery of pulsed electric field ablative energy to tissue | |
| US12274491B2 (en) | Epicardial ablation catheter |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: IOWA APPROACH, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VISWANATHAN, RAJU;REEL/FRAME:045956/0988 Effective date: 20180516 Owner name: IOWA APPROACH, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GLL, LLC;LONG, GARY L.;REEL/FRAME:045957/0022 Effective date: 20180516 |
|
| AS | Assignment |
Owner name: FARAPULSE, INC., CALIFORNIA Free format text: CHANGE OF NAME;ASSIGNOR:IOWA APPROACH, INC.;REEL/FRAME:046943/0184 Effective date: 20180531 |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
| AS | Assignment |
Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:FARAPULSE, INC.;REEL/FRAME:060802/0286 Effective date: 20210806 Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNOR'S INTEREST;ASSIGNOR:FARAPULSE, INC.;REEL/FRAME:060802/0286 Effective date: 20210806 |